Browse by Title

Type here to filter the list

#
1: Are Nodal ITCs After Neoadjuvant Chemotherapy An Indication For Axillary Dissection? The OPBC-05/EUBREAST-14R/ICARO study

Giacomo Montagna, MD, MPH – Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA ### 970036###Abstract Presenter###Assistant Attending###Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA###
Abstract Presenter: Giacomo Montagna, MD, MPH – Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
### @@@ Giacomo Montagna, MD, MPH – Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA ### 970036###Submitter###Assistant Attending###Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA###
Submitter: Giacomo Montagna, MD, MPH – Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
### @@@ Alison Laws, MD, MPH – Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA, USA ### 970205###Author###Assistant Professor###Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA, USA###
Author: Alison Laws, MD, MPH – Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA, USA
### @@@ Jessica M. Pastoriza, MD – Department of Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA ### 2211793###Author###Assistant Professor, Division of Breast Surgery###Department of Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA###
Author: Jessica M. Pastoriza, MD – Department of Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA
### @@@ Marie-Jeanne Vrancken Peeters, MD, PhD – Stichting HET Netherlands Kanker Instituut-Antoni van Leeuwenhoek, Amsterdam, Netherlands ### 2211895###Author###Department of Surgery###Stichting HET Netherlands Kanker Instituut-Antoni van Leeuwenhoek, Amsterdam, Netherlands###
Author: Marie-Jeanne Vrancken Peeters, MD, PhD – Stichting HET Netherlands Kanker Instituut-Antoni van Leeuwenhoek, Amsterdam, Netherlands
### @@@ Massimo Ferrucci, MD, PhD – Padua Italy ### 2211889###Author###Veneto Institute of Oncology###Padua Italy###
Author: Massimo Ferrucci, MD, PhD – Padua Italy
### @@@ Mary M. Mrdutt, MD, MS – Division of Breast and Melanoma Surgical Oncology, Department of Surgery, Mayo Clinic, Rochester, MN, USA ### 1851516###Author###Assistant Professor of Surgery###Division of Breast and Melanoma Surgical Oncology, Department of Surgery, Mayo Clinic, Rochester, MN, USA###
Author: Mary M. Mrdutt, MD, MS – Division of Breast and Melanoma Surgical Oncology, Department of Surgery, Mayo Clinic, Rochester, MN, USA
### @@@ Güldeniz Karadeniz Cakmak, MD, FEBS – Zonguldak Bulent Ecevit University, School of Medicine, Department of General Surgery, Zonguldak, Turkey ### 2211890###Author###Professor, Head of General Surgery Department###Zonguldak Bulent Ecevit University, School of Medicine, Department of General Surgery, Zonguldak, Turkey###
Author: Güldeniz Karadeniz Cakmak, MD, FEBS – Zonguldak Bulent Ecevit University, School of Medicine, Department of General Surgery, Zonguldak, Turkey
### @@@ Hakan Balbaloglu, MD – Zonguldak Bulent Ecevit University, School of Medicine, Department of General Surgery, Zonguldak, Turkey ### 2211891###Author###Assistant Professor###Zonguldak Bulent Ecevit University, School of Medicine, Department of General Surgery, Zonguldak, Turkey###
Author: Hakan Balbaloglu, MD – Zonguldak Bulent Ecevit University, School of Medicine, Department of General Surgery, Zonguldak, Turkey
### @@@ Nuran Bese, MD – Research Institute of Senology Acibadem, Istanbul, Turkey ### 2211893###Author###Department of Clinical Senology###Research Institute of Senology Acibadem, Istanbul, Turkey###
Author: Nuran Bese, MD – Research Institute of Senology Acibadem, Istanbul, Turkey
### @@@ Neslihan Cabioğlu, MD – Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey ### 2211894###Author###Professor###Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey###
Author: Neslihan Cabioğlu, MD – Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
### @@@ Claire M. M. Eden, MD – New York Presbyterian, Weill Cornell Medicine, New York, NY, USA ### 1849835###Author###Department of Surgery###New York Presbyterian, Weill Cornell Medicine, New York, NY, USA###
Author: Claire M. M. Eden, MD – New York Presbyterian, Weill Cornell Medicine, New York, NY, USA
### @@@ Callie Hlavin, MD, MPH – University of Pittsburgh Medical Center, Pittsburgh, PA, USA ### 2211898###Author###Department of Surgery###University of Pittsburgh Medical Center, Pittsburgh, PA, USA###
Author: Callie Hlavin, MD, MPH – University of Pittsburgh Medical Center, Pittsburgh, PA, USA
### @@@ Susan B. B. Kesmodel, MD, FACS – Department of Surgery, Division of Surgical Oncology, University of Miami Miller School of Medicine, Miami, Florida, USA ### 1214731###Author###Professor of Surgery###Department of Surgery, Division of Surgical Oncology, University of Miami Miller School of Medicine, Miami, Florida, USA###
Author: Susan B. B. Kesmodel, MD, FACS – Department of Surgery, Division of Surgical Oncology, University of Miami Miller School of Medicine, Miami, Florida, USA
### @@@ Tehillah S. Menes, MD – Sheba Medical Center, Tel Hashomer, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel ### 2211892###Author###Department of Surgery###Sheba Medical Center, Tel Hashomer, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel###
Author: Tehillah S. Menes, MD – Sheba Medical Center, Tel Hashomer, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
### @@@ Susie X. Sun, MD – Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA ### 1850566###Author###Assistant Professor###Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA###
Author: Susie X. Sun, MD – Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
### @@@ Ekaterini Christina Tampaki, MD, PhD – KAT Athens General Hospital, Department of Plastic, Reconstructive Surgery & Burn Unit, Athens, Greece; National Organization for the Provision of Healthcare Services, Hellenic National Contact Point, Department of Planning and Monitoring of Medicines Dispensing, Medicines Division, Athens, Greece ### 2211896###Author###National Coordinator for Greece###KAT Athens General Hospital, Department of Plastic, Reconstructive Surgery & Burn Unit, Athens, Greece; National Organization for the Provision of Healthcare Services, Hellenic National Contact Point, Department of Planning and Monitoring of Medicines Dispensing, Medicines Division, Athens, Greece###
Author: Ekaterini Christina Tampaki, MD, PhD – KAT Athens General Hospital, Department of Plastic, Reconstructive Surgery & Burn Unit, Athens, Greece; National Organization for the Provision of Healthcare Services, Hellenic National Contact Point, Department of Planning and Monitoring of Medicines Dispensing, Medicines Division, Athens, Greece
### @@@ Stephanie M. M. Wong, MD, MPH – Department of Surgery, McGill University Medical School, Montreal, QC, Canada; Sir Mortimer B. Davis Jewish General Hospital, QC, Montreal, Canada ### 970043###Author###Assistant Professor###Department of Surgery, McGill University Medical School, Montreal, QC, Canada; Sir Mortimer B. Davis Jewish General Hospital, QC, Montreal, Canada###
Author: Stephanie M. M. Wong, MD, MPH – Department of Surgery, McGill University Medical School, Montreal, QC, Canada; Sir Mortimer B. Davis Jewish General Hospital, QC, Montreal, Canada
### @@@ Jennifer Q. Q. Zhang, MD – Division of Breast Surgery, Department of Surgery, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, USA ### 1849791###Author###Assistant Professor###Division of Breast Surgery, Department of Surgery, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, USA###
Author: Jennifer Q. Q. Zhang, MD – Division of Breast Surgery, Department of Surgery, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, USA
### @@@ Monica Morrow, MD – Memorial Sloan Kettering Cancer Center ### 937326###Author###Breast Service, Department of Surgery###Memorial Sloan Kettering Cancer Center###
Author: Monica Morrow, MD – Memorial Sloan Kettering Cancer Center
### @@@ Walter P. P. Weber, MD (he/him/his) – Breast Center, University Hospital Basel, Basel, Switzerland; University of Basel, Basel, Switzerland ### 1850364###Author###Head of the Division of Breast Surgery###Breast Center, University Hospital Basel, Basel, Switzerland; University of Basel, Basel, Switzerland###
Author: Walter P. P. Weber, MD (he/him/his) – Breast Center, University Hospital Basel, Basel, Switzerland; University of Basel, Basel, Switzerland
### he/him/his
10: Potential Overtreatment of DCIS in Patients with Limited Life Expectancy

Eliza Hersh Lorentzen, MD – Brigham and Women's Hospital ### 2211799###Abstract Presenter###Surgical Resident###Brigham and Women's Hospital###
Abstract Presenter: Eliza Hersh Lorentzen, MD – Brigham and Women's Hospital
### @@@ Eliza Hersh Lorentzen, MD – Brigham and Women's Hospital ### 2211799###Submitter###Surgical Resident###Brigham and Women's Hospital###
Submitter: Eliza Hersh Lorentzen, MD – Brigham and Women's Hospital
### @@@ Eliza Hersh Lorentzen, MD – Brigham and Women's Hospital ### 2211799###Author###Surgical Resident###Brigham and Women's Hospital###
Author: Eliza Hersh Lorentzen, MD – Brigham and Women's Hospital
### @@@ Yu-Jen Chen, MPH – Center for Surgery and Public Health, Brigham and Women's Hospital ### 2211798###Author###Analyst###Center for Surgery and Public Health, Brigham and Women's Hospital###
Author: Yu-Jen Chen, MPH – Center for Surgery and Public Health, Brigham and Women's Hospital
### @@@ Tari A. King, MD (she/her/hers) – Brigham and Women's Hospital, Dana-Farber Cancer Institute ### 1791617###Author###Chief, Division of Breast Surgery###Brigham and Women's Hospital, Dana-Farber Cancer Institute###
Author: Tari A. King, MD (she/her/hers) – Brigham and Women's Hospital, Dana-Farber Cancer Institute
### she/her/hers @@@ Elizabeth A. Mittendorf, MD, PhD, MHCM (she/her/hers) – Brigham and Women's Hospital, Dana Farber Cancer Institute ### 1530213###Author###Professor of Surgery###Brigham and Women's Hospital, Dana Farber Cancer Institute###
Author: Elizabeth A. Mittendorf, MD, PhD, MHCM (she/her/hers) – Brigham and Women's Hospital, Dana Farber Cancer Institute
### she/her/hers @@@ Christina A. Minami, MD, MS (she/her/hers) – Brigham and Women's Hospital, Dana-Farber Cancer Institute ### 2204609###Author###Associate Surgeon###Brigham and Women's Hospital, Dana-Farber Cancer Institute###
Author: Christina A. Minami, MD, MS (she/her/hers) – Brigham and Women's Hospital, Dana-Farber Cancer Institute
### she/her/hers
11: A Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein 2 Inhibits TNBC Lung Metastases

Lillian Hsu, MD (she/her/hers) – MUSC ### 1852605###Abstract Presenter###Resident Physician###MUSC###
Abstract Presenter: Lillian Hsu, MD (she/her/hers) – MUSC
### she/her/hers @@@ Lillian Hsu, MD (she/her/hers) – MUSC ### 1852605###Submitter###Resident Physician###MUSC###
Submitter: Lillian Hsu, MD (she/her/hers) – MUSC
### she/her/hers @@@ Lillian Hsu, MD (she/her/hers) – MUSC ### 1852605###Author###Resident Physician###MUSC###
Author: Lillian Hsu, MD (she/her/hers) – MUSC
### she/her/hers @@@ Patrick Nasarre, PhD – MUSC ### 1851750###Author###Assistant Professor###MUSC###
Author: Patrick Nasarre, PhD – MUSC
### @@@ Julie B. Siegel, MD (she/her/hers) – MUSC ### 1851748###Author###General Surgery Resident###MUSC###
Author: Julie B. Siegel, MD (she/her/hers) – MUSC
### she/her/hers @@@ Eleanor Hilliard, BS – MUSC ### 1851754###Author###Research Assistant###MUSC###
Author: Eleanor Hilliard, BS – MUSC
### @@@ Rupak Mukherjee, PhD – MUSC ### 1851760###Author###Assistant Professor###MUSC###
Author: Rupak Mukherjee, PhD – MUSC
### @@@ Nancy Klauber DeMore, MD – MUSC ### 969493###Author###Professor of Surgery###MUSC###
Author: Nancy Klauber DeMore, MD – MUSC
###
12: Clinical outcomes in BRCA mutation carriers treated with breast conserving therapy

Kerollos N. Wanis, MD, PhD – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA ### 2211960###Abstract Presenter###Fellow###Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA###
Abstract Presenter: Kerollos N. Wanis, MD, PhD – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA
### @@@ Kerollos N. Wanis, MD, PhD – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA ### 2211960###Submitter###Fellow###Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA###
Submitter: Kerollos N. Wanis, MD, PhD – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA
### @@@ Kerollos N. Wanis, MD, PhD – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA ### 2211960###Author###Fellow###Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA###
Author: Kerollos N. Wanis, MD, PhD – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA
### @@@ Henry M. Kuerer, MD, PhD – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA ### 937372###Author###Professor###Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA###
Author: Henry M. Kuerer, MD, PhD – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA
### @@@ Susie X. Sun, MD – Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA ### 1850566###Author###Assistant Professor###Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA###
Author: Susie X. Sun, MD – Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
### @@@ Kelly K. Hunt, MD (she/her/hers) – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA ### 937327###Author###Professor & Chair###Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA###
Author: Kelly K. Hunt, MD (she/her/hers) – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA
### she/her/hers @@@ Alexa C. Glencer, MD – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA ### 2211966###Author###Fellow###Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA###
Author: Alexa C. Glencer, MD – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA
### @@@ Mediget Teshome, MD (she/her/hers) – UCLA ### 894417###Author###Associate Professor###UCLA###
Author: Mediget Teshome, MD (she/her/hers) – UCLA
### she/her/hers @@@ Anthony Lucci, Jr., MD – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA ### 937367###Author###Professor###Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA###
Author: Anthony Lucci, Jr., MD – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA
### @@@ Roi Weiser, MD – Department of Surgical Oncology, MD Anderson Cancer Center ### 2211971###Author###Assistant Professor###Department of Surgical Oncology, MD Anderson Cancer Center###
Author: Roi Weiser, MD – Department of Surgical Oncology, MD Anderson Cancer Center
### @@@ Helen M. Johnson, MD (she/her/hers) – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA ### 1850446###Author###Assistant Professor###Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA###
Author: Helen M. Johnson, MD (she/her/hers) – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA
### she/her/hers @@@ Benjamin D. Smith, MD – Department of Breast Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA ### 944428###Author###Professor###Department of Breast Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA###
Author: Benjamin D. Smith, MD – Department of Breast Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA
### @@@ Angelica M. Gutierrez, MS – Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA ### 2211972###Author###Laboratory Coordinator###Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA###
Author: Angelica M. Gutierrez, MS – Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA
### @@@ Simona F. Shaitelman, MD, EdM – Department of Breast Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA ### 1850450###Author###Professor###Department of Breast Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA###
Author: Simona F. Shaitelman, MD, EdM – Department of Breast Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA
### @@@ Banu K. Arun, MD – Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA ### 2211974###Author###Professor###Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA###
Author: Banu K. Arun, MD – Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA
###
13: Predictors of Nodal Clearance After Neoadjuvant Chemotherapy in Breast Cancer

Selena J. An, MD, MSPH, MA – University of North Carolina ### 1852485###Abstract Presenter###General Surgery Resident###University of North Carolina###
Abstract Presenter: Selena J. An, MD, MSPH, MA – University of North Carolina
### @@@ Selena J. An, MD, MSPH, MA – University of North Carolina ### 1852485###Submitter###General Surgery Resident###University of North Carolina###
Submitter: Selena J. An, MD, MSPH, MA – University of North Carolina
### @@@ Selena J. An, MD, MSPH, MA – University of North Carolina ### 1852485###Author###General Surgery Resident###University of North Carolina###
Author: Selena J. An, MD, MSPH, MA – University of North Carolina
### @@@ Christine Hong Ngoc Che Thai, BS – University of North Carolina ### 2212136###Author###Medical Student###University of North Carolina###
Author: Christine Hong Ngoc Che Thai, BS – University of North Carolina
### @@@ Conner Haase, MD – University of North Carolina ### 2212147###Author###General Surgery Resident###University of North Carolina###
Author: Conner Haase, MD – University of North Carolina
### @@@ Julia M. Selfridge, MD – University of North Carolina ### 2212149###Author###Assistant Professor of Surgical Oncology###University of North Carolina###
Author: Julia M. Selfridge, MD – University of North Carolina
### @@@ Chris Agala, PhD – UNC Hospital ### 2212036###Author###Professor###UNC Hospital###
Author: Chris Agala, PhD – UNC Hospital
### @@@ Kristalyn K. Gallagher, DO (she/her/hers) – UNC School of Medicine ### 1144296###Author###Surgical Director of the Breast Care Program###UNC School of Medicine###
Author: Kristalyn K. Gallagher, DO (she/her/hers) – UNC School of Medicine
### she/her/hers @@@ Philip Spanheimer, MD (he/him/his) – University of North Carolina ### 1851640###Author###Attending###University of North Carolina###
Author: Philip Spanheimer, MD (he/him/his) – University of North Carolina
### he/him/his
14: Three-dimensional navigated mass spectrometry for intraoperative margin assessment during breast cancer surgery

Shaila J. Merchant, MD – Queen's University ### 2211797###Abstract Presenter###Associate Professor / Surgeon###Queen's University###
Abstract Presenter: Shaila J. Merchant, MD – Queen's University
### @@@ Martin Kaufmann, PHD – Queen's University ### 2211957###Author###Research Associate###Queen's University###
Author: Martin Kaufmann, PHD – Queen's University
### @@@ Amoon Jamzad, PhD – Queen's University ### 2211958###Author###Post-doctoral Fellow###Queen's University###
Author: Amoon Jamzad, PhD – Queen's University
### @@@ Tamas Ungi, MD, PhD – Queen's University ### 2211959###Author###Adjunct Assistant Professor###Queen's University###
Author: Tamas Ungi, MD, PhD – Queen's University
### @@@ Jessica Rodgers, PhD – University of Manitoba ### 2211961###Author###Assistant Professor###University of Manitoba###
Author: Jessica Rodgers, PhD – University of Manitoba
### @@@ Teaghan Koster, MD – Queen's University ### 2211962###Author###Resident###Queen's University###
Author: Teaghan Koster, MD – Queen's University
### @@@ Yeung Chris, BSc – Queen's University ### 2211963###Author###Graduate Student###Queen's University###
Author: Yeung Chris, BSc – Queen's University
### @@@ Natasja Janssen, PhD – Queen's University ### 2211964###Author###Post-doctoral Fellow###Queen's University###
Author: Natasja Janssen, PhD – Queen's University
### @@@ Julie McMullen, MSc – Queen's University ### 2211965###Author###Pathologist's Assistant###Queen's University###
Author: Julie McMullen, MSc – Queen's University
### @@@ Kathryn Solberg, MSc – Queen's University ### 2211967###Author###Pathologist's Assistant###Queen's University###
Author: Kathryn Solberg, MSc – Queen's University
### @@@ Joanna Cheesman, MSc – Queen's University ### 2211968###Author###Pathologist's Assistant###Queen's University###
Author: Joanna Cheesman, MSc – Queen's University
### @@@ Kevin Yi Mi Ren, MD – Queen's University ### 2211969###Author###Assistant Professor / Pathologist###Queen's University###
Author: Kevin Yi Mi Ren, MD – Queen's University
### @@@ Sonal Varma, MD – Queen's University ### 2211970###Author###Associate Professor / Pathologist###Queen's University###
Author: Sonal Varma, MD – Queen's University
### @@@ Shaila J. Merchant, MD – Queen's University ### 2211797###Author###Associate Professor / Surgeon###Queen's University###
Author: Shaila J. Merchant, MD – Queen's University
### @@@ Cecil Jay Engel, MD – Queen's University ### 2211973###Author###Associate Professor / Surgeon###Queen's University###
Author: Cecil Jay Engel, MD – Queen's University
### @@@ G Ross Walker, MD – Queen's University ### 2211975###Author###Associate Professor / Surgeon###Queen's University###
Author: G Ross Walker, MD – Queen's University
### @@@ Andrea Gallo, MD – Queen's University ### 2211976###Author###Assistant Professor / Radiologist###Queen's University###
Author: Andrea Gallo, MD – Queen's University
### @@@ Doris Jabs, MD – Queen's University ### 2211977###Author###Assistant Professor / Radiologist###Queen's University###
Author: Doris Jabs, MD – Queen's University
### @@@ Parvin Mousavi, PhD – Queen's University ### 2211978###Author###Professor###Queen's University###
Author: Parvin Mousavi, PhD – Queen's University
### @@@ Gabor Fichtinger, PhD – Queen's University ### 2211979###Author###Professor###Queen's University###
Author: Gabor Fichtinger, PhD – Queen's University
### @@@ John Rudan, MD – Queen's University ### 2211980###Author###Professor / Surgeon###Queen's University###
Author: John Rudan, MD – Queen's University
###
15: Impact of Race on Pathologic Complete Response with Neoadjuvant Chemo-Immunotherapy and Chemotherapy Alone for Early-Stage Triple-Negative Breast Cancer

Natalia Polidorio, MD, PhD – Memorial Sloan Kettering Cancer Center ### 2212102###Abstract Presenter###Breast Service, Department of Surgery###Memorial Sloan Kettering Cancer Center###
Abstract Presenter: Natalia Polidorio, MD, PhD – Memorial Sloan Kettering Cancer Center
### @@@ Natalia Polidorio, MD, PhD – Memorial Sloan Kettering Cancer Center ### 2212102###Submitter###Breast Service, Department of Surgery###Memorial Sloan Kettering Cancer Center###
Submitter: Natalia Polidorio, MD, PhD – Memorial Sloan Kettering Cancer Center
### @@@ Natalia Polidorio, MD, PhD – Memorial Sloan Kettering Cancer Center ### 2212102###Author###Breast Service, Department of Surgery###Memorial Sloan Kettering Cancer Center###
Author: Natalia Polidorio, MD, PhD – Memorial Sloan Kettering Cancer Center
### @@@ Lauren M. Perry, MD, MAS – Memorial Sloan Kettering Cancer Center ### 2212108###Author###Breast Service, Department of Surgery###Memorial Sloan Kettering Cancer Center###
Author: Lauren M. Perry, MD, MAS – Memorial Sloan Kettering Cancer Center
### @@@ Varadan Sevilimedu, DrPH – Memorial Sloan Kettering Cancer Center ### 1849767###Author###Biostatistics Service, Department of Epidemiology and Biostatistics###Memorial Sloan Kettering Cancer Center###
Author: Varadan Sevilimedu, DrPH – Memorial Sloan Kettering Cancer Center
### @@@ Giacomo Montagna, MD, MPH – Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA ### 970036###Author###Assistant Attending###Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA###
Author: Giacomo Montagna, MD, MPH – Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
### @@@ Nour Abuhadra, MD – Memorial Sloan Kettering Cancer Center ### 2212109###Author###Breast Medicine Service, Division of Solid Tumor Oncology###Memorial Sloan Kettering Cancer Center###
Author: Nour Abuhadra, MD – Memorial Sloan Kettering Cancer Center
### @@@ Monica Morrow, MD – Memorial Sloan Kettering Cancer Center ### 937326###Author###Breast Service, Department of Surgery###Memorial Sloan Kettering Cancer Center###
Author: Monica Morrow, MD – Memorial Sloan Kettering Cancer Center
### @@@ Stephanie Downs-Canner, MD – Memorial Sloan Kettering Cancer Center ### 2211828###Author###Breast Service, Department of Surgery###Memorial Sloan Kettering Cancer Center###
Author: Stephanie Downs-Canner, MD – Memorial Sloan Kettering Cancer Center
### @@@ George Plitas, MD – Memorial Sloan Kettering Cancer Center ### 1593048###Author###Breast Service, Department of Surgery###Memorial Sloan Kettering Cancer Center###
Author: George Plitas, MD – Memorial Sloan Kettering Cancer Center
###
16: The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or Ductal Carcinoma in Situ in Patients Diagnosed with Flat Epithelial Atypia by Core Needle Biopsy (TBCRC 034)

Faina Nakhlis, MD – Brigham and Women's Hospital, Dana-Farber Cancer Institute ### 2211874###Abstract Presenter###Breast Surgeon###Brigham and Women's Hospital, Dana-Farber Cancer Institute###
Abstract Presenter: Faina Nakhlis, MD – Brigham and Women's Hospital, Dana-Farber Cancer Institute
### @@@ Faina Nakhlis, MD – Brigham and Women's Hospital, Dana-Farber Cancer Institute ### 2211874###Submitter###Breast Surgeon###Brigham and Women's Hospital, Dana-Farber Cancer Institute###
Submitter: Faina Nakhlis, MD – Brigham and Women's Hospital, Dana-Farber Cancer Institute
### @@@ Faina Nakhlis, MD – Brigham and Women's Hospital, Dana-Farber Cancer Institute ### 2211874###Author###Breast Surgeon###Brigham and Women's Hospital, Dana-Farber Cancer Institute###
Author: Faina Nakhlis, MD – Brigham and Women's Hospital, Dana-Farber Cancer Institute
### @@@ Gabrielle Baker, MD – Beth Israel Deaconess Medical Center ### 2211899###Author###Breast Pathologist###Beth Israel Deaconess Medical Center###
Author: Gabrielle Baker, MD – Beth Israel Deaconess Medical Center
### @@@ Tianyu Li, MS – Dana-Farber Cancer Institute ### 2211900###Author###Biostatistician###Dana-Farber Cancer Institute###
Author: Tianyu Li, MS – Dana-Farber Cancer Institute
### @@@ Rebecca Gelman, PhD – Dana-Farber Cancer Institute ### 2211901###Author###Biostatistician###Dana-Farber Cancer Institute###
Author: Rebecca Gelman, PhD – Dana-Farber Cancer Institute
### @@@ George Plitas, MD – Memorial Sloan Kettering Cancer Center ### 1593048###Author###Breast Service, Department of Surgery###Memorial Sloan Kettering Cancer Center###
Author: George Plitas, MD – Memorial Sloan Kettering Cancer Center
### @@@ Kandice K. Ludwig, MD – Indiana University ### 2211902###Author###Associate Clinical Professor of Surgery###Indiana University###
Author: Kandice K. Ludwig, MD – Indiana University
### @@@ Priscilla McAuliffe, MD – UPMC Hillman Cancer Center ### 1851496###Author###Breast Surgical Oncologist###UPMC Hillman Cancer Center###
Author: Priscilla McAuliffe, MD – UPMC Hillman Cancer Center
### @@@ Marc Boisvert, MD – MedStar Washington Hospital Center, Georgetown University ### 2211903###Author###Site director of the MedStar Breast Health Program###MedStar Washington Hospital Center, Georgetown University###
Author: Marc Boisvert, MD – MedStar Washington Hospital Center, Georgetown University
### @@@ E. Shelley Hwang, MD, MPH – Duke University School of Medicine ### 937373###Author###Mary and Deryl Hart Distinguished Professor of Surgery###Duke University School of Medicine###
Author: E. Shelley Hwang, MD, MPH – Duke University School of Medicine
### @@@ Kristalyn K. Gallagher, DO (she/her/hers) – UNC School of Medicine ### 1144296###Author###Surgical Director of the Breast Care Program###UNC School of Medicine###
Author: Kristalyn K. Gallagher, DO (she/her/hers) – UNC School of Medicine
### she/her/hers @@@ Lisa Jacobs, MD – Johns Hopkins Medicine ### 937472###Author###Division Chief, Breast Cancer Surgery###Johns Hopkins Medicine###
Author: Lisa Jacobs, MD – Johns Hopkins Medicine
### @@@ Suniti Nimbkar, MD – South Shore Hospital in clinical affiliation with Dana-Farber Brigham Cancer Center ### 2211876###Author###Medical Director, Breast Care Center###South Shore Hospital in clinical affiliation with Dana-Farber Brigham Cancer Center###
Author: Suniti Nimbkar, MD – South Shore Hospital in clinical affiliation with Dana-Farber Brigham Cancer Center
### @@@ Sheldon Feldman, MD – Montefiore Medical Center ### 2211792###Author###Chief, Division of Breast Surgery & Breast Surgical Oncology###Montefiore Medical Center###
Author: Sheldon Feldman, MD – Montefiore Medical Center
### @@@ Paulina Lange, BS – Dana-Farber Cancer Institute ### 2211904###Author###-###Dana-Farber Cancer Institute###
Author: Paulina Lange, BS – Dana-Farber Cancer Institute
### @@@ Victoria Attaya, BS – Dana-Farber Cancer Institute ### 2211905###Author###-###Dana-Farber Cancer Institute###
Author: Victoria Attaya, BS – Dana-Farber Cancer Institute
### @@@ Michelle DeMeo, BS – Dana-Farber Cancer Institute ### 2211906###Author###-###Dana-Farber Cancer Institute###
Author: Michelle DeMeo, BS – Dana-Farber Cancer Institute
### @@@ Ashton Fraettarelli, BA – Dana-Farber Cancer Institute ### 2211907###Author###-###Dana-Farber Cancer Institute###
Author: Ashton Fraettarelli, BA – Dana-Farber Cancer Institute
### @@@ Stuart Schnitt, MD – Brigham and Women's Hospital, Dana-Farber Cancer Institute ### 2211875###Author###Chief of Breast Oncologic Pathology###Brigham and Women's Hospital, Dana-Farber Cancer Institute###
Author: Stuart Schnitt, MD – Brigham and Women's Hospital, Dana-Farber Cancer Institute
### @@@ Tari A. King, MD (she/her/hers) – Brigham and Women's Hospital, Dana-Farber Cancer Institute ### 1791617###Author###Chief, Division of Breast Surgery###Brigham and Women's Hospital, Dana-Farber Cancer Institute###
Author: Tari A. King, MD (she/her/hers) – Brigham and Women's Hospital, Dana-Farber Cancer Institute
### she/her/hers
17: Omission of Routine Frozen Section Among Clinically Node-Negative Patients Having Upfront Mastectomy Avoids Unnecessary Axillary Treatment

Rachel Sargent, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center ### 2211780###Abstract Presenter###Breast Surgical Oncology Fellow###Memorial Sloan Kettering Cancer Center###
Abstract Presenter: Rachel Sargent, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center
### she/her/hers @@@ Rachel Sargent, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center ### 2211780###Author###Breast Surgical Oncology Fellow###Memorial Sloan Kettering Cancer Center###
Author: Rachel Sargent, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center
### she/her/hers @@@ Varadan Sevilimedu, DrPH – Memorial Sloan Kettering Cancer Center ### 1849767###Author###Biostatistics Service, Department of Epidemiology and Biostatistics###Memorial Sloan Kettering Cancer Center###
Author: Varadan Sevilimedu, DrPH – Memorial Sloan Kettering Cancer Center
### @@@ Andrea V. Barrio, MD – Memorial Sloan Kettering Cancer Center ### 1502383###Author###Associate Attending/Dept. of Surgery/Breast Service###Memorial Sloan Kettering Cancer Center###
Author: Andrea V. Barrio, MD – Memorial Sloan Kettering Cancer Center
### @@@ Monica Morrow, MD – Memorial Sloan Kettering Cancer Center ### 937326###Author###Breast Service, Department of Surgery###Memorial Sloan Kettering Cancer Center###
Author: Monica Morrow, MD – Memorial Sloan Kettering Cancer Center
### @@@ Anita Mamtani, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center ### 969491###Submitter###Breast Service, Department of Surgery###Memorial Sloan Kettering Cancer Center###
Submitter: Anita Mamtani, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center
### she/her/hers @@@ Anita Mamtani, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center ### 969491###Author###Breast Service, Department of Surgery###Memorial Sloan Kettering Cancer Center###
Author: Anita Mamtani, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center
### she/her/hers
18: SLNB in low-risk breast cancer in patients ≥70 years: practice patterns and trends in a national cohort

Gabriella N. Tortorello, MD – Hospital of the University of Pennsylvania ### 1851157###Abstract Presenter###Resident###Hospital of the University of Pennsylvania###
Abstract Presenter: Gabriella N. Tortorello, MD – Hospital of the University of Pennsylvania
### @@@ Gabriella N. Tortorello, MD – Hospital of the University of Pennsylvania ### 1851157###Submitter###Resident###Hospital of the University of Pennsylvania###
Submitter: Gabriella N. Tortorello, MD – Hospital of the University of Pennsylvania
### @@@ Gabriella N. Tortorello, MD – Hospital of the University of Pennsylvania ### 1851157###Author###Resident###Hospital of the University of Pennsylvania###
Author: Gabriella N. Tortorello, MD – Hospital of the University of Pennsylvania
### @@@ Neha Shafique, MD – Hospital of the University of Pennsylvania ### 2212156###Author###Resident###Hospital of the University of Pennsylvania###
Author: Neha Shafique, MD – Hospital of the University of Pennsylvania
### @@@ Anushka Dheer – Hospital of the University of Pennsylvania ### 2212155###Author###Research Fellow###Hospital of the University of Pennsylvania###
Author: Anushka Dheer – Hospital of the University of Pennsylvania
### @@@ Julia Tchou, MD PhD – University of Pennsylvania ### 1530212###Author###Professor of Clinical Surgery###University of Pennsylvania###
Author: Julia Tchou, MD PhD – University of Pennsylvania
### @@@ Oluwadamilola M. Fayanju, MD, MA, MPHS, FACS (she/her/hers) – University of Pennsylvania ### 1850160###Author###The Helen O. Dickens Presidential Associate Professor & Chief, Division of Breast Surgery###University of Pennsylvania###
Author: Oluwadamilola M. Fayanju, MD, MA, MPHS, FACS (she/her/hers) – University of Pennsylvania
### she/her/hers @@@ John Miura, MD – Hospital of the University of Pennsylvania ### 1502397###Author###Surgical oncologist###Hospital of the University of Pennsylvania###
Author: John Miura, MD – Hospital of the University of Pennsylvania
### @@@ Giorgos Karakousis, MD – Hospital of the University of Pennsylvania ### 915770###Author###Professor of Surgery###Hospital of the University of Pennsylvania###
Author: Giorgos Karakousis, MD – Hospital of the University of Pennsylvania
###
19: Trends in Patient-Reported Outcomes after Breast-Conserving Surgery and Partial Breast vs Whole Breast Irradiation

Julia M. Chandler, MD, MS (she/her/hers) – Memorial Sloan Kettering Cancer Center ### 2212183###Abstract Presenter###Breast Service, Department of Surgery###Memorial Sloan Kettering Cancer Center###
Abstract Presenter: Julia M. Chandler, MD, MS (she/her/hers) – Memorial Sloan Kettering Cancer Center
### she/her/hers @@@ Julia M. Chandler, MD, MS (she/her/hers) – Memorial Sloan Kettering Cancer Center ### 2212183###Author###Breast Service, Department of Surgery###Memorial Sloan Kettering Cancer Center###
Author: Julia M. Chandler, MD, MS (she/her/hers) – Memorial Sloan Kettering Cancer Center
### she/her/hers @@@ Minji Kim, BS – Memorial Sloan Kettering Cancer Center ### 1850764###Author###Plastic and Reconstructive Surgery Service, Department of Surgery###Memorial Sloan Kettering Cancer Center###
Author: Minji Kim, BS – Memorial Sloan Kettering Cancer Center
### @@@ Varadan Sevilimedu, DrPH – Memorial Sloan Kettering Cancer Center ### 1849767###Author###Biostatistics Service, Department of Epidemiology and Biostatistics###Memorial Sloan Kettering Cancer Center###
Author: Varadan Sevilimedu, DrPH – Memorial Sloan Kettering Cancer Center
### @@@ Tiana V. Le, BS – Memorial Sloan Kettering Cancer Center ### 1849768###Author###Breast Service, Department of Surgery###Memorial Sloan Kettering Cancer Center###
Author: Tiana V. Le, BS – Memorial Sloan Kettering Cancer Center
### @@@ Jonas A. Nelson, MD, MPH – Memorial Sloan Kettering Cancer Center ### 1849917###Author###Plastic and Reconstructive Surgery Service, Department of Surgery###Memorial Sloan Kettering Cancer Center###
Author: Jonas A. Nelson, MD, MPH – Memorial Sloan Kettering Cancer Center
### @@@ Lior Z. Braunstein, MD – Memorial Sloan Kettering Cancer Center ### 2212184###Author###Department of Radiation Oncology###Memorial Sloan Kettering Cancer Center###
Author: Lior Z. Braunstein, MD – Memorial Sloan Kettering Cancer Center
### @@@ Monica Morrow, MD – Memorial Sloan Kettering Cancer Center ### 937326###Author###Breast Service, Department of Surgery###Memorial Sloan Kettering Cancer Center###
Author: Monica Morrow, MD – Memorial Sloan Kettering Cancer Center
### @@@ Minna K. Lee, MD – Memorial Sloan Kettering Cancer Center ### 1530221###Author###Breast Service, Department of Surgery###Memorial Sloan Kettering Cancer Center###
Author: Minna K. Lee, MD – Memorial Sloan Kettering Cancer Center
### @@@ Audree B. Tadros, MD, MPH – Memorial Sloan Kettering Cancer Center ### 1502404###Author###Breast Service, Department of Surgery###Memorial Sloan Kettering Cancer Center###
Author: Audree B. Tadros, MD, MPH – Memorial Sloan Kettering Cancer Center
###
2: Phase 3 study of neoadjuvant pembrolizumab or placebo + chemotherapy, followed by adjuvant pembrolizumab or placebo plus endocrine therapy for early-stage high-risk ER+/HER2− breast cancer: KEYNOTE-756

Fatima Cardoso, n/a – Champalimaud Foundation, Lisbon, Portugal ### 2211923###Author###Champalimaud Clinical Centre###Champalimaud Foundation, Lisbon, Portugal###
Author: Fatima Cardoso, n/a – Champalimaud Foundation, Lisbon, Portugal
### @@@ Joyce O’ Shaughnessy, MD – Baylor University Medical CenterTexas Oncology, US Oncology Network, Dallas, TX, USA ### 2211924###Author###Celebrating Women Chair in Breast Cancer Research###Baylor University Medical CenterTexas Oncology, US Oncology Network, Dallas, TX, USA###
Author: Joyce O’ Shaughnessy, MD – Baylor University Medical CenterTexas Oncology, US Oncology Network, Dallas, TX, USA
### @@@ Heather McArthur, MD MPH (she/her/hers) – Dallas, TX, USA ### 1530225###Abstract Presenter###University of Texas Southwestern Medical Center###Dallas, TX, USA###
Abstract Presenter: Heather McArthur, MD MPH (she/her/hers) – Dallas, TX, USA
### she/her/hers @@@ Heather McArthur, MD MPH (she/her/hers) – Dallas, TX, USA ### 1530225###Submitter###University of Texas Southwestern Medical Center###Dallas, TX, USA###
Submitter: Heather McArthur, MD MPH (she/her/hers) – Dallas, TX, USA
### she/her/hers @@@ Heather McArthur, MD MPH (she/her/hers) – Dallas, TX, USA ### 1530225###Author###University of Texas Southwestern Medical Center###Dallas, TX, USA###
Author: Heather McArthur, MD MPH (she/her/hers) – Dallas, TX, USA
### she/her/hers @@@ Peter Schmid, n/a – Barts Cancer Institute, Queen Mary University London, London, UK ### 970234###Author###Centre for Experimental Cancer Medicine###Barts Cancer Institute, Queen Mary University London, London, UK###
Author: Peter Schmid, n/a – Barts Cancer Institute, Queen Mary University London, London, UK
### @@@ Javier Cortes, n/a – Quironsalud Group, Barcelona, Spain and Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain ### 2211925###Author###International Breast Cancer Center###Quironsalud Group, Barcelona, Spain and Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain###
Author: Javier Cortes, n/a – Quironsalud Group, Barcelona, Spain and Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain
### @@@ Nadia Harbeck, n/a – LMU University Hospital, Munich, Germany ### 2211926###Author###Breast Center, Dept. OB&GYN###LMU University Hospital, Munich, Germany###
Author: Nadia Harbeck, n/a – LMU University Hospital, Munich, Germany
### @@@ Melinda L. Telli, n/a – Stanford, CA, USA ### 2211927###Author###Stanford University School of Medicine###Stanford, CA, USA###
Author: Melinda L. Telli, n/a – Stanford, CA, USA
### @@@ David W. Cescon, n/a – Toronto, Ontario, Canada ### 2211928###Author###Princess Margaret Cancer Centre###Toronto, Ontario, Canada###
Author: David W. Cescon, n/a – Toronto, Ontario, Canada
### @@@ Peter A. Fasching, n/a – Comprehensive Cancer Center Erlangen-EMN, Bavarian Cancer Research Center (BZKF), Erlangen, Germany ### 2211929###Author###University Hospital Erlangen###Comprehensive Cancer Center Erlangen-EMN, Bavarian Cancer Research Center (BZKF), Erlangen, Germany###
Author: Peter A. Fasching, n/a – Comprehensive Cancer Center Erlangen-EMN, Bavarian Cancer Research Center (BZKF), Erlangen, Germany
### @@@ Zhimin Shao, n/a – Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China ### 2211930###Author###Department of Breast Surgery###Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China###
Author: Zhimin Shao, n/a – Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
### @@@ Delphine Loirat, n/a – Paris, France ### 2211931###Author###Institut Curie###Paris, France###
Author: Delphine Loirat, n/a – Paris, France
### @@@ Yeon Hee Park, n/a – Sungkyunkwan University School of Medicine, Seoul, Republic of Korea ### 2211932###Author###Samsung Medical Center###Sungkyunkwan University School of Medicine, Seoul, Republic of Korea###
Author: Yeon Hee Park, n/a – Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
### @@@ Manuel Gonzalez Fernandez, n/a – IMAT-Oncomedica, Montería, Colombia ### 2211933###Author###Hemato Oncólogo###IMAT-Oncomedica, Montería, Colombia###
Author: Manuel Gonzalez Fernandez, n/a – IMAT-Oncomedica, Montería, Colombia
### @@@ Gábor Rubovszky, n/a – Budapest, Hungary ### 2211934###Author###National Institute of Oncology###Budapest, Hungary###
Author: Gábor Rubovszky, n/a – Budapest, Hungary
### @@@ Seock-Ah Im, n/a – Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea ### 2211935###Author###Seoul National University Hospital###Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea###
Author: Seock-Ah Im, n/a – Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea
### @@@ Rina Hui, n/a – Westmead Hospital and the University of Sydney, Sydney, NSW, Australia; Centre of Cancer Medicine, the University of Hong Kong, Hong Kong ### 2211936###Author###Westmead Breast Cancer Institute###Westmead Hospital and the University of Sydney, Sydney, NSW, Australia; Centre of Cancer Medicine, the University of Hong Kong, Hong Kong###
Author: Rina Hui, n/a – Westmead Hospital and the University of Sydney, Sydney, NSW, Australia; Centre of Cancer Medicine, the University of Hong Kong, Hong Kong
### @@@ Toshimi Takano, n/a – Tokyo, Japan ### 2211937###Author###The Cancer Institute Hospital of JFCR###Tokyo, Japan###
Author: Toshimi Takano, n/a – Tokyo, Japan
### @@@ Fabrice André, n/a – Gustave Roussy, Villejuif, France ### 2211938###Author###Faculté de Medicine Paris-Sud XI###Gustave Roussy, Villejuif, France###
Author: Fabrice André, n/a – Gustave Roussy, Villejuif, France
### @@@ Hiroyuki Yasojima, n/a – NHO Osaka National Hospital, Osaka, Japan ### 2211939###Author###Department of Surgery Breast Oncology###NHO Osaka National Hospital, Osaka, Japan###
Author: Hiroyuki Yasojima, n/a – NHO Osaka National Hospital, Osaka, Japan
### @@@ Zhenzhen Liu, n/a – Henan Breast Cancer Center, Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China ### 2211940###Author###Department of Breast Disease###Henan Breast Cancer Center, Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China###
Author: Zhenzhen Liu, n/a – Henan Breast Cancer Center, Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China
###
20: Single-cell transcriptomic analysis identifies divergent tumor epithelial cell states in colorectal metastasis

Muhammad B. Mirza, MD – Vanderbilt University Medical Center ### 1850959###Abstract Presenter###Post-doctoral Research Fellow###Vanderbilt University Medical Center###
Abstract Presenter: Muhammad B. Mirza, MD – Vanderbilt University Medical Center
### @@@ Muhammad B. Mirza, MD – Vanderbilt University Medical Center ### 1850959###Submitter###Post-doctoral Research Fellow###Vanderbilt University Medical Center###
Submitter: Muhammad B. Mirza, MD – Vanderbilt University Medical Center
### @@@ Muhammad B. Mirza, MD – Vanderbilt University Medical Center ### 1850959###Author###Post-doctoral Research Fellow###Vanderbilt University Medical Center###
Author: Muhammad B. Mirza, MD – Vanderbilt University Medical Center
### @@@ Matthew Alexander Cottam, PhD – Vanderbilt University Medical Center ### 2212240###Author###staff scientist###Vanderbilt University Medical Center###
Author: Matthew Alexander Cottam, PhD – Vanderbilt University Medical Center
### @@@ Kamran Idrees, MD, MSCI, MMHC, FACS – Vanderbilt University Medical Center ### 937418###Author###Associate Professor of Surgery###Vanderbilt University Medical Center###
Author: Kamran Idrees, MD, MSCI, MMHC, FACS – Vanderbilt University Medical Center
###
2021-2023 Clinical Investigator Award for Under-Represented Black, Indigenous and People of Color (BIPOC) Surgeons

Chukwuemeka Ihemelandu, MD – MedStar Georgetown University Hospital ### 915767###Presenter###Associate Professor###MedStar Georgetown University Hospital###
Presenter: Chukwuemeka Ihemelandu, MD – MedStar Georgetown University Hospital
###
21: Stage-Specific Analysis of Racial Disparities in Colon Cancer Gene Expression Profiles

Mohamad El Moheb, MD – University of Virginia ### 2212154###Abstract Presenter###General Surgery Resident###University of Virginia###
Abstract Presenter: Mohamad El Moheb, MD – University of Virginia
### @@@ Mohamad El Moheb, MD – University of Virginia ### 2212154###Submitter###General Surgery Resident###University of Virginia###
Submitter: Mohamad El Moheb, MD – University of Virginia
### @@@ Chengli Shen, MS, PhD – University of Virginia ### 2211867###Author###Research Scientist###University of Virginia###
Author: Chengli Shen, MS, PhD – University of Virginia
### @@@ Susan J. Kim, MD (she/her/hers) – University of Virginia ### 2211866###Author###Post-doctoral Research Fellow###University of Virginia###
Author: Susan J. Kim, MD (she/her/hers) – University of Virginia
### she/her/hers @@@ Hongji Zhang, Md PhD – University of Virginia ### 1850006###Author###Assistant Professor###University of Virginia###
Author: Hongji Zhang, Md PhD – University of Virginia
### @@@ Russell Witt, MD – University of Virginia ### 2212122###Author###Assistant Professor in Surgery###University of Virginia###
Author: Russell Witt, MD – University of Virginia
### @@@ Allan Tsung, MD – University of Virginia ### 1850005###Author###Chair of Department of Surgery, Professor of Surgery, Principal Investigator###University of Virginia###
Author: Allan Tsung, MD – University of Virginia
###
22: Circulating Hybrid Cells as a Blood Based Screening Tool for Colorectal Neoplasia

Ranish K. Patel, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA ### 2211841###Abstract Presenter###Resident Physician###Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA###
Abstract Presenter: Ranish K. Patel, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
### @@@ Ranish K. Patel, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA ### 2211841###Submitter###Resident Physician###Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA###
Submitter: Ranish K. Patel, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
### @@@ Ranish K. Patel, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA ### 2211841###Author###Resident Physician###Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA###
Author: Ranish K. Patel, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
### @@@ Michael S. Parappilly, BS – Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University, Portland, OR 97239 USA ### 2211842###Author###Medical Student###Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University, Portland, OR 97239 USA###
Author: Michael S. Parappilly, BS – Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University, Portland, OR 97239 USA
### @@@ Shahrose Rahman, MD – Department of Surgery, Division of Gastrointestinal and General Surgery, Oregon Health & Science University, Portland, OR 97239 USA ### 2211843###Author###Resident###Department of Surgery, Division of Gastrointestinal and General Surgery, Oregon Health & Science University, Portland, OR 97239 USA###
Author: Shahrose Rahman, MD – Department of Surgery, Division of Gastrointestinal and General Surgery, Oregon Health & Science University, Portland, OR 97239 USA
### @@@ Ethan S. Lu, n/a – Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University, Portland, OR 97239 USA ### 2211872###Author###Student###Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University, Portland, OR 97239 USA###
Author: Ethan S. Lu, n/a – Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University, Portland, OR 97239 USA
### @@@ Ashvin M. Nair, n/a – Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University, Portland, OR 97239 USA ### 2211873###Author###Student###Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University, Portland, OR 97239 USA###
Author: Ashvin M. Nair, n/a – Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University, Portland, OR 97239 USA
### @@@ Emile J. Latour, MS – Biostatistics Shared Resource, Knight Cancer Institute, Portland, OR 97239 USA ### 2211844###Author###Biostatistician###Biostatistics Shared Resource, Knight Cancer Institute, Portland, OR 97239 USA###
Author: Emile J. Latour, MS – Biostatistics Shared Resource, Knight Cancer Institute, Portland, OR 97239 USA
### @@@ Skye C. Mayo, MD MPH (he/him/his) – Department of Surgery, Division of Surgical Oncology, Oregon Health & Science University; Knight Cancer Institute; Portland, OR 97239 USA ### 969545###Author###Associate Professor###Department of Surgery, Division of Surgical Oncology, Oregon Health & Science University; Knight Cancer Institute; Portland, OR 97239 USA###
Author: Skye C. Mayo, MD MPH (he/him/his) – Department of Surgery, Division of Surgical Oncology, Oregon Health & Science University; Knight Cancer Institute; Portland, OR 97239 USA
### he/him/his @@@ Gregory A. Coté, MD MS – Department of Medicine, Division of Gastroenterology & Hepatology, Oregon Health & Science University; Knight Cancer Institute; Portland, OR 97239 USA ### 2211845###Author###Professor & Division Head###Department of Medicine, Division of Gastroenterology & Hepatology, Oregon Health & Science University; Knight Cancer Institute; Portland, OR 97239 USA###
Author: Gregory A. Coté, MD MS – Department of Medicine, Division of Gastroenterology & Hepatology, Oregon Health & Science University; Knight Cancer Institute; Portland, OR 97239 USA
### @@@ Vassiliki L. Tsikitis, MD – Department of Surgery, Division of Gastrointestinal and General Surgery, Oregon Health & Science University; Knight Cancer Institute; Portland, OR 97239 USA ### 2211846###Author###Professor & Division Head###Department of Surgery, Division of Gastrointestinal and General Surgery, Oregon Health & Science University; Knight Cancer Institute; Portland, OR 97239 USA###
Author: Vassiliki L. Tsikitis, MD – Department of Surgery, Division of Gastrointestinal and General Surgery, Oregon Health & Science University; Knight Cancer Institute; Portland, OR 97239 USA
### @@@ Melissa H. Wong, PhD – Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University; Knight Cancer Institute; Portland, OR 97239 USA ### 2211847###Author###Professor###Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University; Knight Cancer Institute; Portland, OR 97239 USA###
Author: Melissa H. Wong, PhD – Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University; Knight Cancer Institute; Portland, OR 97239 USA
###
23: Rate of Neoplasia in Patients with Complicated Acute Appendicitis Managed Nonoperatively

Jessica J. Lie, MD MPH – University of British Columbia ### 1530290###Abstract Presenter###Resident###University of British Columbia###
Abstract Presenter: Jessica J. Lie, MD MPH – University of British Columbia
### @@@ Jessica J. Lie, MD MPH – University of British Columbia ### 1530290###Submitter###Resident###University of British Columbia###
Submitter: Jessica J. Lie, MD MPH – University of British Columbia
### @@@ Jessica J. Lie, MD MPH – University of British Columbia ### 1530290###Author###Resident###University of British Columbia###
Author: Jessica J. Lie, MD MPH – University of British Columbia
### @@@ Kylie Nabata, MD – University of British Columbia ### 2212218###Author###Resident###University of British Columbia###
Author: Kylie Nabata, MD – University of British Columbia
### @@@ Jenny Zhang, n/a – University of British Columbia ### 2212219###Author###Research Assistant###University of British Columbia###
Author: Jenny Zhang, n/a – University of British Columbia
### @@@ Darren Zhao, n/a – University of British Columbia ### 2212220###Author###Research Assistant###University of British Columbia###
Author: Darren Zhao, n/a – University of British Columbia
### @@@ Morad Hameed, MD MPH FRCSC FACS – University of British Columbia ### 2212221###Author###Division Head, Surgeon###University of British Columbia###
Author: Morad Hameed, MD MPH FRCSC FACS – University of British Columbia
### @@@ Philip Dawe, MD FRCSC – University of British Columbia ### 2212222###Author###ACS Lead, Surgeon###University of British Columbia###
Author: Philip Dawe, MD FRCSC – University of British Columbia
### @@@ Trevor Hamilton, MD, MSc, FRCSC, FACS – University of British Columbia ### 2211877###Author###Surgical Oncologist###University of British Columbia###
Author: Trevor Hamilton, MD, MSc, FRCSC, FACS – University of British Columbia
###
24: Phase 1b Randomized Controlled Trial of Perioperative Tadalafil and Influenza Vaccination in Cancer Patients Undergoing Major Surgical Resection of a Primary Abdominal Malignancy (PERIOP-04)

Leonard Angka, n/a – Ottawa Hospital Research Institute ### 2211827###Author###Researcher###Ottawa Hospital Research Institute###
Author: Leonard Angka, n/a – Ottawa Hospital Research Institute
### @@@ Victoria Ivankovic, MD (she/her/hers) – University of Ottawa ### 2212038###Author###Surgical Resident###University of Ottawa###
Author: Victoria Ivankovic, MD (she/her/hers) – University of Ottawa
### she/her/hers @@@ Henna Mistry, BSc – Ottawa Hospital Research Institute (OHRI) ### 2212039###Author###PhD Student###Ottawa Hospital Research Institute (OHRI)###
Author: Henna Mistry, BSc – Ottawa Hospital Research Institute (OHRI)
### @@@ Gayashan Tennakoon, BSc, MSc – University of Toronto ### 2212040###Author###Medical Student###University of Toronto###
Author: Gayashan Tennakoon, BSc, MSc – University of Toronto
### @@@ Lee-Hwa Tail, PhD – Universite de Sherbrooke ### 2212041###Author###Associate Professor###Universite de Sherbrooke###
Author: Lee-Hwa Tail, PhD – Universite de Sherbrooke
### @@@ Carolyn Nessim, MD, MSc, FRCSC, FACS (she/her/hers) – The Ottawa Hospital, University of Ottawa, Ottawa Hospital Research Institute ### 1795369###Author###Surgical Oncologist, Associate Professor, Clinician Investigator, CGSO Program Director###The Ottawa Hospital, University of Ottawa, Ottawa Hospital Research Institute###
Author: Carolyn Nessim, MD, MSc, FRCSC, FACS (she/her/hers) – The Ottawa Hospital, University of Ottawa, Ottawa Hospital Research Institute
### she/her/hers @@@ Guillaume Martel, BSc, MSc, MD, FRCSC – Ottawa Hospital Research Institute ### 2212042###Author###Associate Professor###Ottawa Hospital Research Institute###
Author: Guillaume Martel, BSc, MSc, MD, FRCSC – Ottawa Hospital Research Institute
### @@@ Jad Abou Khalil, BSc, MSc, MD, FRCSC – Ottawa Hospital Research Institute ### 2212043###Author###Assistant Professor###Ottawa Hospital Research Institute###
Author: Jad Abou Khalil, BSc, MSc, MD, FRCSC – Ottawa Hospital Research Institute
### @@@ Kimberly Bertens, BSc, MSc, MD, FRCSC – Ottawa Hospital Research Institute (OHRI) ### 2212044###Author###Assistant Professor###Ottawa Hospital Research Institute (OHRI)###
Author: Kimberly Bertens, BSc, MSc, MD, FRCSC – Ottawa Hospital Research Institute (OHRI)
### @@@ Rodney Breau, BSc, MSc, MD, FRCSC – Ottawa Hospital Research Institute (OHRI) ### 2212045###Author###Professor###Ottawa Hospital Research Institute (OHRI)###
Author: Rodney Breau, BSc, MSc, MD, FRCSC – Ottawa Hospital Research Institute (OHRI)
### @@@ Brittany Dingley, BSc, MSc, MD, FRCSC – Ottawa Hospital Research Institute (OHRI) ### 2212046###Author###Assistant Professor###Ottawa Hospital Research Institute (OHRI)###
Author: Brittany Dingley, BSc, MSc, MD, FRCSC – Ottawa Hospital Research Institute (OHRI)
### @@@ Rebecca C. Auer, MD, MSc, FRCSC, FACS (she/her/hers) – Ottawa Hospital Research Institute ### 969495###Abstract Presenter###Director of Cancer Research###Ottawa Hospital Research Institute###
Abstract Presenter: Rebecca C. Auer, MD, MSc, FRCSC, FACS (she/her/hers) – Ottawa Hospital Research Institute
### she/her/hers @@@ Rebecca C. Auer, MD, MSc, FRCSC, FACS (she/her/hers) – Ottawa Hospital Research Institute ### 969495###Submitter###Director of Cancer Research###Ottawa Hospital Research Institute###
Submitter: Rebecca C. Auer, MD, MSc, FRCSC, FACS (she/her/hers) – Ottawa Hospital Research Institute
### she/her/hers
25: GNAS Driver Mutations in Primary and Metastatic Nonmucinous Appendiceal Adenocarcinoma Versus Analogous Colorectal Cancers. An AACR Project GENIE Analysis.

Andrew M. Fleming, MD – Department of Surgery, University of Tennessee Health Science Center ### 970048###Abstract Presenter###Surgery Resident###Department of Surgery, University of Tennessee Health Science Center###
Abstract Presenter: Andrew M. Fleming, MD – Department of Surgery, University of Tennessee Health Science Center
### @@@ Andrew M. Fleming, MD – Department of Surgery, University of Tennessee Health Science Center ### 970048###Submitter###Surgery Resident###Department of Surgery, University of Tennessee Health Science Center###
Submitter: Andrew M. Fleming, MD – Department of Surgery, University of Tennessee Health Science Center
### @@@ Andrew M. Fleming, MD – Department of Surgery, University of Tennessee Health Science Center ### 970048###Author###Surgery Resident###Department of Surgery, University of Tennessee Health Science Center###
Author: Andrew M. Fleming, MD – Department of Surgery, University of Tennessee Health Science Center
### @@@ Leah E. Hendrick, MD, MS – Moffitt Cancer Center ### 2212000###Author###Surgical Oncology Fellow###Moffitt Cancer Center###
Author: Leah E. Hendrick, MD, MS – Moffitt Cancer Center
### @@@ Julia P. Pedo Freitas, MD – Department of Surgery, The University of Tennessee Health Science Center ### 2212001###Author###Surgery Resident###Department of Surgery, The University of Tennessee Health Science Center###
Author: Julia P. Pedo Freitas, MD – Department of Surgery, The University of Tennessee Health Science Center
### @@@ Suraj Sarvode Mothi, MPH – Department of Biostatistics, St. Jude Children’s Research Hospital ### 2212002###Author###Senior Biostatistician###Department of Biostatistics, St. Jude Children’s Research Hospital###
Author: Suraj Sarvode Mothi, MPH – Department of Biostatistics, St. Jude Children’s Research Hospital
### @@@ Ian B. Solsky, MD – Department of Surgery, The University of Tennessee Health Science Center ### 2212003###Author###Assistant Professor of Surgery###Department of Surgery, The University of Tennessee Health Science Center###
Author: Ian B. Solsky, MD – Department of Surgery, The University of Tennessee Health Science Center
### @@@ Danny Yakoub, MD, PhD, FACS – Department of Surgery, Medical College of Georgia, Augusta University, Augusta, GA, USA ### 2211869###Author###Chief of Surgical Oncology###Department of Surgery, Medical College of Georgia, Augusta University, Augusta, GA, USA###
Author: Danny Yakoub, MD, PhD, FACS – Department of Surgery, Medical College of Georgia, Augusta University, Augusta, GA, USA
### @@@ Andrew J. Murphy, MD – Department of Surgery, St. Jude Children’s Research Hospital ### 1851432###Author###Chief, General Pediatric Surgery Division###Department of Surgery, St. Jude Children’s Research Hospital###
Author: Andrew J. Murphy, MD – Department of Surgery, St. Jude Children’s Research Hospital
### @@@ Elizabeth Gleeson, MD, MPH – Department of Surgery, University of North Carolina ### 2211870###Author###Assistant Professor of Surgery###Department of Surgery, University of North Carolina###
Author: Elizabeth Gleeson, MD, MPH – Department of Surgery, University of North Carolina
### @@@ Evan S. Glazer, MD, PhD, FACS, FSSO (he/him/his) – Department of Surgery, University of Tennessee Health Science Center ### 969527###Author###Associate Professor of Surgery###Department of Surgery, University of Tennessee Health Science Center###
Author: Evan S. Glazer, MD, PhD, FACS, FSSO (he/him/his) – Department of Surgery, University of Tennessee Health Science Center
### he/him/his @@@ David Shibata, MD, FACS, FSSO, FASCRS – University of Tennessee Health Science Center, Department of Surgery ### 937416###Author###Professor and Chair of the Department of Surgery###University of Tennessee Health Science Center, Department of Surgery###
Author: David Shibata, MD, FACS, FSSO, FASCRS – University of Tennessee Health Science Center, Department of Surgery
### @@@ Jeremiah L. Deneve, DO (he/him/his) – University of North Carolina at Chapel Hill ### 1214707###Author###Associate Professor of Surgery###University of North Carolina at Chapel Hill###
Author: Jeremiah L. Deneve, DO (he/him/his) – University of North Carolina at Chapel Hill
### he/him/his
26: The Prognostic Role of Post-operative ctDNA after Resection of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis

Brett L. Ecker, MD – Rutgers Cancer Institute of New Jersey - Rutgers Robert Wood Johnson Medical School ### 1851342###Abstract Presenter###Assistant Professor of Surgery###Rutgers Cancer Institute of New Jersey - Rutgers Robert Wood Johnson Medical School###
Abstract Presenter: Brett L. Ecker, MD – Rutgers Cancer Institute of New Jersey - Rutgers Robert Wood Johnson Medical School
### @@@ Emma R. Vail, n/a – Johns Hopkins University School of Medicine ### 2212189###Author###Medical Student###Johns Hopkins University School of Medicine###
Author: Emma R. Vail, n/a – Johns Hopkins University School of Medicine
### @@@ H. Richard Alexander, Jr., MD (he/him/his) – Division of Surgical Oncology, Rutgers Cancer Institute of New Jersey - Rutgers Robert Wood Johnson Medical School ### 917895###Author###Chief Surgical Officer, Professor and Head###Division of Surgical Oncology, Rutgers Cancer Institute of New Jersey - Rutgers Robert Wood Johnson Medical School###
Author: H. Richard Alexander, Jr., MD (he/him/his) – Division of Surgical Oncology, Rutgers Cancer Institute of New Jersey - Rutgers Robert Wood Johnson Medical School
### he/him/his @@@ Toni Beninato, MD, MS – Division of Surgical Oncology, Rutgers Cancer Institute of New Jersey - Rutgers Robert Wood Johnson Medical School ### 1851304###Author###Associate Professor of Surgery###Division of Surgical Oncology, Rutgers Cancer Institute of New Jersey - Rutgers Robert Wood Johnson Medical School###
Author: Toni Beninato, MD, MS – Division of Surgical Oncology, Rutgers Cancer Institute of New Jersey - Rutgers Robert Wood Johnson Medical School
### @@@ Mariam F. Eskander, MD, MPH – Rutgers Cancer Institute of New Jersey ### 970179###Author###Surgical Oncologist###Rutgers Cancer Institute of New Jersey###
Author: Mariam F. Eskander, MD, MPH – Rutgers Cancer Institute of New Jersey
### @@@ Miral S. Grandhi, MD – Division of Surgical Oncology, Rutgers Cancer Institute of New Jersey - Rutgers Robert Wood Johnson Medical School ### 969542###Author###Associate Professor of Surgery, Director of Hepatobiliary Surgery, Program Director of Complex General Surgical Oncology Fellowship Program###Division of Surgical Oncology, Rutgers Cancer Institute of New Jersey - Rutgers Robert Wood Johnson Medical School###
Author: Miral S. Grandhi, MD – Division of Surgical Oncology, Rutgers Cancer Institute of New Jersey - Rutgers Robert Wood Johnson Medical School
### @@@ Haejin In, MD, MPH, MBA (she/her/hers) – Rutgers Cancer Institute of New Jersey ### 1852166###Author###Associate Professor of Surgery, Division of Surgical Oncology###Rutgers Cancer Institute of New Jersey###
Author: Haejin In, MD, MPH, MBA (she/her/hers) – Rutgers Cancer Institute of New Jersey
### she/her/hers @@@ Timothy J. Kennedy, MD – Division of Surgical Oncology, Rutgers Cancer Institute of New Jersey - Rutgers Robert Wood Johnson Medical School ### 1851341###Author###Associate Professor of Surgery###Division of Surgical Oncology, Rutgers Cancer Institute of New Jersey - Rutgers Robert Wood Johnson Medical School###
Author: Timothy J. Kennedy, MD – Division of Surgical Oncology, Rutgers Cancer Institute of New Jersey - Rutgers Robert Wood Johnson Medical School
### @@@ Russell C. Langan, MD – Rutgers Cancer Institute of New Jersey, Cooperman Barnabas Medical Center - Rutgers Robert Wood Johnson Medical School ### 937455###Author###Director of Surgical Oncology, Associate Chief Surgical Officer, Associate Professor of Surgery###Rutgers Cancer Institute of New Jersey, Cooperman Barnabas Medical Center - Rutgers Robert Wood Johnson Medical School###
Author: Russell C. Langan, MD – Rutgers Cancer Institute of New Jersey, Cooperman Barnabas Medical Center - Rutgers Robert Wood Johnson Medical School
### @@@ Jason C. Maggi, MD – Division of Surgical Oncology, Rutgers Cancer Institute of New Jersey - Rutgers Robert Wood Johnson Medical School ### 2212019###Author###Assistant Professor of Surgery###Division of Surgical Oncology, Rutgers Cancer Institute of New Jersey - Rutgers Robert Wood Johnson Medical School###
Author: Jason C. Maggi, MD – Division of Surgical Oncology, Rutgers Cancer Institute of New Jersey - Rutgers Robert Wood Johnson Medical School
### @@@ Henry A. Pitt, MD – Rutgers Cancer Institute of New Jersey - Rutgers Robert Wood Johnson Medical School ### 1860012###Author###Chief of Oncologic Quality, Professor of Surgery###Rutgers Cancer Institute of New Jersey - Rutgers Robert Wood Johnson Medical School###
Author: Henry A. Pitt, MD – Rutgers Cancer Institute of New Jersey - Rutgers Robert Wood Johnson Medical School
### @@@ Shishir K. Maithel, MD, FACS – Winship Cancer Institute of Emory University ### 917909###Author###Professor, Department of Surgery###Winship Cancer Institute of Emory University###
Author: Shishir K. Maithel, MD, FACS – Winship Cancer Institute of Emory University
### @@@ Brett L. Ecker, MD – Rutgers Cancer Institute of New Jersey - Rutgers Robert Wood Johnson Medical School ### 1851342###Author###Assistant Professor of Surgery###Rutgers Cancer Institute of New Jersey - Rutgers Robert Wood Johnson Medical School###
Author: Brett L. Ecker, MD – Rutgers Cancer Institute of New Jersey - Rutgers Robert Wood Johnson Medical School
###
27: Evaluation of Pathologic Complete Response as a Surrogate Endpoint in Rectal Cancer Clinical Trials: A Systematic Review and Meta-Analysis

Kavin Sugumar, MD (he/him/his) – Tulane University ### 2212181###Abstract Presenter###Surgical Resident###Tulane University###
Abstract Presenter: Kavin Sugumar, MD (he/him/his) – Tulane University
### he/him/his @@@ Jessica J. Lie, MD MPH – University of British Columbia ### 1530290###Author###Resident###University of British Columbia###
Author: Jessica J. Lie, MD MPH – University of British Columbia
### @@@ Chee-Chee Stucky, MD – Mayo Clinic Arizona ### 2119273###Author###Associate Professor of Surgery###Mayo Clinic Arizona###
Author: Chee-Chee Stucky, MD – Mayo Clinic Arizona
### @@@ Yu-Hui Chang, MPH, PhD – Mayo Clinic Arizona ### 2212029###Author###Assistant Professor of Surgery###Mayo Clinic Arizona###
Author: Yu-Hui Chang, MPH, PhD – Mayo Clinic Arizona
### @@@ Justin Brady, MD – Mayo Clinic Arizona ### 2212165###Author###Assistant Professor###Mayo Clinic Arizona###
Author: Justin Brady, MD – Mayo Clinic Arizona
### @@@ Nabil Wasif, MD, MPH – Mayo Clinic in Arizona ### 937476###Author###Professor of Surgery###Mayo Clinic in Arizona###
Author: Nabil Wasif, MD, MPH – Mayo Clinic in Arizona
### @@@ David Etzioni, MD, MS – Mayo Clinic Arizona ### 2212028###Author###Professor of Surgery###Mayo Clinic Arizona###
Author: David Etzioni, MD, MS – Mayo Clinic Arizona
### @@@ Zhi Ven Fong, MD MPH DrPH – Mayo Clinic Arizona ### 2211985###Submitter###Assistant Professor of Surgery###Mayo Clinic Arizona###
Submitter: Zhi Ven Fong, MD MPH DrPH – Mayo Clinic Arizona
### @@@ Zhi Ven Fong, MD MPH DrPH – Mayo Clinic Arizona ### 2211985###Author###Assistant Professor of Surgery###Mayo Clinic Arizona###
Author: Zhi Ven Fong, MD MPH DrPH – Mayo Clinic Arizona
###
28: Observed Changes in the Distribution of Colon Cancer Metastasis: A National Cancer Database Review and Institutional Experience

Kyle R. Stephens, MD – University of Louisville, Department of Surgery ### 2212255###Abstract Presenter###Resident###University of Louisville, Department of Surgery###
Abstract Presenter: Kyle R. Stephens, MD – University of Louisville, Department of Surgery
### @@@ Kyle R. Stephens, MD – University of Louisville, Department of Surgery ### 2212255###Submitter###Resident###University of Louisville, Department of Surgery###
Submitter: Kyle R. Stephens, MD – University of Louisville, Department of Surgery
### @@@ Kyle R. Stephens, MD – University of Louisville, Department of Surgery ### 2212255###Author###Resident###University of Louisville, Department of Surgery###
Author: Kyle R. Stephens, MD – University of Louisville, Department of Surgery
### @@@ Walter Donica, MD – University of Louisville ### 2212158###Author###General Surgery Resident###University of Louisville###
Author: Walter Donica, MD – University of Louisville
### @@@ Michael E. Egger, MD, MPH – University of Louisville ### 969528###Author###Surgical oncologist###University of Louisville###
Author: Michael E. Egger, MD, MPH – University of Louisville
### @@@ Prejesh Philips, MD – University of Louisville ### 1529650###Author###Associate Professor of Surgery###University of Louisville###
Author: Prejesh Philips, MD – University of Louisville
### @@@ Charles Scoggins, MD – Department of Surgery, University of Louisville ### 1850525###Author###Surgical Oncologist###Department of Surgery, University of Louisville###
Author: Charles Scoggins, MD – Department of Surgery, University of Louisville
### @@@ Kelly McMasters, MD, PhD (he/him/his) – The Hiram C. Polk Jr., MD Department of Surgery University of Louisville School of Medicine ### 1851798###Author###Ben A. Reid, Sr., MD Professor and Chair###The Hiram C. Polk Jr., MD Department of Surgery University of Louisville School of Medicine###
Author: Kelly McMasters, MD, PhD (he/him/his) – The Hiram C. Polk Jr., MD Department of Surgery University of Louisville School of Medicine
### he/him/his @@@ Robert CG Martin, II, MD – Department of Surgery, University of Louisville ### 969995###Author###Surgical Oncologist###Department of Surgery, University of Louisville###
Author: Robert CG Martin, II, MD – Department of Surgery, University of Louisville
###
29: Lower Social Support Predicts Higher Cortisol for Breast Cancer Patients in Disadvantaged Neighborhoods

Alexandra E. Hernandez, MD, MPH – University of Miami ### 1851136###Abstract Presenter###Research fellow###University of Miami###
Abstract Presenter: Alexandra E. Hernandez, MD, MPH – University of Miami
### @@@ Alexandra E. Hernandez, MD, MPH – University of Miami ### 1851136###Submitter###Research fellow###University of Miami###
Submitter: Alexandra E. Hernandez, MD, MPH – University of Miami
### @@@ Alexandra E. Hernandez, MD, MPH – University of Miami ### 1851136###Author###Research fellow###University of Miami###
Author: Alexandra E. Hernandez, MD, MPH – University of Miami
### @@@ Ibane Aizpurua, MS – University of the Basque Country, Department of Basic Psychological Processes and their Development ### 2211947###Author###Postdoctoral Scholar###University of the Basque Country, Department of Basic Psychological Processes and their Development###
Author: Ibane Aizpurua, MS – University of the Basque Country, Department of Basic Psychological Processes and their Development
### @@@ Peter A. Borowsky, MD – Sylvester Comprehensive Cancer Center, University of Miami Health System ### 2211948###Author###Postdoctoral Scholar###Sylvester Comprehensive Cancer Center, University of Miami Health System###
Author: Peter A. Borowsky, MD – Sylvester Comprehensive Cancer Center, University of Miami Health System
### @@@ Molly Ream, MS – Sylvester Comprehensive Cancer Center, University of Miami Health System ### 2211949###Author###Doctoral Student###Sylvester Comprehensive Cancer Center, University of Miami Health System###
Author: Molly Ream, MS – Sylvester Comprehensive Cancer Center, University of Miami Health System
### @@@ Michael Antoni, PhD – Sylvester Comprehensive Cancer Center, University of Miami Health System ### 1852030###Author###Professor###Sylvester Comprehensive Cancer Center, University of Miami Health System###
Author: Michael Antoni, PhD – Sylvester Comprehensive Cancer Center, University of Miami Health System
### @@@ Neha Goel, MD, MPH – Dewitt Daughtry Department of Surgery, University of Miami, Miami, Florida; Sylvester Comprehensive Cancer Center, Miami, FL ### 1214717###Author###Associate Professor of Surgery###Dewitt Daughtry Department of Surgery, University of Miami, Miami, Florida; Sylvester Comprehensive Cancer Center, Miami, FL###
Author: Neha Goel, MD, MPH – Dewitt Daughtry Department of Surgery, University of Miami, Miami, Florida; Sylvester Comprehensive Cancer Center, Miami, FL
###
3: Oncologic Outcomes with De-Escalation of Axillary Surgery after Neoadjuvant Chemotherapy for Breast Cancer: Results from >1,500 patients on the I-SPY2 Clinical Trial

Judy C. Boughey, MD (she/her/hers) – Mayo Clinic ### 937371###Abstract Presenter###Chair, Division of Breast and Melanoma Surgical Oncology###Mayo Clinic###
Abstract Presenter: Judy C. Boughey, MD (she/her/hers) – Mayo Clinic
### she/her/hers @@@ Judy C. Boughey, MD (she/her/hers) – Mayo Clinic ### 937371###Submitter###Chair, Division of Breast and Melanoma Surgical Oncology###Mayo Clinic###
Submitter: Judy C. Boughey, MD (she/her/hers) – Mayo Clinic
### she/her/hers @@@ Judy C. Boughey, MD (she/her/hers) – Mayo Clinic ### 937371###Author###Chair, Division of Breast and Melanoma Surgical Oncology###Mayo Clinic###
Author: Judy C. Boughey, MD (she/her/hers) – Mayo Clinic
### she/her/hers @@@ Hongmei Yu, Ph.D. – Quantum Leap Healthcare Collaborative ### 1850556###Author###n/a###Quantum Leap Healthcare Collaborative###
Author: Hongmei Yu, Ph.D. – Quantum Leap Healthcare Collaborative
### @@@ Kayla Switalla, B.S. – University of California, San Francisco ### 2212089###Author###Clinical Fellow###University of California, San Francisco###
Author: Kayla Switalla, B.S. – University of California, San Francisco
### @@@ Ladores Velle, B.S. – University of California, San Francisco ### 2212090###Author###Research Assistant, Department of Surgery###University of California, San Francisco###
Author: Ladores Velle, B.S. – University of California, San Francisco
### @@@ Anne M. Wallace, M.D. – UC San Diego Health ### 2212207###Author###Professor of Surgery###UC San Diego Health###
Author: Anne M. Wallace, M.D. – UC San Diego Health
### @@@ Rachel B. Lancaster, M.D. – The University of Alabama at Birmingham Medical Center ### 2212208###Author###Associate Professor of Surgery###The University of Alabama at Birmingham Medical Center###
Author: Rachel B. Lancaster, M.D. – The University of Alabama at Birmingham Medical Center
### @@@ Chantal R. Reyna, M.D. – Loyola University Medical Center ### 2212093###Author###Associate Professor; Primary Department: Surgical Oncology###Loyola University Medical Center###
Author: Chantal R. Reyna, M.D. – Loyola University Medical Center
### @@@ Todd M. Tuttle, MD MS – Division of Surgical Oncology, Department of Surgery, University of Minnesota ### 937433###Author###Professor###Division of Surgical Oncology, Department of Surgery, University of Minnesota###
Author: Todd M. Tuttle, MD MS – Division of Surgical Oncology, Department of Surgery, University of Minnesota
### @@@ Nora Jaskowiak, M.D. – The University of Chicago Medicine ### 2212091###Author###Professor of Surgery###The University of Chicago Medicine###
Author: Nora Jaskowiak, M.D. – The University of Chicago Medicine
### @@@ Julia Tchou, MD PhD – University of Pennsylvania ### 1530212###Author###Professor of Clinical Surgery###University of Pennsylvania###
Author: Julia Tchou, MD PhD – University of Pennsylvania
### @@@ Roshni Rao, MD – Columbia University Medical Center ### 969518###Author###Associate Professor of Surgery###Columbia University Medical Center###
Author: Roshni Rao, MD – Columbia University Medical Center
### @@@ Marie Catherine Lee, MD, FACS – Moffitt Cancer Center ### 1851109###Author###Senior Member Breast Surgical Oncology###Moffitt Cancer Center###
Author: Marie Catherine Lee, MD, FACS – Moffitt Cancer Center
### @@@ Arpana M. Naik, M.D. – Oregon Health & Science University ### 2212092###Author###Associate Professor of Surgery, Division of Surgical Oncology, School of Medicine###Oregon Health & Science University###
Author: Arpana M. Naik, M.D. – Oregon Health & Science University
### @@@ Mehra Golshan, MD, MBA, FACS – Yale School of Medicine Department of Surgery ### 1791618###Author###Professor of Surgery (Oncology, Breast); Executive Vice Chair, Surgery; Deputy Chief Medical Officer###Yale School of Medicine Department of Surgery###
Author: Mehra Golshan, MD, MBA, FACS – Yale School of Medicine Department of Surgery
### @@@ Cletus A. Arciero, M.D. – Emory University School of Medicine ### 2204762###Author###Professor, Division of Surgical Oncology, Department of Surgery###Emory University School of Medicine###
Author: Cletus A. Arciero, M.D. – Emory University School of Medicine
### @@@ Candice A. Sauder, M.D. – UC Davis Comprehensive Cancer Center ### 970268###Author###Assistant Professor, Department of Surgery###UC Davis Comprehensive Cancer Center###
Author: Candice A. Sauder, M.D. – UC Davis Comprehensive Cancer Center
### @@@ Cindy B. Matsen, M.D. – University of Utah Health ### 969522###Author###Associate Professor of Surgery###University of Utah Health###
Author: Cindy B. Matsen, M.D. – University of Utah Health
### @@@ Laura Essermann, M.D., M.B.A – University of California, San Francisco ### 1850554###Author###Professor of Surgery###University of California, San Francisco###
Author: Laura Essermann, M.D., M.B.A – University of California, San Francisco
### @@@ Rita A. Mukhtar, MD – University of California, San Francisco ### 937434###Author###Associate Professor###University of California, San Francisco###
Author: Rita A. Mukhtar, MD – University of California, San Francisco
### @@@ ISPY2 Locoregional Working Group, . – UCSF ### 2212206###Author###Working Group###UCSF###
Author: ISPY2 Locoregional Working Group, . – UCSF
###
30: Impact of Social Determinants of Health on Melanoma Nodal Surveillance in a Multi-Institutional Cohort

Kelsey B. Montgomery, MD – Department of Surgery, University of Alabama at Birmingham ### 1530259###Abstract Presenter###General Surgery Resident###Department of Surgery, University of Alabama at Birmingham###
Abstract Presenter: Kelsey B. Montgomery, MD – Department of Surgery, University of Alabama at Birmingham
### @@@ Kelsey B. Montgomery, MD – Department of Surgery, University of Alabama at Birmingham ### 1530259###Submitter###General Surgery Resident###Department of Surgery, University of Alabama at Birmingham###
Submitter: Kelsey B. Montgomery, MD – Department of Surgery, University of Alabama at Birmingham
### @@@ Kelsey B. Montgomery, MD – Department of Surgery, University of Alabama at Birmingham ### 1530259###Author###General Surgery Resident###Department of Surgery, University of Alabama at Birmingham###
Author: Kelsey B. Montgomery, MD – Department of Surgery, University of Alabama at Birmingham
### @@@ M. Chandler C. McLeod, PhD – Department of Surgery, University of Alabama at Birmingham ### 1851378###Author###Biostatistician###Department of Surgery, University of Alabama at Birmingham###
Author: M. Chandler C. McLeod, PhD – Department of Surgery, University of Alabama at Birmingham
### @@@ Danielle K. DePalo, MD (she/her/hers) – Department of General Surgery, University of Massachusetts Chan Medical School, Boston, MA ### 1530301###Author###Resident###Department of General Surgery, University of Massachusetts Chan Medical School, Boston, MA###
Author: Danielle K. DePalo, MD (she/her/hers) – Department of General Surgery, University of Massachusetts Chan Medical School, Boston, MA
### she/her/hers @@@ Michelle M. Dugan, MD – Cutaneous Oncology Department, Moffitt Cancer Center, Tampa, FL ### 2204602###Author###Research Fellow###Cutaneous Oncology Department, Moffitt Cancer Center, Tampa, FL###
Author: Michelle M. Dugan, MD – Cutaneous Oncology Department, Moffitt Cancer Center, Tampa, FL
### @@@ Jonathan S. Zager, MD – H. Lee Moffitt Cancer Center and Research Institute ### 917915###Author###Cutaneous Surgeon###H. Lee Moffitt Cancer Center and Research Institute###
Author: Jonathan S. Zager, MD – H. Lee Moffitt Cancer Center and Research Institute
### @@@ Kelly M. Elleson, MD – Department of Cutaneous Oncology, Moffitt Cancer Center ### 1534861###Author###Research Fellow###Department of Cutaneous Oncology, Moffitt Cancer Center###
Author: Kelly M. Elleson, MD – Department of Cutaneous Oncology, Moffitt Cancer Center
### @@@ Michael S. Sabel, MD – University of Michigan ### 1851377###Author###Professor###University of Michigan###
Author: Michael S. Sabel, MD – University of Michigan
### @@@ Tina J. Hieken, MD – Mayo Clinic ### 937357###Author###Professor of Surgery###Mayo Clinic###
Author: Tina J. Hieken, MD – Mayo Clinic
### @@@ Lisa Kottschade, APRN, C.N.P – Mayo Clinic ### 2204745###Author###Nurse Practitioner###Mayo Clinic###
Author: Lisa Kottschade, APRN, C.N.P – Mayo Clinic
### @@@ David W. Ollila, MD – Department of Surgery, University of North Carolina ### 937358###Author###Professor of Surgery###Department of Surgery, University of North Carolina###
Author: David W. Ollila, MD – Department of Surgery, University of North Carolina
### @@@ Veronica Pham, MPH – Department of Surgery, University of North Carolina ### 2212103###Author###Research Manager###Department of Surgery, University of North Carolina###
Author: Veronica Pham, MPH – Department of Surgery, University of North Carolina
### @@@ Dion Archer, BSBA – Department of Surgery, University of North Carolina ### 1852249###Author###Research Coordinator###Department of Surgery, University of North Carolina###
Author: Dion Archer, BSBA – Department of Surgery, University of North Carolina
### @@@ Russell S. Berman, MD (he/him/his) – Department of Surgery, NYU Langone Health ### 1262631###Author###Professor###Department of Surgery, NYU Langone Health###
Author: Russell S. Berman, MD (he/him/his) – Department of Surgery, NYU Langone Health
### he/him/his @@@ Ann Y. Lee, MD – Department of Surgery, NYU Langone Health ### 1214740###Author###Assistant Professor###Department of Surgery, NYU Langone Health###
Author: Ann Y. Lee, MD – Department of Surgery, NYU Langone Health
### @@@ Jessica A. Cintolo-Gonzalez, MD – Department of Surgery, University of Vemont ### 1534967###Author###Associate Professor###Department of Surgery, University of Vemont###
Author: Jessica A. Cintolo-Gonzalez, MD – Department of Surgery, University of Vemont
### @@@ Hannah G. McDonald, MD – Department of Surgery, University of Kentucky ### 1850054###Author###General Surgery Resident###Department of Surgery, University of Kentucky###
Author: Hannah G. McDonald, MD – Department of Surgery, University of Kentucky
### @@@ Erin E. Burke, MD MS – Department of Surgery, University of Kentucky ### 1527022###Author###Assistant Professor###Department of Surgery, University of Kentucky###
Author: Erin E. Burke, MD MS – Department of Surgery, University of Kentucky
### @@@ Kristen E. Rhodin, MD, MHS – Duke University Medical Center ### 1530206###Author###General Surgery Resident###Duke University Medical Center###
Author: Kristen E. Rhodin, MD, MHS – Duke University Medical Center
### @@@ Georgia M. Beasley, MD MHS (she/her/hers) – Duke University Medical Center ### 938016###Author###Associate Professor of Surgery with tenure###Duke University Medical Center###
Author: Georgia M. Beasley, MD MHS (she/her/hers) – Duke University Medical Center
### she/her/hers @@@ Kristy K. Broman, MD, MPH (she/her/hers) – Department of Surgery, University of Alabama at Birmingham ### 970017###Author###Assistant Professor###Department of Surgery, University of Alabama at Birmingham###
Author: Kristy K. Broman, MD, MPH (she/her/hers) – Department of Surgery, University of Alabama at Birmingham
### she/her/hers
31: Gender Differences Amongst Leaders in Surgical Oncology

Fedra Fallahian, MD – University of Texas Southwestern ### 2212190###Abstract Presenter###Breast Surgical Oncology Fellow###University of Texas Southwestern###
Abstract Presenter: Fedra Fallahian, MD – University of Texas Southwestern
### @@@ Fedra Fallahian, MD – University of Texas Southwestern ### 2212190###Submitter###Breast Surgical Oncology Fellow###University of Texas Southwestern###
Submitter: Fedra Fallahian, MD – University of Texas Southwestern
### @@@ Fedra Fallahian, MD – University of Texas Southwestern ### 2212190###Author###Breast Surgical Oncology Fellow###University of Texas Southwestern###
Author: Fedra Fallahian, MD – University of Texas Southwestern
### @@@ Catherine Jennings, MD – UT Southwestern ### 2212096###Author###Breast Fellow###UT Southwestern###
Author: Catherine Jennings, MD – UT Southwestern
### @@@ Rachel Wooldridge, MD – UT Southwestern ### 1851192###Author###Breast Surgical Oncologist###UT Southwestern###
Author: Rachel Wooldridge, MD – UT Southwestern
### @@@ Anthony Froix, MD – UT Ssouthwestern ### 1851194###Author###Breast Surgical Oncologist###UT Ssouthwestern###
Author: Anthony Froix, MD – UT Ssouthwestern
### @@@ Stephanie Serres, MD, PhD – UT Southwestern ### 1851502###Author###Breast Surgical Oncologist###UT Southwestern###
Author: Stephanie Serres, MD, PhD – UT Southwestern
### @@@ Deborah E. Farr, MD – UT Southwestern ### 1530304###Author###Breast Surgical Oncologist###UT Southwestern###
Author: Deborah E. Farr, MD – UT Southwestern
### @@@ Anvy Nguyen, MD – UT Southwestern ### 2212099###Author###Breast Surgical Oncologist###UT Southwestern###
Author: Anvy Nguyen, MD – UT Southwestern
### @@@ Shruti Zaveri, MD – UT Southwestern ### 2212098###Author###Breast Surgical Oncologist###UT Southwestern###
Author: Shruti Zaveri, MD – UT Southwestern
### @@@ Marilyn Leitch, MD – UT Southwestern ### 1851193###Author###Breast Surgical Oncologist###UT Southwestern###
Author: Marilyn Leitch, MD – UT Southwestern
###
32: The Impact of Neighborhood Socioeconomic Deprivation on Overall Survival for Resectable Pancreatic Cancer Patients in Florida: An Incidence-Based Retrospective Cohort Study

Nadege T. Fackche, MD (she/her/hers) – Moffitt Cancer Center ### 2212192###Abstract Presenter###Clinical Fellow###Moffitt Cancer Center###
Abstract Presenter: Nadege T. Fackche, MD (she/her/hers) – Moffitt Cancer Center
### she/her/hers @@@ Nadege T. Fackche, MD (she/her/hers) – Moffitt Cancer Center ### 2212192###Submitter###Clinical Fellow###Moffitt Cancer Center###
Submitter: Nadege T. Fackche, MD (she/her/hers) – Moffitt Cancer Center
### she/her/hers @@@ Nadege T. Fackche, MD (she/her/hers) – Moffitt Cancer Center ### 2212192###Author###Clinical Fellow###Moffitt Cancer Center###
Author: Nadege T. Fackche, MD (she/her/hers) – Moffitt Cancer Center
### she/her/hers @@@ Jenny B Permuth, PhD – Moffitt Cancer Center ### 2204785###Author###GI Oncology###Moffitt Cancer Center###
Author: Jenny B Permuth, PhD – Moffitt Cancer Center
### @@@ Susan T. Vadaparampil, PhD, MPH – Moffitt Cancer Center ### 2212193###Author###Professor###Moffitt Cancer Center###
Author: Susan T. Vadaparampil, PhD, MPH – Moffitt Cancer Center
### @@@ Dung-Tsa Chen, PhD – Moffitt Cancer Center ### 2212194###Author###Faculty###Moffitt Cancer Center###
Author: Dung-Tsa Chen, PhD – Moffitt Cancer Center
### @@@ Jiannong Li, PhD – Moffitt Cancer Center ### 2212195###Author###Faculty, Bioinformatics###Moffitt Cancer Center###
Author: Jiannong Li, PhD – Moffitt Cancer Center
### @@@ Nathanael Stanley, PhD – Moffitt Cancer Center ### 2212196###Author###Applied research scientist###Moffitt Cancer Center###
Author: Nathanael Stanley, PhD – Moffitt Cancer Center
### @@@ Margaret A Park, PhD – Moffitt Cancer Center ### 2204780###Author###GI Oncology###Moffitt Cancer Center###
Author: Margaret A Park, PhD – Moffitt Cancer Center
### @@@ Cheryl Knott, PhD – University of Maryland ### 2212197###Author###Professor, behavioral and community health###University of Maryland###
Author: Cheryl Knott, PhD – University of Maryland
### @@@ Daniel A. Anaya, MD, MSHCT – Moffitt Cancer Center ### 1795359###Author###Professor and Chief, GI Surgery. Head - Hepatobiliary Section###Moffitt Cancer Center###
Author: Daniel A. Anaya, MD, MSHCT – Moffitt Cancer Center
### @@@ Jason B. B. Fleming, MD (he/him/his) – Moffitt Cancer Center ### 1824899###Author###GI Oncology###Moffitt Cancer Center###
Author: Jason B. B. Fleming, MD (he/him/his) – Moffitt Cancer Center
### he/him/his @@@ Benjamin Powers, MD – University of Maryland ### 2212169###Author###University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center###University of Maryland###
Author: Benjamin Powers, MD – University of Maryland
###
33: Racial Disparities Among Histologic Subtypes and Clinical Outcomes in Retroperitoneal Liposarcoma

Noor Habboosh, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center; Montefiore Medical Center/Albert Einstein College of Medicine ### 2211981###Abstract Presenter###Surgical Oncology Research Fellow; Surgical Resident###Memorial Sloan Kettering Cancer Center; Montefiore Medical Center/Albert Einstein College of Medicine###
Abstract Presenter: Noor Habboosh, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center; Montefiore Medical Center/Albert Einstein College of Medicine
### she/her/hers @@@ Noor Habboosh, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center; Montefiore Medical Center/Albert Einstein College of Medicine ### 2211981###Submitter###Surgical Oncology Research Fellow; Surgical Resident###Memorial Sloan Kettering Cancer Center; Montefiore Medical Center/Albert Einstein College of Medicine###
Submitter: Noor Habboosh, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center; Montefiore Medical Center/Albert Einstein College of Medicine
### she/her/hers @@@ Priyanka Parmar, MD – Montefiore Medical Center/Albert Einstein College of Medicine ### 2211982###Author###Surgical Resident###Montefiore Medical Center/Albert Einstein College of Medicine###
Author: Priyanka Parmar, MD – Montefiore Medical Center/Albert Einstein College of Medicine
### @@@ Rajika Jindani, MD – Montefiore Medical Center/Albert Einstein College of Medicine ### 2211983###Author###Surgical Resident###Montefiore Medical Center/Albert Einstein College of Medicine###
Author: Rajika Jindani, MD – Montefiore Medical Center/Albert Einstein College of Medicine
### @@@ Katia Papalezova, MD – Montefiore Medical Center/Albert Einstein College of Medicine ### 2211984###Author###Attending - Surgical Oncology###Montefiore Medical Center/Albert Einstein College of Medicine###
Author: Katia Papalezova, MD – Montefiore Medical Center/Albert Einstein College of Medicine
###
34: High Tumor Grade Predicts Somatic/Germline RET Mutation Status and Greater Regional Lymph Node Burden in Medullary Thyroid Carcinoma

Aradhya Nigam, MD (he/him/his) – Medstar Georgetown University Hospital ### 1530265###Abstract Presenter###Resident Physician###Medstar Georgetown University Hospital###
Abstract Presenter: Aradhya Nigam, MD (he/him/his) – Medstar Georgetown University Hospital
### he/him/his @@@ Aradhya Nigam, MD (he/him/his) – Medstar Georgetown University Hospital ### 1530265###Submitter###Resident Physician###Medstar Georgetown University Hospital###
Submitter: Aradhya Nigam, MD (he/him/his) – Medstar Georgetown University Hospital
### he/him/his @@@ Aradhya Nigam, MD (he/him/his) – Medstar Georgetown University Hospital ### 1530265###Author###Resident Physician###Medstar Georgetown University Hospital###
Author: Aradhya Nigam, MD (he/him/his) – Medstar Georgetown University Hospital
### he/him/his @@@ Bin Xu, MD, PhD – Memorial Sloan Kettering ### 2212084###Author###Assistant Attending###Memorial Sloan Kettering###
Author: Bin Xu, MD, PhD – Memorial Sloan Kettering
### @@@ Philip Spanheimer, MD (he/him/his) – University of North Carolina ### 1851640###Author###Attending###University of North Carolina###
Author: Philip Spanheimer, MD (he/him/his) – University of North Carolina
### he/him/his @@@ R Michael Tuttle, MD – Memorial Sloan Kettering ### 2212085###Author###Attending###Memorial Sloan Kettering###
Author: R Michael Tuttle, MD – Memorial Sloan Kettering
### @@@ Richard Wong, MD, PhD – Memorial Sloan Kettering ### 2212086###Author###Attending###Memorial Sloan Kettering###
Author: Richard Wong, MD, PhD – Memorial Sloan Kettering
### @@@ Ashok R. Shaha, MD (he/him/his) – Memorial Sloan Kettering ### 1533003###Author###Attending###Memorial Sloan Kettering###
Author: Ashok R. Shaha, MD (he/him/his) – Memorial Sloan Kettering
### he/him/his @@@ Ian Ganly, MD, PhD – Memorial Sloan Kettering ### 2212087###Author###Attending###Memorial Sloan Kettering###
Author: Ian Ganly, MD, PhD – Memorial Sloan Kettering
### @@@ Rony Ghossein, MD – Memorial Sloan Kettering ### 2212088###Author###Attending###Memorial Sloan Kettering###
Author: Rony Ghossein, MD – Memorial Sloan Kettering
### @@@ Brian R. Untch, MD – Memorial Sloan Kettering ### 937412###Author###Attending###Memorial Sloan Kettering###
Author: Brian R. Untch, MD – Memorial Sloan Kettering
###
35: Re-Evaluation of the Importance of Tumor Size in Surgical Decision-Making for Well-Differentiated Thyroid Cancer

Jesse E. Passman, MD MPH (he/him/his) – Department of Surgery, Hospital of the University of Pennsylvania ### 1849746###Abstract Presenter###Surgery Resident###Department of Surgery, Hospital of the University of Pennsylvania###
Abstract Presenter: Jesse E. Passman, MD MPH (he/him/his) – Department of Surgery, Hospital of the University of Pennsylvania
### he/him/his @@@ Jesse E. Passman, MD MPH (he/him/his) – Department of Surgery, Hospital of the University of Pennsylvania ### 1849746###Submitter###Surgery Resident###Department of Surgery, Hospital of the University of Pennsylvania###
Submitter: Jesse E. Passman, MD MPH (he/him/his) – Department of Surgery, Hospital of the University of Pennsylvania
### he/him/his @@@ Jesse E. Passman, MD MPH (he/him/his) – Department of Surgery, Hospital of the University of Pennsylvania ### 1849746###Author###Surgery Resident###Department of Surgery, Hospital of the University of Pennsylvania###
Author: Jesse E. Passman, MD MPH (he/him/his) – Department of Surgery, Hospital of the University of Pennsylvania
### he/him/his @@@ Sara P. Ginzberg, MD MSHP (she/her/hers) – Hospital of the University of Pennsylvania ### 1530236###Author###Resident, Department of Surgery###Hospital of the University of Pennsylvania###
Author: Sara P. Ginzberg, MD MSHP (she/her/hers) – Hospital of the University of Pennsylvania
### she/her/hers @@@ James Sharpe, MS – University of Pennsylvania Health System ### 2212198###Author###Statistician###University of Pennsylvania Health System###
Author: James Sharpe, MS – University of Pennsylvania Health System
### @@@ Caitlin Finn, MD MSHP – Weill Cornell Medicine Department of Surgery ### 2212199###Author###Surgery Resident###Weill Cornell Medicine Department of Surgery###
Author: Caitlin Finn, MD MSHP – Weill Cornell Medicine Department of Surgery
### @@@ Rachel R. Kelz, MD MSCE MBA – University of Pennsylvania ### 1851165###Author###Professor###University of Pennsylvania###
Author: Rachel R. Kelz, MD MSCE MBA – University of Pennsylvania
### @@@ Heather Wachtel, MD (she/her/hers) – Department of Surgery, Hospital of the University of Pennsylvania ### 1214763###Author###Associate Professor of Surgery###Department of Surgery, Hospital of the University of Pennsylvania###
Author: Heather Wachtel, MD (she/her/hers) – Department of Surgery, Hospital of the University of Pennsylvania
### she/her/hers
36: Phosphoproteomic Mass Spectrometry Reveals A Novel Therapeutic Target in Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors

Tracey Pu, MD – National Cancer Institute | National Institutes of Health ### 1849919###Abstract Presenter###Surgical Oncology Research Fellow###National Cancer Institute | National Institutes of Health###
Abstract Presenter: Tracey Pu, MD – National Cancer Institute | National Institutes of Health
### @@@ Tracey Pu, MD – National Cancer Institute | National Institutes of Health ### 1849919###Submitter###Surgical Oncology Research Fellow###National Cancer Institute | National Institutes of Health###
Submitter: Tracey Pu, MD – National Cancer Institute | National Institutes of Health
### @@@ Tracey Pu, MD – National Cancer Institute | National Institutes of Health ### 1849919###Author###Surgical Oncology Research Fellow###National Cancer Institute | National Institutes of Health###
Author: Tracey Pu, MD – National Cancer Institute | National Institutes of Health
### @@@ Steven Forsythe, PhD – National Cancer Institute | National Institutes of Health ### 2212260###Author###Postdoctoral Fellow###National Cancer Institute | National Institutes of Health###
Author: Steven Forsythe, PhD – National Cancer Institute | National Institutes of Health
### @@@ Priyanka Desai, PhD – National Cancer Institute | National Institutes of Health ### 2212263###Author###Postdoctoral Fellow###National Cancer Institute | National Institutes of Health###
Author: Priyanka Desai, PhD – National Cancer Institute | National Institutes of Health
### @@@ Brian A. Joughin, PhD – Massachusetts Institute of Technology ### 2212264###Author###Research Scientist###Massachusetts Institute of Technology###
Author: Brian A. Joughin, PhD – Massachusetts Institute of Technology
### @@@ Ronald Holewinski, PhD – Fredrick National Labratory for Cancer Research ### 2212213###Author###Scientist II###Fredrick National Labratory for Cancer Research###
Author: Ronald Holewinski, PhD – Fredrick National Labratory for Cancer Research
### @@@ Thorkell Andresson, PhD – Fredrick National Labratory for Cancer Research ### 2212214###Author###Scientist, Team Lead###Fredrick National Labratory for Cancer Research###
Author: Thorkell Andresson, PhD – Fredrick National Labratory for Cancer Research
### @@@ Carolina Larrain, MD – National Cancer Institute ### 2212216###Author###Surgical Oncology Research Fellow###National Cancer Institute###
Author: Carolina Larrain, MD – National Cancer Institute
### @@@ Jack Victory, MD – National Cancer Institute ### 2212217###Author###Surgical Oncology Research Fellow###National Cancer Institute###
Author: Jack Victory, MD – National Cancer Institute
### @@@ Amber Leila Sarvestani, MD – NCI ### 1534946###Author###Surgical Oncology Research Fellow###NCI###
Author: Amber Leila Sarvestani, MD – NCI
### @@@ Yuri Lin, BS – National Cancer Institute ### 2212215###Author###Postbaccalaureate###National Cancer Institute###
Author: Yuri Lin, BS – National Cancer Institute
### @@@ Sarfraz R. Akmal, BS – Rutgers New Jersey Medical School ### 2212265###Author###Medical Student###Rutgers New Jersey Medical School###
Author: Sarfraz R. Akmal, BS – Rutgers New Jersey Medical School
### @@@ Suresh Kumar, PhD – National Institutes of Health ### 2212266###Author###Staff Scientist###National Institutes of Health###
Author: Suresh Kumar, PhD – National Institutes of Health
### @@@ Naris Nilubol, MD – National Cancer Institute | National Institutes of Health ### 2211946###Author###Attending Surgeon###National Cancer Institute | National Institutes of Health###
Author: Naris Nilubol, MD – National Cancer Institute | National Institutes of Health
### @@@ Jeremy L. Davis, MD, FACS (he/him/his) – National Cancer Institute ### 969549###Author###Principal Investigator###National Cancer Institute###
Author: Jeremy L. Davis, MD, FACS (he/him/his) – National Cancer Institute
### he/him/his @@@ Andrew M. Blakely, MD – National Cancer Institute ### 1849920###Author###Principal Investigator###National Cancer Institute###
Author: Andrew M. Blakely, MD – National Cancer Institute
### @@@ David E. Kleiner, MD, PhD – National Cancer Institute | National Institutes of Health ### 2212268###Author###Senior Research Physician###National Cancer Institute | National Institutes of Health###
Author: David E. Kleiner, MD, PhD – National Cancer Institute | National Institutes of Health
### @@@ Samira Sadowski, MD – National Cancer Institute | National Institutes of Health ### 2212270###Author###Assistant Clinical Investigator###National Cancer Institute | National Institutes of Health###
Author: Samira Sadowski, MD – National Cancer Institute | National Institutes of Health
### @@@ Jadira del Rivero, MD – Developmental Therapeutics Branch/NIH ### 2212271###Author###Associate Research Physician###Developmental Therapeutics Branch/NIH###
Author: Jadira del Rivero, MD – Developmental Therapeutics Branch/NIH
### @@@ Michael B. Yaffe, MD, PhD – BIDMC, Koch Institute for Integrative Cancer Research at MIT ### 2212273###Author###Attending Surgeon###BIDMC, Koch Institute for Integrative Cancer Research at MIT###
Author: Michael B. Yaffe, MD, PhD – BIDMC, Koch Institute for Integrative Cancer Research at MIT
### @@@ Jonathan M. Hernandez, MD – Surgical Oncology Program, National Cancer Institute ### 972423###Author###Investigator###Surgical Oncology Program, National Cancer Institute###
Author: Jonathan M. Hernandez, MD – Surgical Oncology Program, National Cancer Institute
###
37: Image-based Measures of Obesity are Associated with Alterations in Metabolic Pathways in Non-Small Cell Lung Cancer.

Akhil Goud Pachimatla – Roswell park Comprehensive Cancer center ### 2212127###Abstract Presenter###Post-Doctoral Research Affiliate###Roswell park Comprehensive Cancer center###
Abstract Presenter: Akhil Goud Pachimatla – Roswell park Comprehensive Cancer center
### @@@ Akhil Goud Pachimatla – Roswell park Comprehensive Cancer center ### 2212127###Submitter###Post-Doctoral Research Affiliate###Roswell park Comprehensive Cancer center###
Submitter: Akhil Goud Pachimatla – Roswell park Comprehensive Cancer center
### @@@ Akhil Goud Pachimatla – Roswell park Comprehensive Cancer center ### 2212127###Author###Post-Doctoral Research Affiliate###Roswell park Comprehensive Cancer center###
Author: Akhil Goud Pachimatla – Roswell park Comprehensive Cancer center
### @@@ Yeshwanth Vedire, MD – Roswell park comprehensive cancer center ### 2212130###Author###Post- Doctoral Research Affiliate###Roswell park comprehensive cancer center###
Author: Yeshwanth Vedire, MD – Roswell park comprehensive cancer center
### @@@ Sukumar Kalvapudi, MD – Roswell park comprehensive cancer center ### 2212131###Author###Post- Doctoral Research Affiliate###Roswell park comprehensive cancer center###
Author: Sukumar Kalvapudi, MD – Roswell park comprehensive cancer center
### @@@ kaylan Gee, MD – Roswell park comprehensive cancer center ### 2212132###Author###Post-Doctoral Research Affiliate###Roswell park comprehensive cancer center###
Author: kaylan Gee, MD – Roswell park comprehensive cancer center
### @@@ Hua-Hsin Hsiao, MD – Roswell Park Comprehensive cancer center ### 2212133###Author###Biostatistician###Roswell Park Comprehensive cancer center###
Author: Hua-Hsin Hsiao, MD – Roswell Park Comprehensive cancer center
### @@@ Todd Demmy, MD – Roswell Park Comprehensive Cancer Center ### 2204636###Author###Professor###Roswell Park Comprehensive Cancer Center###
Author: Todd Demmy, MD – Roswell Park Comprehensive Cancer Center
### @@@ Spencer Rosario, PhD – Roswell Park Comprehensive cancer center ### 2212134###Author###Assistant professor###Roswell Park Comprehensive cancer center###
Author: Spencer Rosario, PhD – Roswell Park Comprehensive cancer center
### @@@ Sai Yendamuri, MD, MBA – Roswell Park Comprehensive Cancer Center ### 2204635###Author###Professor and Chair of Thoracic Surgery###Roswell Park Comprehensive Cancer Center###
Author: Sai Yendamuri, MD, MBA – Roswell Park Comprehensive Cancer Center
###
38: Correlation between DOI (Depth of Invasion) on MRI and DOI on HPE in Squamous Cell Carcinoma Oral Tongue and Proposal of corresponding Radiological Staging Cut-offs: An Experience in 887 Patients at a tertiary Cancer Care Centre in India

kalpit goriwal, DNB, MNAMS, FMAS, DrNB* (he/him/his) – National Board of Examinations ### 2212056###Abstract Presenter###DrNB (Doctorate of National Board) Surgical Oncology###National Board of Examinations###
Abstract Presenter: kalpit goriwal, DNB, MNAMS, FMAS, DrNB* (he/him/his) – National Board of Examinations
### he/him/his @@@ kalpit goriwal, DNB, MNAMS, FMAS, DrNB* (he/him/his) – National Board of Examinations ### 2212056###Submitter###DrNB (Doctorate of National Board) Surgical Oncology###National Board of Examinations###
Submitter: kalpit goriwal, DNB, MNAMS, FMAS, DrNB* (he/him/his) – National Board of Examinations
### he/him/his @@@ kalpit goriwal, DNB, MNAMS, FMAS, DrNB* (he/him/his) – National Board of Examinations ### 2212056###Author###DrNB (Doctorate of National Board) Surgical Oncology###National Board of Examinations###
Author: kalpit goriwal, DNB, MNAMS, FMAS, DrNB* (he/him/his) – National Board of Examinations
### he/him/his @@@ kaustubh patel, MS, M.Ch (Surgical Oncology) – HCG Cancer Centre ### 2212058###Author###consultant###HCG Cancer Centre###
Author: kaustubh patel, MS, M.Ch (Surgical Oncology) – HCG Cancer Centre
### @@@ naman pandya, MS (OMFS) – HCG Cancer Centre ### 2212057###Author###fellow###HCG Cancer Centre###
Author: naman pandya, MS (OMFS) – HCG Cancer Centre
### @@@ dushyant mandlik, MS – HCG Cancer Centre ### 2212059###Author###consultant###HCG Cancer Centre###
Author: dushyant mandlik, MS – HCG Cancer Centre
###
39: SDHB-associated Pheochromocytomas: What is their clinical behavior?

Thomas Szabo Yamashita, MD (he/him/his) – Emory ### 970114###Abstract Presenter###Assistant Professor###Emory###
Abstract Presenter: Thomas Szabo Yamashita, MD (he/him/his) – Emory
### he/him/his @@@ Thomas Szabo Yamashita, MD (he/him/his) – Emory ### 970114###Submitter###Assistant Professor###Emory###
Submitter: Thomas Szabo Yamashita, MD (he/him/his) – Emory
### he/him/his @@@ Thomas Szabo Yamashita, MD (he/him/his) – Emory ### 970114###Author###Assistant Professor###Emory###
Author: Thomas Szabo Yamashita, MD (he/him/his) – Emory
### he/him/his @@@ Andres Tames-Elorduy, MD – MD Anderson ### 2211785###Author###Research Fellow###MD Anderson###
Author: Andres Tames-Elorduy, MD – MD Anderson
### @@@ Catherine Skefos, n/a – MD Anderson Cancer Center ### 2211786###Author###Genetic Counselor###MD Anderson Cancer Center###
Author: Catherine Skefos, n/a – MD Anderson Cancer Center
### @@@ Jeena Varghese, MD – MD Anderson Cancer Center ### 2211787###Author###Assistant Professor###MD Anderson Cancer Center###
Author: Jeena Varghese, MD – MD Anderson Cancer Center
### @@@ Mouhammed Habra, MD – MD Anderson Cancer Center ### 2211788###Author###Assistant Professor###MD Anderson Cancer Center###
Author: Mouhammed Habra, MD – MD Anderson Cancer Center
### @@@ Sarah B. Fisher, MD – MD Anderson Cancer Center ### 1429041###Author###Assistant Professor###MD Anderson Cancer Center###
Author: Sarah B. Fisher, MD – MD Anderson Cancer Center
### @@@ Paul H. Graham, MD – MD Anderson Cancer Center ### 1791621###Author###Assistant Professor###MD Anderson Cancer Center###
Author: Paul H. Graham, MD – MD Anderson Cancer Center
### @@@ Elizabeth G. Grubbs, MD – MD Anderson Cancer Center ### 937401###Author###Professor###MD Anderson Cancer Center###
Author: Elizabeth G. Grubbs, MD – MD Anderson Cancer Center
### @@@ Steven Waguespack, MD – MD Anderson Cancer Center ### 2211789###Author###Professor###MD Anderson Cancer Center###
Author: Steven Waguespack, MD – MD Anderson Cancer Center
### @@@ Camilo Jimenez, MD – MD Anderson Cancer Center ### 2211790###Author###Professor###MD Anderson Cancer Center###
Author: Camilo Jimenez, MD – MD Anderson Cancer Center
### @@@ Nancy D. Perrier, MD – The University of Texas MD Anderson Cancer Center ### 2211791###Author###Professor###The University of Texas MD Anderson Cancer Center###
Author: Nancy D. Perrier, MD – The University of Texas MD Anderson Cancer Center
###
4: International Validation of a Staging Model for de novo Metastatic Breast Cancer

Jennifer K. Plichta, MD, MS (she/her/hers) – Duke University School of Medicine ### 1184674###Abstract Presenter###Associate Professor of Surgery, Surgical Oncology###Duke University School of Medicine###
Abstract Presenter: Jennifer K. Plichta, MD, MS (she/her/hers) – Duke University School of Medicine
### she/her/hers @@@ Jennifer K. Plichta, MD, MS (she/her/hers) – Duke University School of Medicine ### 1184674###Submitter###Associate Professor of Surgery, Surgical Oncology###Duke University School of Medicine###
Submitter: Jennifer K. Plichta, MD, MS (she/her/hers) – Duke University School of Medicine
### she/her/hers @@@ Jennifer K. Plichta, MD, MS (she/her/hers) – Duke University School of Medicine ### 1184674###Author###Associate Professor of Surgery, Surgical Oncology###Duke University School of Medicine###
Author: Jennifer K. Plichta, MD, MS (she/her/hers) – Duke University School of Medicine
### she/her/hers @@@ Samantha M. Thomas, MS – Duke Cancer Institute ### 1849711###Author###Principal Biostatistician###Duke Cancer Institute###
Author: Samantha M. Thomas, MS – Duke Cancer Institute
### @@@ Sabine Siesling, PhD – Department of Research and Development, Netherlands Comprehensive CancerOrganisation (IKNL), Utrecht, The Netherlands; Department of Health Technology andServices Research, University of Twente, Technical Medical Centre, Enschede, TheNetherlands ### 2212135###Author###Clinical Epidemiologist, Senior Researcher, Full Professor at University of Twente###Department of Research and Development, Netherlands Comprehensive CancerOrganisation (IKNL), Utrecht, The Netherlands; Department of Health Technology andServices Research, University of Twente, Technical Medical Centre, Enschede, TheNetherlands###
Author: Sabine Siesling, PhD – Department of Research and Development, Netherlands Comprehensive CancerOrganisation (IKNL), Utrecht, The Netherlands; Department of Health Technology andServices Research, University of Twente, Technical Medical Centre, Enschede, TheNetherlands
### @@@ Linda De Munck, MSc – Department of Research and Development; Netherlands Comprehensive CancerOrganisation (IKNL), Utrecht, The Netherlands ### 2212137###Author###Research###Department of Research and Development; Netherlands Comprehensive CancerOrganisation (IKNL), Utrecht, The Netherlands###
Author: Linda De Munck, MSc – Department of Research and Development; Netherlands Comprehensive CancerOrganisation (IKNL), Utrecht, The Netherlands
### @@@ Amélie Lusque, MS – Biostatistics & Health Data Science Unit, Institut Claudius Regaud, IUCT-oncopole,Toulouse, France ### 2212138###Author###Biostatistician###Biostatistics & Health Data Science Unit, Institut Claudius Regaud, IUCT-oncopole,Toulouse, France###
Author: Amélie Lusque, MS – Biostatistics & Health Data Science Unit, Institut Claudius Regaud, IUCT-oncopole,Toulouse, France
### @@@ Thomas Grinda, MD, MSc – Department of Cancer Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94800Villejuif, France ### 2212139###Author###Assistant spécialiste###Department of Cancer Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94800Villejuif, France###
Author: Thomas Grinda, MD, MSc – Department of Cancer Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94800Villejuif, France
### @@@ Lovedeep Gondara, PhD, MS – BCCancer –Data and Analytics ### 2212140###Author###Research Scientist###BCCancer –Data and Analytics###
Author: Lovedeep Gondara, PhD, MS – BCCancer –Data and Analytics
### @@@ Stephen Chia, MD, FRCP – Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada ### 2212141###Author###Physician###Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada###
Author: Stephen Chia, MD, FRCP – Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada
### @@@ Paula Cabrera-Galeana, MD, MSc – Breast Medical Oncology Department, Instituto Nacional de Cancerología ### 1851662###Author###Medical Oncologist###Breast Medical Oncology Department, Instituto Nacional de Cancerología###
Author: Paula Cabrera-Galeana, MD, MSc – Breast Medical Oncology Department, Instituto Nacional de Cancerología
### @@@ Nancy Reynoso-Noverón, MD, MS – Instituto Nacional de Cancerología, CDMX, México ### 2212142###Author###Director of Research###Instituto Nacional de Cancerología, CDMX, México###
Author: Nancy Reynoso-Noverón, MD, MS – Instituto Nacional de Cancerología, CDMX, México
### @@@ Sara López-Tarruella Cobo, MD, PhD – Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria GregorioMarañón (IiSGM), Universidad Complutense. CIBERONC-ISCIII. GEICAM Spanish BreastCancer Group. Madris, Spain ### 2212143###Author###Medical Oncologist###Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria GregorioMarañón (IiSGM), Universidad Complutense. CIBERONC-ISCIII. GEICAM Spanish BreastCancer Group. Madris, Spain###
Author: Sara López-Tarruella Cobo, MD, PhD – Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria GregorioMarañón (IiSGM), Universidad Complutense. CIBERONC-ISCIII. GEICAM Spanish BreastCancer Group. Madris, Spain
### @@@ Isabel Alvarez Lopez, MD – Medical Oncology Unit of Donostia University Hospital (Donostialdea IHO); GEICAM,Madrid, Spain ### 2212145###Author###Attending Physician###Medical Oncology Unit of Donostia University Hospital (Donostialdea IHO); GEICAM,Madrid, Spain###
Author: Isabel Alvarez Lopez, MD – Medical Oncology Unit of Donostia University Hospital (Donostialdea IHO); GEICAM,Madrid, Spain
### @@@ Stephen B. Edge, MD (he/him/his) – Department of Surgical Oncology and Cancer Prevention and Control, University atBuffalo. Buffalo, NY, USA; Roswell Park Comprehensive Cancer Center. Buffalo, NY, USA ### 1795371###Author###Professor of Oncology###Department of Surgical Oncology and Cancer Prevention and Control, University atBuffalo. Buffalo, NY, USA; Roswell Park Comprehensive Cancer Center. Buffalo, NY, USA###
Author: Stephen B. Edge, MD (he/him/his) – Department of Surgical Oncology and Cancer Prevention and Control, University atBuffalo. Buffalo, NY, USA; Roswell Park Comprehensive Cancer Center. Buffalo, NY, USA
### he/him/his @@@ Gabriel Hortobagyi, MD – Department of Breast Medical Oncology, Division of Cancer Medicine, The University ofTexas MD Anderson Cancer Center, Houston, TX, USA ### 2212146###Author###Nellie B. Connally Chair in Breast Cancer###Department of Breast Medical Oncology, Division of Cancer Medicine, The University ofTexas MD Anderson Cancer Center, Houston, TX, USA###
Author: Gabriel Hortobagyi, MD – Department of Breast Medical Oncology, Division of Cancer Medicine, The University ofTexas MD Anderson Cancer Center, Houston, TX, USA
###
40: Spatial Transcriptomics Reveals Molecular Subtypes of Pancreatobiliary IPMN

Matthew K. Iyer, MD/PhD (he/him/his) – University of Michigan ### 1530293###Abstract Presenter###Clinical Assistant Professor###University of Michigan###
Abstract Presenter: Matthew K. Iyer, MD/PhD (he/him/his) – University of Michigan
### he/him/his @@@ Matthew K. Iyer, MD/PhD (he/him/his) – University of Michigan ### 1530293###Submitter###Clinical Assistant Professor###University of Michigan###
Submitter: Matthew K. Iyer, MD/PhD (he/him/his) – University of Michigan
### he/him/his @@@ Matthew K. Iyer, MD/PhD (he/him/his) – University of Michigan ### 1530293###Author###Clinical Assistant Professor###University of Michigan###
Author: Matthew K. Iyer, MD/PhD (he/him/his) – University of Michigan
### he/him/his @@@ Ashley Fletcher, BS – Duke University Medical Center ### 1850024###Author###Bioinformatics Staff###Duke University Medical Center###
Author: Ashley Fletcher, BS – Duke University Medical Center
### @@@ Chanjuan Shi, MD, PhD – Duke University ### 2212148###Author###Professor of Pathology###Duke University###
Author: Chanjuan Shi, MD, PhD – Duke University
### @@@ Elishama Kanu, MD – Duke University ### 1849699###Author###Resident###Duke University###
Author: Elishama Kanu, MD – Duke University
### @@@ Matthew Bao, BS – Duke University ### 1849958###Author###Clinical Research Assistant###Duke University###
Author: Matthew Bao, BS – Duke University
### @@@ Austin M. Eckhoff, MD – Duke University Medical Center ### 918099###Author###General Surgery Resident###Duke University Medical Center###
Author: Austin M. Eckhoff, MD – Duke University Medical Center
### @@@ Daniel P. Nussbaum, MD – Duke University Medical Center ### 1849701###Author###Assistant Professor of Surgery###Duke University Medical Center###
Author: Daniel P. Nussbaum, MD – Duke University Medical Center
### @@@ Peter J. Allen, MD – Duke University Medical Center ### 937324###Author###Professor of Surgery###Duke University Medical Center###
Author: Peter J. Allen, MD – Duke University Medical Center
###
41: Combination of tumor and CAF subtypes better predict response to neoadjuvant therapy in pancreatic cancer

Jaewon Lee, MD – University of North Carolina at Chapel Hill ### 2212254###Abstract Presenter###Surgical Oncology Fellow###University of North Carolina at Chapel Hill###
Abstract Presenter: Jaewon Lee, MD – University of North Carolina at Chapel Hill
### @@@ Jaewon Lee, MD – University of North Carolina at Chapel Hill ### 2212254###Submitter###Surgical Oncology Fellow###University of North Carolina at Chapel Hill###
Submitter: Jaewon Lee, MD – University of North Carolina at Chapel Hill
### @@@ Jaewon Lee, MD – University of North Carolina at Chapel Hill ### 2212254###Author###Surgical Oncology Fellow###University of North Carolina at Chapel Hill###
Author: Jaewon Lee, MD – University of North Carolina at Chapel Hill
### @@@ Joseph Kearney, M.D. – UNC Hospitals- General Surgery ### 1530263###Author###Surgery resident, Clinical research fellow###UNC Hospitals- General Surgery###
Author: Joseph Kearney, M.D. – UNC Hospitals- General Surgery
### @@@ Priscilla Chan, n/a – UNC Chapel Hill ### 2212256###Author###Research Technician###UNC Chapel Hill###
Author: Priscilla Chan, n/a – UNC Chapel Hill
### @@@ Elena Kharitonova, n/a – University of North Carolina at Chapel Hill ### 2212257###Author###Graduate Student###University of North Carolina at Chapel Hill###
Author: Elena Kharitonova, n/a – University of North Carolina at Chapel Hill
### @@@ Arthi Hariharan, n/a – University of North Carolina at Chapel Hill ### 2212258###Author###Graduate Research Assistant###University of North Carolina at Chapel Hill###
Author: Arthi Hariharan, n/a – University of North Carolina at Chapel Hill
### @@@ Michelle LaBella, MD – University of North Carolina ### 2212123###Author###Resident###University of North Carolina###
Author: Michelle LaBella, MD – University of North Carolina
### @@@ Ashley Morrison, n/a – University of North Carolina at Chapel Hill ### 2212259###Author###Research Technician###University of North Carolina at Chapel Hill###
Author: Ashley Morrison, n/a – University of North Carolina at Chapel Hill
### @@@ Ashley Cliff, PhD – University of North Carolina at Chapel Hill ### 2212261###Author###Research Associate###University of North Carolina at Chapel Hill###
Author: Ashley Cliff, PhD – University of North Carolina at Chapel Hill
### @@@ Michael Meyers, MD – University of North Carolina at Chapel Hill ### 1851985###Author###Professor###University of North Carolina at Chapel Hill###
Author: Michael Meyers, MD – University of North Carolina at Chapel Hill
### @@@ Hong Jin Kim, MD – University of North Carolina at Chapel Hill ### 1214733###Author###Professor###University of North Carolina at Chapel Hill###
Author: Hong Jin Kim, MD – University of North Carolina at Chapel Hill
### @@@ Naim Rashid, PhD – University of North Carolina at Chapel Hill ### 2212262###Author###Associate Professor###University of North Carolina at Chapel Hill###
Author: Naim Rashid, PhD – University of North Carolina at Chapel Hill
### @@@ Xianlu Peng, PhD – University of North Carolina at Chapel Hill ### 1851982###Author###Assistant Professor###University of North Carolina at Chapel Hill###
Author: Xianlu Peng, PhD – University of North Carolina at Chapel Hill
### @@@ Jen Jen Yeh, MD – University of North Carolina at Chapel Hill ### 2105683###Author###Professor###University of North Carolina at Chapel Hill###
Author: Jen Jen Yeh, MD – University of North Carolina at Chapel Hill
###
42: Salvage Hepatic Artery Infusion Chemotherapy after First Line Systemic Failure in Patients with Unresectable Cholangiocarcinoma

Misha Armstrong, MD MPH (she/her/hers) – New York Presbyterian / Weill Cornell Medicine ### 2211986###Abstract Presenter###General Surgery Resident###New York Presbyterian / Weill Cornell Medicine###
Abstract Presenter: Misha Armstrong, MD MPH (she/her/hers) – New York Presbyterian / Weill Cornell Medicine
### she/her/hers @@@ Misha Armstrong, MD MPH (she/her/hers) – New York Presbyterian / Weill Cornell Medicine ### 2211986###Submitter###General Surgery Resident###New York Presbyterian / Weill Cornell Medicine###
Submitter: Misha Armstrong, MD MPH (she/her/hers) – New York Presbyterian / Weill Cornell Medicine
### she/her/hers @@@ Naaz Nasar, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center ### 2204684###Author###Research Fellow###Memorial Sloan Kettering Cancer Center###
Author: Naaz Nasar, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center
### she/her/hers @@@ Joanne Chou, MS – Memorial Sloan Kettering Cancer Center ### 1850548###Author###Biostatistician###Memorial Sloan Kettering Cancer Center###
Author: Joanne Chou, MS – Memorial Sloan Kettering Cancer Center
### @@@ Mithat Gonen, PhD – Memorial Sloan Kettering Cancer Center ### 1849709###Author###Chief of Epidemiology and Biostatistics###Memorial Sloan Kettering Cancer Center###
Author: Mithat Gonen, PhD – Memorial Sloan Kettering Cancer Center
### @@@ Kevin C. C. Soares, MD – Memorial Sloan Kettering Cancer Center ### 1850358###Author###Assistant Attending Surgeon###Memorial Sloan Kettering Cancer Center###
Author: Kevin C. C. Soares, MD – Memorial Sloan Kettering Cancer Center
### @@@ Vinod P. Balachandran, MD – Memorial Sloan Kettering Cancer Center ### 1807418###Author###Assistant Attending Surgeon###Memorial Sloan Kettering Cancer Center###
Author: Vinod P. Balachandran, MD – Memorial Sloan Kettering Cancer Center
### @@@ Jeffrey A. Drebin, MD, PhD – Memorial Sloan Kettering Cancer Center ### 1850356###Author###Chair of Surgery###Memorial Sloan Kettering Cancer Center###
Author: Jeffrey A. Drebin, MD, PhD – Memorial Sloan Kettering Cancer Center
### @@@ T. Peter Kingham, MD – Memorial Sloan Kettering Cancer Center ### 1850357###Author###Attending Surgeon###Memorial Sloan Kettering Cancer Center###
Author: T. Peter Kingham, MD – Memorial Sloan Kettering Cancer Center
### @@@ Alice C. Wei, MD, MS, FRCSC (she/her/hers) – Memorial Sloan Kettering Cancer Center ### 937479###Author###Attending Surgeon###Memorial Sloan Kettering Cancer Center###
Author: Alice C. Wei, MD, MS, FRCSC (she/her/hers) – Memorial Sloan Kettering Cancer Center
### she/her/hers @@@ Michael I. I. D'Angelica, MD – Memorial Sloan Kettering Cancer Center ### 894400###Author###Attending Surgeon###Memorial Sloan Kettering Cancer Center###
Author: Michael I. I. D'Angelica, MD – Memorial Sloan Kettering Cancer Center
### @@@ Andrea Cercek, MD – Memorial Sloan Kettering Cancer Center ### 1850438###Author###Associate Attending###Memorial Sloan Kettering Cancer Center###
Author: Andrea Cercek, MD – Memorial Sloan Kettering Cancer Center
### @@@ James J. J. Harding, MD – Memorial Sloan Kettering Cancer Center ### 1850445###Author###Assistant Attending###Memorial Sloan Kettering Cancer Center###
Author: James J. J. Harding, MD – Memorial Sloan Kettering Cancer Center
### @@@ Eileen M. O'Reilly, MD – Memorial Sloan Kettering Cancer Center ### 1851041###Author###Chair of Medical Oncology###Memorial Sloan Kettering Cancer Center###
Author: Eileen M. O'Reilly, MD – Memorial Sloan Kettering Cancer Center
### @@@ Ghassan K. Abou-Alfa, MD, MBA – Memorial Sloan Kettering Cancer Center ### 1214110###Author###Attending###Memorial Sloan Kettering Cancer Center###
Author: Ghassan K. Abou-Alfa, MD, MBA – Memorial Sloan Kettering Cancer Center
### @@@ Wungki Park, MD – Memorial Sloan Kettering Cancer Center ### 2204688###Author###Attending###Memorial Sloan Kettering Cancer Center###
Author: Wungki Park, MD – Memorial Sloan Kettering Cancer Center
### @@@ Louise Connell, MD – Memorial Sloan Kettering Cancer Center ### 2211999###Author###Attending###Memorial Sloan Kettering Cancer Center###
Author: Louise Connell, MD – Memorial Sloan Kettering Cancer Center
### @@@ Nancy E. Kemeny, MD – Memorial Sloan Kettering Cancer Center ### 1850439###Author###Attending###Memorial Sloan Kettering Cancer Center###
Author: Nancy E. Kemeny, MD – Memorial Sloan Kettering Cancer Center
### @@@ William R. R. Jarnagin, MD – Memorial Sloan Kettering Cancer Center ### 1850359###Author###Chief of Hepatopancreatobiliary Surgery###Memorial Sloan Kettering Cancer Center###
Author: William R. R. Jarnagin, MD – Memorial Sloan Kettering Cancer Center
###
43: An Update On The Phase I Study to Evaluate the Safety and Tolerability of SX-682 in Combination with Anti-PD1 as Maintenance Therapy for Unresectable Pancreatic Adenocarcinoma

Nicholas A. Ullman, MD – University of Rochester Medical Center ### 970003###Abstract Presenter###Surgery Resident###University of Rochester Medical Center###
Abstract Presenter: Nicholas A. Ullman, MD – University of Rochester Medical Center
### @@@ Nicholas A. Ullman, MD – University of Rochester Medical Center ### 970003###Submitter###Surgery Resident###University of Rochester Medical Center###
Submitter: Nicholas A. Ullman, MD – University of Rochester Medical Center
### @@@ Nicholas A. Ullman, MD – University of Rochester Medical Center ### 970003###Author###Surgery Resident###University of Rochester Medical Center###
Author: Nicholas A. Ullman, MD – University of Rochester Medical Center
### @@@ Richard Dunne, MD – University of Rochester ### 1849891###Author###Medical Oncoligst###University of Rochester###
Author: Richard Dunne, MD – University of Rochester
### @@@ Daniel Mulkerin, MD – University of Rochester ### 1849899###Author###Medical Oncologist###University of Rochester###
Author: Daniel Mulkerin, MD – University of Rochester
### @@@ Brian Belt, JD – University of Rochester ### 1849892###Author###Linehan Lab Manager###University of Rochester###
Author: Brian Belt, JD – University of Rochester
### @@@ Luis I. Ruffolo, MD – University of Rochester ### 969999###Author###Surgery Resident###University of Rochester###
Author: Luis I. Ruffolo, MD – University of Rochester
### @@@ Paul R. Burchard, MD – University of Rochester ### 1184658###Author###Surgery Resident###University of Rochester###
Author: Paul R. Burchard, MD – University of Rochester
### @@@ Matthew Byrne, MD – University of Rochester Medical Center ### 2211781###Author###Resident###University of Rochester Medical Center###
Author: Matthew Byrne, MD – University of Rochester Medical Center
### @@@ Mary Georger, MS – University of Rochester ### 1849893###Author###Histopathologist###University of Rochester###
Author: Mary Georger, MS – University of Rochester
### @@@ Aram Hezel, MD – University of Rochester ### 1849894###Author###Medical Oncologist###University of Rochester###
Author: Aram Hezel, MD – University of Rochester
### @@@ Jason Zittel, MD – University of Rochester ### 1849895###Author###Medical Oncologist###University of Rochester###
Author: Jason Zittel, MD – University of Rochester
### @@@ Wenjia Wang, MD – University of Rochester ### 1849896###Author###Medical Oncologist###University of Rochester###
Author: Wenjia Wang, MD – University of Rochester
### @@@ Erika Ramsdale, MD – University of Rochester ### 1849870###Author###Medical Oncologist###University of Rochester###
Author: Erika Ramsdale, MD – University of Rochester
### @@@ Vivek Kaul, MD – University of Rochester ### 1849897###Author###Gastroenterologist###University of Rochester###
Author: Vivek Kaul, MD – University of Rochester
### @@@ John Zebala, MD – Syntrix Pharmaceuticals ### 1849898###Author###Syntrix CEO###Syntrix Pharmaceuticals###
Author: John Zebala, MD – Syntrix Pharmaceuticals
### @@@ David Linehan, MD – University of Rochester Medical Center ### 937335###Author###Surgical Oncologist###University of Rochester Medical Center###
Author: David Linehan, MD – University of Rochester Medical Center
###
44: Utility of circulating tumor DNA (ctDNA) for detection of minimal residual disease (MRD) after curative-intent therapy in localized pancreatic cancer (PDAC)

Ujwal R. Yanala, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center. ### 2211941###Abstract Presenter###Surgical Oncology Fellow###University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.###
Abstract Presenter: Ujwal R. Yanala, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
### @@@ Ujwal R. Yanala, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center. ### 2211941###Submitter###Surgical Oncology Fellow###University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.###
Submitter: Ujwal R. Yanala, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
### @@@ Ujwal R. Yanala, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center. ### 2211941###Author###Surgical Oncology Fellow###University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.###
Author: Ujwal R. Yanala, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
### @@@ Mary Martos, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center. ### 2204759###Author###Resident###University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.###
Author: Mary Martos, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
### @@@ Erin M. Dickey, MD, MBS – Department of Surgery, University of Miami Miller School of Medicine ### 2204637###Author###Post Doctoral Fellow###Department of Surgery, University of Miami Miller School of Medicine###
Author: Erin M. Dickey, MD, MBS – Department of Surgery, University of Miami Miller School of Medicine
### @@@ Andres Corona, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center. ### 2212063###Author###Resident###University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.###
Author: Andres Corona, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
### @@@ Nkiruka Ezenwajiaku, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center. ### 2204760###Author###Assistant Professor###University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.###
Author: Nkiruka Ezenwajiaku, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
### @@@ Joseph Pizzolato, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center. ### 2212064###Author###Associate Professor###University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.###
Author: Joseph Pizzolato, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
### @@@ Gretel Terrero, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center. ### 2212065###Author###Associate Professor###University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.###
Author: Gretel Terrero, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
### @@@ Caitlin A. Hester, MD – Division of Surgical Oncology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Cente ### 2211945###Author###Assistant Professor of Clinical Surgery###Division of Surgical Oncology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Cente###
Author: Caitlin A. Hester, MD – Division of Surgical Oncology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Cente
### @@@ Nipun B. Merchant, MD – Department of Surgery, University of Miami ### 1849851###Author###Surgical Oncologist###Department of Surgery, University of Miami###
Author: Nipun B. Merchant, MD – Department of Surgery, University of Miami
### @@@ Peter Hosein, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center. ### 1852103###Author###Associate Professor###University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.###
Author: Peter Hosein, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
### @@@ Jashodeep Datta, MD (he/him/his) – Department of Surgery, University of Miami Sylvester Comprehensive Cancer Center ### 1849948###Author###Assistant Professor of Surgery###Department of Surgery, University of Miami Sylvester Comprehensive Cancer Center###
Author: Jashodeep Datta, MD (he/him/his) – Department of Surgery, University of Miami Sylvester Comprehensive Cancer Center
### he/him/his
45: Postoperative Complications Following Neoadjuvant Therapy and Surgery in a Phase 2 Borderline Resectable Pancreatic Cancer Clinical Trial (Alliance A021501)

Rebecca A. Snyder, MD, MPH (she/her/hers) – The University of Texas MD Anderson Cancer Center ### 1849816###Abstract Presenter###Associate Professor###The University of Texas MD Anderson Cancer Center###
Abstract Presenter: Rebecca A. Snyder, MD, MPH (she/her/hers) – The University of Texas MD Anderson Cancer Center
### she/her/hers @@@ Rebecca A. Snyder, MD, MPH (she/her/hers) – The University of Texas MD Anderson Cancer Center ### 1849816###Submitter###Associate Professor###The University of Texas MD Anderson Cancer Center###
Submitter: Rebecca A. Snyder, MD, MPH (she/her/hers) – The University of Texas MD Anderson Cancer Center
### she/her/hers @@@ Rebecca A. Snyder, MD, MPH (she/her/hers) – The University of Texas MD Anderson Cancer Center ### 1849816###Author###Associate Professor###The University of Texas MD Anderson Cancer Center###
Author: Rebecca A. Snyder, MD, MPH (she/her/hers) – The University of Texas MD Anderson Cancer Center
### she/her/hers @@@ Tyler J. Zemla, MS – Alliance Statistics and Data Management Center ### 2211782###Author###Principal Biostatistician###Alliance Statistics and Data Management Center###
Author: Tyler J. Zemla, MS – Alliance Statistics and Data Management Center
### @@@ Qian Shi, PhD – Alliance Statistics and Data Management Center ### 2211783###Author###Professor of Biostatistics and Oncology, Lead Statistician###Alliance Statistics and Data Management Center###
Author: Qian Shi, PhD – Alliance Statistics and Data Management Center
### @@@ Diana Segovia, BS – Alliance Statistics and Data Management Center ### 2211784###Author###Statistical Programmer###Alliance Statistics and Data Management Center###
Author: Diana Segovia, BS – Alliance Statistics and Data Management Center
### @@@ Syed A. Ahmad, MD (he/him/his) – University of Cincinnati Cancer Center ### 1803898###Author###Professor of Surgery, Director University of Cincinnati Cancer Center###University of Cincinnati Cancer Center###
Author: Syed A. Ahmad, MD (he/him/his) – University of Cincinnati Cancer Center
### he/him/his @@@ Eileen M. O'Reilly, MD – Memorial Sloan Kettering Cancer Center ### 1851041###Author###Chair of Medical Oncology###Memorial Sloan Kettering Cancer Center###
Author: Eileen M. O'Reilly, MD – Memorial Sloan Kettering Cancer Center
### @@@ Joseph M. Herman, MD – Northwell Health Cancer Institute ### 1852587###Author###Director of Clinical Research###Northwell Health Cancer Institute###
Author: Joseph M. Herman, MD – Northwell Health Cancer Institute
### @@@ Matthew H.G Katz, MD (he/him/his) – Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center ### 937480###Author###Professor and Chair###Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center###
Author: Matthew H.G Katz, MD (he/him/his) – Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center
### he/him/his
46: A novel mechanism of immunotherapy sensitivity following platinum chemotherapy resistance in pancreatic cancer patients with germline homologous recombination deficiency

Ifeanyichukwu Ogobuiro, MD, MHS – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center ### 1530239###Abstract Presenter###T32 Surgical Oncology Research Fellow/Radiation Oncology Resident###University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center###
Abstract Presenter: Ifeanyichukwu Ogobuiro, MD, MHS – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
### @@@ Ifeanyichukwu Ogobuiro, MD, MHS – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center ### 1530239###Submitter###T32 Surgical Oncology Research Fellow/Radiation Oncology Resident###University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center###
Submitter: Ifeanyichukwu Ogobuiro, MD, MHS – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
### @@@ Ifeanyichukwu Ogobuiro, MD, MHS – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center ### 1530239###Author###T32 Surgical Oncology Research Fellow/Radiation Oncology Resident###University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center###
Author: Ifeanyichukwu Ogobuiro, MD, MHS – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
### @@@ Karthik Rajkumar, PhD – University of Miami ### 2212200###Author###Post-Doc###University of Miami###
Author: Karthik Rajkumar, PhD – University of Miami
### @@@ Anna Bianchi, PhD – University of Miami School of Medicine - Miami, FL ### 1184669###Author###Computational and Cancer Biology Scientist###University of Miami School of Medicine - Miami, FL###
Author: Anna Bianchi, PhD – University of Miami School of Medicine - Miami, FL
### @@@ Lucas Caeiro, PhD – University of Miami School of Medicine - Miami, FL ### 2212201###Author###Post-Doc###University of Miami School of Medicine - Miami, FL###
Author: Lucas Caeiro, PhD – University of Miami School of Medicine - Miami, FL
### @@@ Haleh Amirian, MD, MS – University of Miami School of Medicine - Miami, FL ### 1852092###Author###Post-Doc###University of Miami School of Medicine - Miami, FL###
Author: Haleh Amirian, MD, MS – University of Miami School of Medicine - Miami, FL
### @@@ Luis Nivelo, MS – University of Miami School of Medicine - Miami, FL ### 2212202###Author###PhD Candidate###University of Miami School of Medicine - Miami, FL###
Author: Luis Nivelo, MS – University of Miami School of Medicine - Miami, FL
### @@@ Iago De Castro Silva, MD – University of South Florida ### 1850058###Author###Surgery Resident###University of South Florida###
Author: Iago De Castro Silva, MD – University of South Florida
### @@@ Andrew Adam, MS – University of Miami School of Medicine - Miami, FL ### 2212203###Author###PhD Candidate###University of Miami School of Medicine - Miami, FL###
Author: Andrew Adam, MS – University of Miami School of Medicine - Miami, FL
### @@@ Vanessa Garrido, PhD – University of Miami School of Medicine - Miami, FL ### 2212204###Author###Post-Doc###University of Miami School of Medicine - Miami, FL###
Author: Vanessa Garrido, PhD – University of Miami School of Medicine - Miami, FL
### @@@ Samara Singh, BS – University of Miami School of Medicine - Miami, FL ### 1850131###Author###PhD Candidate###University of Miami School of Medicine - Miami, FL###
Author: Samara Singh, BS – University of Miami School of Medicine - Miami, FL
### @@@ Nagaraj Nagathihalli, PhD – University of Miami School of Medicine - Miami, FL ### 1850137###Author###Research Associate Professor###University of Miami School of Medicine - Miami, FL###
Author: Nagaraj Nagathihalli, PhD – University of Miami School of Medicine - Miami, FL
### @@@ Nipun B. Merchant, MD – Department of Surgery, University of Miami ### 1849851###Author###Surgical Oncologist###Department of Surgery, University of Miami###
Author: Nipun B. Merchant, MD – Department of Surgery, University of Miami
### @@@ Ramiro Verdun, PhD – University of Miami School of Medicine - Miami, FL ### 2212205###Author###Research Professor###University of Miami School of Medicine - Miami, FL###
Author: Ramiro Verdun, PhD – University of Miami School of Medicine - Miami, FL
### @@@ Jashodeep Datta, MD (he/him/his) – Department of Surgery, University of Miami Sylvester Comprehensive Cancer Center ### 1849948###Author###Assistant Professor of Surgery###Department of Surgery, University of Miami Sylvester Comprehensive Cancer Center###
Author: Jashodeep Datta, MD (he/him/his) – Department of Surgery, University of Miami Sylvester Comprehensive Cancer Center
### he/him/his
47: Chemotherapy Dose Density is Prognostic for Patients with Resectable Pancreas Cancer: A Secondary Analysis of SWOG S1505

Sameer H. Patel, MD, FSSO (he/him/his) – Division of Surgical Oncology, University of Cincinnati, Cincinnati, OH, United States ### 1529257###Abstract Presenter###Associate Professor###Division of Surgical Oncology, University of Cincinnati, Cincinnati, OH, United States###
Abstract Presenter: Sameer H. Patel, MD, FSSO (he/him/his) – Division of Surgical Oncology, University of Cincinnati, Cincinnati, OH, United States
### he/him/his @@@ Sameer H. Patel, MD, FSSO (he/him/his) – Division of Surgical Oncology, University of Cincinnati, Cincinnati, OH, United States ### 1529257###Submitter###Associate Professor###Division of Surgical Oncology, University of Cincinnati, Cincinnati, OH, United States###
Submitter: Sameer H. Patel, MD, FSSO (he/him/his) – Division of Surgical Oncology, University of Cincinnati, Cincinnati, OH, United States
### he/him/his @@@ Sameer H. Patel, MD, FSSO (he/him/his) – Division of Surgical Oncology, University of Cincinnati, Cincinnati, OH, United States ### 1529257###Author###Associate Professor###Division of Surgical Oncology, University of Cincinnati, Cincinnati, OH, United States###
Author: Sameer H. Patel, MD, FSSO (he/him/his) – Division of Surgical Oncology, University of Cincinnati, Cincinnati, OH, United States
### he/him/his @@@ Sarah Colby, PhD – Fred Hutchinson Cancer Center ### 2211800###Author###SWOG Statistical and Data Management Center###Fred Hutchinson Cancer Center###
Author: Sarah Colby, PhD – Fred Hutchinson Cancer Center
### @@@ Davendra Sohal, MD – University of Cincinnati College of Medicine ### 2211801###Author###Medical Oncology###University of Cincinnati College of Medicine###
Author: Davendra Sohal, MD – University of Cincinnati College of Medicine
### @@@ Katherine Guthrie, PhD – Fred Hutchinson Cancer Center ### 2211802###Author###SWOG Statistical and Data Management Center###Fred Hutchinson Cancer Center###
Author: Katherine Guthrie, PhD – Fred Hutchinson Cancer Center
### @@@ Lisa Kachnic, MD – Columbia University Irving Medical Center ### 2211803###Author###Radiation Oncology###Columbia University Irving Medical Center###
Author: Lisa Kachnic, MD – Columbia University Irving Medical Center
### @@@ Gabriela Chiorean, MD – University of Washington ### 2211804###Author###Medical Oncology###University of Washington###
Author: Gabriela Chiorean, MD – University of Washington
### @@@ Andrew M. Lowy, MD – Department of Surgery, Division of Surgical Oncology, University of California, San Diego ### 1851132###Author###Professor Surgery###Department of Surgery, Division of Surgical Oncology, University of California, San Diego###
Author: Andrew M. Lowy, MD – Department of Surgery, Division of Surgical Oncology, University of California, San Diego
### @@@ Flavio G. Rocha, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA ### 937409###Author###Professor###Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA###
Author: Flavio G. Rocha, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
### @@@ Philip Philip, MD – Wayne State University Henry Ford Cancer Institute ### 2211805###Author###Medical Oncology###Wayne State University Henry Ford Cancer Institute###
Author: Philip Philip, MD – Wayne State University Henry Ford Cancer Institute
### @@@ Syed A. Ahmad, MD (he/him/his) – University of Cincinnati Cancer Center ### 1803898###Author###Professor of Surgery, Director University of Cincinnati Cancer Center###University of Cincinnati Cancer Center###
Author: Syed A. Ahmad, MD (he/him/his) – University of Cincinnati Cancer Center
### he/him/his
48: Highly Sensitive Low Input Methylated Digital Droplet PCR Assay for Pancreatic Adenocarcinoma Molecular Subtyping

Hannah Trembath, MD – University of North Carolina ### 1851983###Abstract Presenter###General Surgery Resident###University of North Carolina###
Abstract Presenter: Hannah Trembath, MD – University of North Carolina
### @@@ Hannah Trembath, MD – University of North Carolina ### 1851983###Submitter###General Surgery Resident###University of North Carolina###
Submitter: Hannah Trembath, MD – University of North Carolina
### @@@ Hannah Trembath, MD – University of North Carolina ### 1851983###Author###General Surgery Resident###University of North Carolina###
Author: Hannah Trembath, MD – University of North Carolina
### @@@ Ian McCabe, B.S. – University of North Carolina at Chapel Hill ### 1851977###Author###PhD Student###University of North Carolina at Chapel Hill###
Author: Ian McCabe, B.S. – University of North Carolina at Chapel Hill
### @@@ Sandra Zarmer, B.S. – University of North Carolina at Chapel Hill ### 1851975###Author###PhD Student###University of North Carolina at Chapel Hill###
Author: Sandra Zarmer, B.S. – University of North Carolina at Chapel Hill
### @@@ Zachary Schrank, B.S. – University of North Carolina at Chapel Hill ### 1852173###Author###Medical Student###University of North Carolina at Chapel Hill###
Author: Zachary Schrank, B.S. – University of North Carolina at Chapel Hill
### @@@ Hannah Thel, B.S. – University of North Carolina at Chapel Hill ### 1852176###Author###Medical Student###University of North Carolina at Chapel Hill###
Author: Hannah Thel, B.S. – University of North Carolina at Chapel Hill
### @@@ Justin Ashby, B.S. – University of North Carolina at Chapel Hill ### 2212094###Author###Medical Student###University of North Carolina at Chapel Hill###
Author: Justin Ashby, B.S. – University of North Carolina at Chapel Hill
### @@@ Joseph Kearney, M.D. – UNC Hospitals- General Surgery ### 1530263###Author###Surgery resident, Clinical research fellow###UNC Hospitals- General Surgery###
Author: Joseph Kearney, M.D. – UNC Hospitals- General Surgery
### @@@ Yi Xu, B.S. – University of North Carolina at Chapel Hill ### 1852183###Author###PhD Student###University of North Carolina at Chapel Hill###
Author: Yi Xu, B.S. – University of North Carolina at Chapel Hill
### @@@ Gabriela Herrera, B.S. – University of North Carolina at Chapel Hill ### 1851980###Author###Research Technician###University of North Carolina at Chapel Hill###
Author: Gabriela Herrera, B.S. – University of North Carolina at Chapel Hill
### @@@ Des Weighill, Ph.D. – University of North Carolina at Chapel Hill ### 1852174###Author###Postdoctoral Associate###University of North Carolina at Chapel Hill###
Author: Des Weighill, Ph.D. – University of North Carolina at Chapel Hill
### @@@ Jen Jen Yeh, MD – University of North Carolina at Chapel Hill ### 2105683###Author###Professor###University of North Carolina at Chapel Hill###
Author: Jen Jen Yeh, MD – University of North Carolina at Chapel Hill
###
49: A Prospective Evaluation of a Modified Hepatic Arterial Infusion Floxuridine Reduced-Dose Protocol for Patients with Unresectable Colorectal Liver Metastases

Issac R. Schwantes, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA ### 2212233###Abstract Presenter###Resident Physician###Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA###
Abstract Presenter: Issac R. Schwantes, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
### @@@ Issac R. Schwantes, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA ### 2212233###Submitter###Resident Physician###Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA###
Submitter: Issac R. Schwantes, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
### @@@ Issac R. Schwantes, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA ### 2212233###Author###Resident Physician###Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA###
Author: Issac R. Schwantes, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
### @@@ Skye C. Mayo, MD MPH (he/him/his) – Department of Surgery, Division of Surgical Oncology, Oregon Health & Science University; Knight Cancer Institute; Portland, OR 97239 USA ### 969545###Author###Associate Professor###Department of Surgery, Division of Surgical Oncology, Oregon Health & Science University; Knight Cancer Institute; Portland, OR 97239 USA###
Author: Skye C. Mayo, MD MPH (he/him/his) – Department of Surgery, Division of Surgical Oncology, Oregon Health & Science University; Knight Cancer Institute; Portland, OR 97239 USA
### he/him/his @@@ Ranish K. Patel, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA ### 2211841###Author###Resident Physician###Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA###
Author: Ranish K. Patel, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
### @@@ Adel Kardosh, MD PhD – Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA ### 1533002###Author###Professor###Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA###
Author: Adel Kardosh, MD PhD – Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
### @@@ Jillian Paxton, PharmD – OHSU, Department of Pharmacy Services, Portland, OR 97239 USA ### 2212234###Author###Clinical Pharmacist###OHSU, Department of Pharmacy Services, Portland, OR 97239 USA###
Author: Jillian Paxton, PharmD – OHSU, Department of Pharmacy Services, Portland, OR 97239 USA
### @@@ Robert Eil, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA ### 2212235###Author###Assistant Professor###Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA###
Author: Robert Eil, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
### @@@ Emerson Chen, MD – Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA ### 2212236###Author###Assistant Professor###Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA###
Author: Emerson Chen, MD – Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
### @@@ Flavio G. Rocha, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA ### 937409###Author###Professor###Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA###
Author: Flavio G. Rocha, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
### @@@ Emile J. Latour, MS – Biostatistics Shared Resource, Knight Cancer Institute, Portland, OR 97239 USA ### 2211844###Author###Biostatistician###Biostatistics Shared Resource, Knight Cancer Institute, Portland, OR 97239 USA###
Author: Emile J. Latour, MS – Biostatistics Shared Resource, Knight Cancer Institute, Portland, OR 97239 USA
### @@@ Guillaume Pegna, MD – Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA ### 2212237###Author###Assistant Professor###Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA###
Author: Guillaume Pegna, MD – Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
### @@@ Charles Lopez, MD PhD – Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA ### 2212238###Author###Professor###Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA###
Author: Charles Lopez, MD PhD – Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
###
5: Change in Biomarker Profile after neoadjuvant chemotherapy is especially common in patients with HER2+ breast cancer subtype

Soumy Gottipati, BS (she/her/hers) – UCSF ### 2211993###Abstract Presenter###Research Assistant and Clinical Research Coordinator###UCSF###
Abstract Presenter: Soumy Gottipati, BS (she/her/hers) – UCSF
### she/her/hers @@@ Soumy Gottipati, BS (she/her/hers) – UCSF ### 2211993###Author###Research Assistant and Clinical Research Coordinator###UCSF###
Author: Soumy Gottipati, BS (she/her/hers) – UCSF
### she/her/hers @@@ molly Baxter, BA – UCSF ### 2211994###Author###research fellow###UCSF###
Author: molly Baxter, BA – UCSF
### @@@ Yunn-yi Chen, MD PhD – UCSF ### 2211995###Author###Professor of Clinical Pathology###UCSF###
Author: Yunn-yi Chen, MD PhD – UCSF
### @@@ Sara J Venters, PhD – UCSF ### 2211996###Author###Research Scientist###UCSF###
Author: Sara J Venters, PhD – UCSF
### @@@ Macy Goldbach, BS – University of Pennsylvania ### 1851262###Author###Research Fellow###University of Pennsylvania###
Author: Macy Goldbach, BS – University of Pennsylvania
### @@@ Diego Gonzalves, BA – University of Pennsylvania ### 1851263###Author###Research Fellow###University of Pennsylvania###
Author: Diego Gonzalves, BA – University of Pennsylvania
### @@@ Anupma Nayak, MD – University of Pennsylvania ### 1851561###Author###Associate Professor###University of Pennsylvania###
Author: Anupma Nayak, MD – University of Pennsylvania
### @@@ Rita A. Mukhtar, MD – University of California, San Francisco ### 937434###Author###Associate Professor###University of California, San Francisco###
Author: Rita A. Mukhtar, MD – University of California, San Francisco
### @@@ Judy C. Boughey, MD (she/her/hers) – Mayo Clinic ### 937371###Author###Chair, Division of Breast and Melanoma Surgical Oncology###Mayo Clinic###
Author: Judy C. Boughey, MD (she/her/hers) – Mayo Clinic
### she/her/hers @@@ Julia Tchou, MD PhD – University of Pennsylvania ### 1530212###Author###Professor of Clinical Surgery###University of Pennsylvania###
Author: Julia Tchou, MD PhD – University of Pennsylvania
###
50: Novel Targets in Liver Metastases: Characterizing the Role of CD93 on Liver Sinusoidal Endothelial Cells

Elliott J. Yee, MD (he/him/his) – University of Colorado - Anschutz, CO ### 1850008###Abstract Presenter###General Surgery Resident###University of Colorado - Anschutz, CO###
Abstract Presenter: Elliott J. Yee, MD (he/him/his) – University of Colorado - Anschutz, CO
### he/him/his @@@ Elliott J. Yee, MD (he/him/his) – University of Colorado - Anschutz, CO ### 1850008###Submitter###General Surgery Resident###University of Colorado - Anschutz, CO###
Submitter: Elliott J. Yee, MD (he/him/his) – University of Colorado - Anschutz, CO
### he/him/his @@@ Elliott J. Yee, MD (he/him/his) – University of Colorado - Anschutz, CO ### 1850008###Author###General Surgery Resident###University of Colorado - Anschutz, CO###
Author: Elliott J. Yee, MD (he/him/his) – University of Colorado - Anschutz, CO
### he/him/his @@@ Isaac Vigil, BS – University of Colorado - Anschutz, CO ### 2211795###Author###Professional Research Assistant###University of Colorado - Anschutz, CO###
Author: Isaac Vigil, BS – University of Colorado - Anschutz, CO
### @@@ Yi Sun, MD – University of Colorado - Anschutz, CO ### 2211825###Author###Associate research professor###University of Colorado - Anschutz, CO###
Author: Yi Sun, MD – University of Colorado - Anschutz, CO
### @@@ Carlton Barnett, MD – University of Colorado - Anschutz, CO ### 2211826###Author###Professor###University of Colorado - Anschutz, CO###
Author: Carlton Barnett, MD – University of Colorado - Anschutz, CO
### @@@ Richard D. Schulick, MD, MBA – University of Colorado, Department of Surgery ### 1849721###Author###Chair of Surgery and Cancer Center Director###University of Colorado, Department of Surgery###
Author: Richard D. Schulick, MD, MBA – University of Colorado, Department of Surgery
### @@@ Yuwen Zhu, PhD – University of Colorado - Anschutz, CO ### 2211796###Author###Associate Professor###University of Colorado - Anschutz, CO###
Author: Yuwen Zhu, PhD – University of Colorado - Anschutz, CO
###
51: A Chemoresistance Signature to Predict FOLFIRINOX Sensitivity in Pancreatic Adenocarcinoma

Zachary Gao, MD – Baylor College of Medicine ### 1850521###Abstract Presenter###Research Resident###Baylor College of Medicine###
Abstract Presenter: Zachary Gao, MD – Baylor College of Medicine
### @@@ Zachary Gao, MD – Baylor College of Medicine ### 1850521###Submitter###Research Resident###Baylor College of Medicine###
Submitter: Zachary Gao, MD – Baylor College of Medicine
### @@@ Zachary Gao, MD – Baylor College of Medicine ### 1850521###Author###Research Resident###Baylor College of Medicine###
Author: Zachary Gao, MD – Baylor College of Medicine
### @@@ Jiangling Dong, PhD – Baylor College of Medicine ### 2211950###Author###Postdoctoral Researcher###Baylor College of Medicine###
Author: Jiangling Dong, PhD – Baylor College of Medicine
### @@@ Harinarayanan Janakiraman, PhD – Baylor College of Medicine ### 2211951###Author###Staff Scientist###Baylor College of Medicine###
Author: Harinarayanan Janakiraman, PhD – Baylor College of Medicine
### @@@ Jasmine Choi, BS – Baylor College of Medicine ### 2211952###Author###Research Technician###Baylor College of Medicine###
Author: Jasmine Choi, BS – Baylor College of Medicine
### @@@ Derek Erstad, MD – Baylor College of Medicine, Department of Surgery ### 2211953###Author###Assistant Professor###Baylor College of Medicine, Department of Surgery###
Author: Derek Erstad, MD – Baylor College of Medicine, Department of Surgery
### @@@ William Fisher, MD – Baylor College of Medicine, Department of Surgery ### 2211954###Author###Professor###Baylor College of Medicine, Department of Surgery###
Author: William Fisher, MD – Baylor College of Medicine, Department of Surgery
### @@@ George Van Buren, MD – Baylor College of Medicine, Department of Surgery ### 1850526###Author###Associate Professor###Baylor College of Medicine, Department of Surgery###
Author: George Van Buren, MD – Baylor College of Medicine, Department of Surgery
### @@@ Sung Wook Kang, PhD – Baylor College of Medicine ### 2211955###Author###Research Fellow###Baylor College of Medicine###
Author: Sung Wook Kang, PhD – Baylor College of Medicine
### @@@ Hyun-Sung Lee, MD, PhD – Baylor College of Medicine ### 2211956###Author###Associate Professor###Baylor College of Medicine###
Author: Hyun-Sung Lee, MD, PhD – Baylor College of Medicine
### @@@ E. Ramsay Camp, MD – Baylor College of Medicine ### 1499821###Author###Professor###Baylor College of Medicine###
Author: E. Ramsay Camp, MD – Baylor College of Medicine
###
52: Anti-HER-2 Chimeric Antigen Receptor T (CAR-T) Cells Immunotherapy for Pancreatic Cancer: An Innovative Surgically Derived Tumor Spheroid Model

‪lior Orbach, MD (he/him/his) – Surgery Division, Tel Aviv Sourasky Medical Center ### 2212012###Abstract Presenter###Resident###Surgery Division, Tel Aviv Sourasky Medical Center###
Abstract Presenter: ‪lior Orbach, MD (he/him/his) – Surgery Division, Tel Aviv Sourasky Medical Center
### he/him/his @@@ ‪lior Orbach, MD (he/him/his) – Surgery Division, Tel Aviv Sourasky Medical Center ### 2212012###Author###Resident###Surgery Division, Tel Aviv Sourasky Medical Center###
Author: ‪lior Orbach, MD (he/him/his) – Surgery Division, Tel Aviv Sourasky Medical Center
### he/him/his @@@ Shelly Loewenstein (she/her/hers) – Surgery Division, Tel Aviv Sourasky medical center ### 1534907###Author###Surgical Oncology research lab manager###Surgery Division, Tel Aviv Sourasky medical center###
Author: Shelly Loewenstein (she/her/hers) – Surgery Division, Tel Aviv Sourasky medical center
### she/her/hers @@@ Veronika Lerman, n/a – Immunology and Advanced CAR–T based cell therapy Laboratory, Tel-Aviv Sourasky Medical Center. ### 2212013###Author###Msc student###Immunology and Advanced CAR–T based cell therapy Laboratory, Tel-Aviv Sourasky Medical Center.###
Author: Veronika Lerman, n/a – Immunology and Advanced CAR–T based cell therapy Laboratory, Tel-Aviv Sourasky Medical Center.
### @@@ Daniella Vaskovich, n/a – Department of Physiology and Pharmacology, Faculty of Medicine, Tel-Aviv University ### 2212014###Author###MD-PhD student###Department of Physiology and Pharmacology, Faculty of Medicine, Tel-Aviv University###
Author: Daniella Vaskovich, n/a – Department of Physiology and Pharmacology, Faculty of Medicine, Tel-Aviv University
### @@@ Ron Kleiner, n/a – Department of Physiology and Pharmacology, Faculty of Medicine, Tel Aviv University ### 2212015###Author###PhD student###Department of Physiology and Pharmacology, Faculty of Medicine, Tel Aviv University###
Author: Ron Kleiner, n/a – Department of Physiology and Pharmacology, Faculty of Medicine, Tel Aviv University
### @@@ Anat Globerson Levin, n/a – Tel-Aviv Sourasky Medical Center ### 2212016###Author###Head of Immunology and Advanced CAR-T based cell therapy laboratory###Tel-Aviv Sourasky Medical Center###
Author: Anat Globerson Levin, n/a – Tel-Aviv Sourasky Medical Center
### @@@ Ronit Satchi-Fainaro, n/a – Department of Physiology and Pharmacology, Faculty of Medicine, Tel Aviv University ### 2212017###Author###Head cancer research and nanomedicine laboratory###Department of Physiology and Pharmacology, Faculty of Medicine, Tel Aviv University###
Author: Ronit Satchi-Fainaro, n/a – Department of Physiology and Pharmacology, Faculty of Medicine, Tel Aviv University
### @@@ Guy Lahat, n/a (he/him/his) – Tel-Aviv Sourasky Medical Center ### 1849774###Author###Head of Surgery Division###Tel-Aviv Sourasky Medical Center###
Author: Guy Lahat, n/a (he/him/his) – Tel-Aviv Sourasky Medical Center
### he/him/his
53: Preoperative exercise therapy attenuates surgical stress induced liver metastases by inducing Kupffer cell-mediated anti-tumor immunity

Susan J. Kim, MD (she/her/hers) – University of Virginia ### 2211866###Abstract Presenter###Post-doctoral Research Fellow###University of Virginia###
Abstract Presenter: Susan J. Kim, MD (she/her/hers) – University of Virginia
### she/her/hers @@@ Susan J. Kim, MD (she/her/hers) – University of Virginia ### 2211866###Submitter###Post-doctoral Research Fellow###University of Virginia###
Submitter: Susan J. Kim, MD (she/her/hers) – University of Virginia
### she/her/hers @@@ Susan J. Kim, MD (she/her/hers) – University of Virginia ### 2211866###Author###Post-doctoral Research Fellow###University of Virginia###
Author: Susan J. Kim, MD (she/her/hers) – University of Virginia
### she/her/hers @@@ Chengli Shen, MS, PhD – University of Virginia ### 2211867###Author###Research Scientist###University of Virginia###
Author: Chengli Shen, MS, PhD – University of Virginia
### @@@ Yunwei Zhang, MD PhD – University of Virginia ### 2211868###Author###Post-Doctoral Research Associate###University of Virginia###
Author: Yunwei Zhang, MD PhD – University of Virginia
### @@@ Hongji Zhang, Md PhD – University of Virginia ### 1850006###Author###Assistant Professor###University of Virginia###
Author: Hongji Zhang, Md PhD – University of Virginia
### @@@ Allan Tsung, MD – University of Virginia ### 1850005###Author###Chair of Department of Surgery, Professor of Surgery, Principal Investigator###University of Virginia###
Author: Allan Tsung, MD – University of Virginia
###
54: Galectin-9 is a regulator of immune interactions in the tumor microenvironment and represents a novel therapeutic target in biliary tract cancer.

Emilie A.K Warren, MD – Emory University ### 1850583###Abstract Presenter###Resident, Department of Surgery###Emory University###
Abstract Presenter: Emilie A.K Warren, MD – Emory University
### @@@ Emilie A.K Warren, MD – Emory University ### 1850583###Submitter###Resident, Department of Surgery###Emory University###
Submitter: Emilie A.K Warren, MD – Emory University
### @@@ Jacklyn N. Hammons, n/a – Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA ### 1850608###Author###Senior Research Specialist###Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA###
Author: Jacklyn N. Hammons, n/a – Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA
### @@@ Jessica M. Keilson, MD – Emory University ### 2212144###Author###Resident, Department of Surgery###Emory University###
Author: Jessica M. Keilson, MD – Emory University
### @@@ Guillermo O. Rangel Rivera, PhD – Division of Surgical Oncology, Department of Surgery, Department of Microbiology and Immunology, Winship Cancer Institute, Emory University, Atlanta, GA ### 2212101###Author###Graduate Student, MD PhD Candidate###Division of Surgical Oncology, Department of Surgery, Department of Microbiology and Immunology, Winship Cancer Institute, Emory University, Atlanta, GA###
Author: Guillermo O. Rangel Rivera, PhD – Division of Surgical Oncology, Department of Surgery, Department of Microbiology and Immunology, Winship Cancer Institute, Emory University, Atlanta, GA
### @@@ Megan M. Wyatt, MS – Division of Surgical Oncology, Department of Surgery, Department of Microbiology and Immunology, Winship Cancer Institute, Emory University ### 2212100###Author###Research Lab Manager, Senior Scientist###Division of Surgical Oncology, Department of Surgery, Department of Microbiology and Immunology, Winship Cancer Institute, Emory University###
Author: Megan M. Wyatt, MS – Division of Surgical Oncology, Department of Surgery, Department of Microbiology and Immunology, Winship Cancer Institute, Emory University
### @@@ Caroline R. Goel, MD – Emory University ### 1851519###Author###Resident, Department of Surgery###Emory University###
Author: Caroline R. Goel, MD – Emory University
### @@@ Curtis J. Henry, PhD – Emory University School of Medicine ### 2212150###Author###Assistant Professor, Division of Hematology & Oncology, Department of Pediatrics###Emory University School of Medicine###
Author: Curtis J. Henry, PhD – Emory University School of Medicine
### @@@ Sarah Kulkarni, n/a – Rollins School of Public Health, Emory University ### 2212151###Author###Graduate student, Department of Biostatistics and Bioinformatics###Rollins School of Public Health, Emory University###
Author: Sarah Kulkarni, n/a – Rollins School of Public Health, Emory University
### @@@ Yuan Liu, PhD, MS – Rollins School of Public Health, Emory University ### 2212152###Author###Associate Professor, Department of Biostatistics and Bioinformatics###Rollins School of Public Health, Emory University###
Author: Yuan Liu, PhD, MS – Rollins School of Public Health, Emory University
### @@@ Brian Robinson, MD, PhD – Emory University School of Medicine ### 2212162###Author###Assistant Professor, Department of Pathology and Laboratory Medicine###Emory University School of Medicine###
Author: Brian Robinson, MD, PhD – Emory University School of Medicine
### @@@ Alyssa M. Krasinskas, MD – Emory University School of Medicine ### 2212163###Author###Professor, Department of Pathology and Laboratory Medicine###Emory University School of Medicine###
Author: Alyssa M. Krasinskas, MD – Emory University School of Medicine
### @@@ Nilofer S. Azad, MD (she/her/hers) – Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD ### 1883441###Author###Co-Director of Cancer Genetics and Epigenetics, Professor of Oncology###Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD###
Author: Nilofer S. Azad, MD (she/her/hers) – Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
### she/her/hers @@@ Mark Yarchoan, MD – Johns Hopkins Hospital ### 2211913###Author###Associate Professor###Johns Hopkins Hospital###
Author: Mark Yarchoan, MD – Johns Hopkins Hospital
### @@@ Shishir K. Maithel, MD, FACS – Winship Cancer Institute of Emory University ### 917909###Author###Professor, Department of Surgery###Winship Cancer Institute of Emory University###
Author: Shishir K. Maithel, MD, FACS – Winship Cancer Institute of Emory University
### @@@ Chrystal M. Paulos, PhD – Division of Surgical Oncology, Department of Surgery, Department of Microbiology and Immunology, Winship Cancer Institute, Emory University ### 1850614###Author###Associate Professor, Director of Translational Research for Cutaneous Malignancies, PI###Division of Surgical Oncology, Department of Surgery, Department of Microbiology and Immunology, Winship Cancer Institute, Emory University###
Author: Chrystal M. Paulos, PhD – Division of Surgical Oncology, Department of Surgery, Department of Microbiology and Immunology, Winship Cancer Institute, Emory University
### @@@ Gregory B. Lesinski, PhD, MPH – Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University ### 1850615###Author###Professor, Co-Director Translational GI Malignancy Program###Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University###
Author: Gregory B. Lesinski, PhD, MPH – Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University
###
55: Autophagy Inhibition Enhances the Maturation and Activity of Tertiary Lymphoid Structures in Patients with Pancreatic Cancer

Renee R. Anderko, PhD (she/her/hers) – University of Pittsburgh, UPMC Hillman Cancer Center ### 2212223###Abstract Presenter###Postdoctoral Associate###University of Pittsburgh, UPMC Hillman Cancer Center###
Abstract Presenter: Renee R. Anderko, PhD (she/her/hers) – University of Pittsburgh, UPMC Hillman Cancer Center
### she/her/hers @@@ Renee R. Anderko, PhD (she/her/hers) – University of Pittsburgh, UPMC Hillman Cancer Center ### 2212223###Submitter###Postdoctoral Associate###University of Pittsburgh, UPMC Hillman Cancer Center###
Submitter: Renee R. Anderko, PhD (she/her/hers) – University of Pittsburgh, UPMC Hillman Cancer Center
### she/her/hers @@@ Renee R. Anderko, PhD (she/her/hers) – University of Pittsburgh, UPMC Hillman Cancer Center ### 2212223###Author###Postdoctoral Associate###University of Pittsburgh, UPMC Hillman Cancer Center###
Author: Renee R. Anderko, PhD (she/her/hers) – University of Pittsburgh, UPMC Hillman Cancer Center
### she/her/hers @@@ Annie Walgren, n/a – University of Pittsburgh, UPMC Hillman Cancer Center ### 2212224###Author###Undergraduate Research Fellow###University of Pittsburgh, UPMC Hillman Cancer Center###
Author: Annie Walgren, n/a – University of Pittsburgh, UPMC Hillman Cancer Center
### @@@ Pranav Murthy, MS – University of Pittsburgh, UPMC Hillman Cancer Center ### 2212225###Author###Research Fellow###University of Pittsburgh, UPMC Hillman Cancer Center###
Author: Pranav Murthy, MS – University of Pittsburgh, UPMC Hillman Cancer Center
### @@@ Sarah Bradley, n/a – University of Pittsburgh, UPMC Hillman Cancer Center ### 2212226###Author###Graduate Student Researcher###University of Pittsburgh, UPMC Hillman Cancer Center###
Author: Sarah Bradley, n/a – University of Pittsburgh, UPMC Hillman Cancer Center
### @@@ Sheryl Kunning, n/a – University of Pittsburgh, UPMC Hillman Cancer Center ### 2212227###Author###Senior Laboratory Technician###University of Pittsburgh, UPMC Hillman Cancer Center###
Author: Sheryl Kunning, n/a – University of Pittsburgh, UPMC Hillman Cancer Center
### @@@ Nathan Bahary, MD, PhD – AHN Cancer Institute ### 1849810###Author###Division Chief of Medical Oncology###AHN Cancer Institute###
Author: Nathan Bahary, MD, PhD – AHN Cancer Institute
### @@@ Aatur Singhi, MD, PhD – University of Pittsburgh Medical Center ### 937362###Author###Associate Professor of Anatomic Pathology###University of Pittsburgh Medical Center###
Author: Aatur Singhi, MD, PhD – University of Pittsburgh Medical Center
### @@@ Michael Lotze, MD – University of Pittsburgh, UPMC Hillman Cancer Center ### 2212228###Author###Professor of Surgery, Bioengineering, and Immunology###University of Pittsburgh, UPMC Hillman Cancer Center###
Author: Michael Lotze, MD – University of Pittsburgh, UPMC Hillman Cancer Center
### @@@ Herbert J. Zeh, III, MD – Department of Surgery, University of Texas Southwestern Medical Center ### 952880###Author###Professor and Chair###Department of Surgery, University of Texas Southwestern Medical Center###
Author: Herbert J. Zeh, III, MD – Department of Surgery, University of Texas Southwestern Medical Center
### @@@ Amer H. Zureikat, MD – Division of Surgical Oncology, University of Pittsburgh Medical Center ### 937460###Author###Professor and Chief###Division of Surgical Oncology, University of Pittsburgh Medical Center###
Author: Amer H. Zureikat, MD – Division of Surgical Oncology, University of Pittsburgh Medical Center
### @@@ Tullia Bruno, PhD – University of Pittsburgh, UPMC Hillman Cancer Center ### 2212229###Author###Assistant Professor of Immunology###University of Pittsburgh, UPMC Hillman Cancer Center###
Author: Tullia Bruno, PhD – University of Pittsburgh, UPMC Hillman Cancer Center
###
56: Disrupting TNFR2 Signaling Improves Chemotherapy sensitivity in Pancreatic Cancer

Haleh Amirian, MD, MS – University of Miami School of Medicine - Miami, FL ### 1852092###Abstract Presenter###Post-Doc###University of Miami School of Medicine - Miami, FL###
Abstract Presenter: Haleh Amirian, MD, MS – University of Miami School of Medicine - Miami, FL
### @@@ Haleh Amirian, MD, MS – University of Miami School of Medicine - Miami, FL ### 1852092###Submitter###Post-Doc###University of Miami School of Medicine - Miami, FL###
Submitter: Haleh Amirian, MD, MS – University of Miami School of Medicine - Miami, FL
### @@@ Anna Bianchi, PhD – University of Miami School of Medicine - Miami, FL ### 1184669###Author###Computational and Cancer Biology Scientist###University of Miami School of Medicine - Miami, FL###
Author: Anna Bianchi, PhD – University of Miami School of Medicine - Miami, FL
### @@@ Karthik Rajkumar, PhD – University of Miami ### 2212200###Author###Post-Doc###University of Miami###
Author: Karthik Rajkumar, PhD – University of Miami
### @@@ Andrew Adam, MS – University of Miami School of Medicine - Miami, FL ### 2212203###Author###PhD Candidate###University of Miami School of Medicine - Miami, FL###
Author: Andrew Adam, MS – University of Miami School of Medicine - Miami, FL
### @@@ Iago De Castro Silva, MD – University of South Florida ### 1850058###Author###Surgery Resident###University of South Florida###
Author: Iago De Castro Silva, MD – University of South Florida
### @@@ Ifeanyichukwu Ogobuiro, MD, MHS – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center ### 1530239###Author###T32 Surgical Oncology Research Fellow/Radiation Oncology Resident###University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center###
Author: Ifeanyichukwu Ogobuiro, MD, MHS – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
### @@@ Samara Singh, BS – University of Miami School of Medicine - Miami, FL ### 1850131###Author###PhD Candidate###University of Miami School of Medicine - Miami, FL###
Author: Samara Singh, BS – University of Miami School of Medicine - Miami, FL
### @@@ Siddharth Mehra, Ph.D. – UM ### 1850132###Author###Postdoc###UM###
Author: Siddharth Mehra, Ph.D. – UM
### @@@ Erin M. Dickey, MD, MBS – Department of Surgery, University of Miami Miller School of Medicine ### 2204637###Author###Post Doctoral Fellow###Department of Surgery, University of Miami Miller School of Medicine###
Author: Erin M. Dickey, MD, MBS – Department of Surgery, University of Miami Miller School of Medicine
### @@@ Nagaraj Nagathihalli, PhD – University of Miami School of Medicine - Miami, FL ### 1850137###Author###Research Associate Professor###University of Miami School of Medicine - Miami, FL###
Author: Nagaraj Nagathihalli, PhD – University of Miami School of Medicine - Miami, FL
### @@@ Nipun B. Merchant, MD – Department of Surgery, University of Miami ### 1849851###Author###Surgical Oncologist###Department of Surgery, University of Miami###
Author: Nipun B. Merchant, MD – Department of Surgery, University of Miami
### @@@ Jashodeep Datta, MD (he/him/his) – Department of Surgery, University of Miami Sylvester Comprehensive Cancer Center ### 1849948###Author###Assistant Professor of Surgery###Department of Surgery, University of Miami Sylvester Comprehensive Cancer Center###
Author: Jashodeep Datta, MD (he/him/his) – Department of Surgery, University of Miami Sylvester Comprehensive Cancer Center
### he/him/his
57: Predicting Local Recurrence of Colorectal Liver Metastasis After Hepatectomy Using Artificial Intelligence

Hardik Y. Patel, D.O. (he/him/his) – The Feinstein Institutes for Medical Research ### 1852582###Abstract Presenter###Research Fellow###The Feinstein Institutes for Medical Research###
Abstract Presenter: Hardik Y. Patel, D.O. (he/him/his) – The Feinstein Institutes for Medical Research
### he/him/his @@@ Hardik Y. Patel, D.O. (he/him/his) – The Feinstein Institutes for Medical Research ### 1852582###Submitter###Research Fellow###The Feinstein Institutes for Medical Research###
Submitter: Hardik Y. Patel, D.O. (he/him/his) – The Feinstein Institutes for Medical Research
### he/him/his @@@ Hardik Y. Patel, D.O. (he/him/his) – The Feinstein Institutes for Medical Research ### 1852582###Author###Research Fellow###The Feinstein Institutes for Medical Research###
Author: Hardik Y. Patel, D.O. (he/him/his) – The Feinstein Institutes for Medical Research
### he/him/his @@@ Matthew Baker, D.O. – Staten Island University Hospital ### 1534958###Author###Surgical Resident###Staten Island University Hospital###
Author: Matthew Baker, D.O. – Staten Island University Hospital
### @@@ Joseph Doran, M.D. – Staten Island University Hospital ### 2212187###Author###Surgical Resident###Staten Island University Hospital###
Author: Joseph Doran, M.D. – Staten Island University Hospital
### @@@ Gary Deutsch, MD – Northwell Health ### 1851696###Author###Attending Physician###Northwell Health###
Author: Gary Deutsch, MD – Northwell Health
### @@@ Theodoros Zanos, PhD – Feinstein Institutes for Medical Research ### 2211992###Author###Associate Professor###Feinstein Institutes for Medical Research###
Author: Theodoros Zanos, PhD – Feinstein Institutes for Medical Research
###
58: Uveal Melanoma Immunogenomics Predict Immunotherapy Resistance and Susceptibility

Shravan Leonard-Murali, MD – Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA Department of Surgery, Allegheny Health Network, Pittsburgh, PA, USA ### 969992###Abstract Presenter###Resident Physician/Postdoctoral Research Fellow###Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA Department of Surgery, Allegheny Health Network, Pittsburgh, PA, USA###
Abstract Presenter: Shravan Leonard-Murali, MD – Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA Department of Surgery, Allegheny Health Network, Pittsburgh, PA, USA
### @@@ Shravan Leonard-Murali, MD – Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA Department of Surgery, Allegheny Health Network, Pittsburgh, PA, USA ### 969992###Submitter###Resident Physician/Postdoctoral Research Fellow###Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA Department of Surgery, Allegheny Health Network, Pittsburgh, PA, USA###
Submitter: Shravan Leonard-Murali, MD – Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA Department of Surgery, Allegheny Health Network, Pittsburgh, PA, USA
### @@@ Shravan Leonard-Murali, MD – Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA Department of Surgery, Allegheny Health Network, Pittsburgh, PA, USA ### 969992###Author###Resident Physician/Postdoctoral Research Fellow###Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA Department of Surgery, Allegheny Health Network, Pittsburgh, PA, USA###
Author: Shravan Leonard-Murali, MD – Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA Department of Surgery, Allegheny Health Network, Pittsburgh, PA, USA
### @@@ Chetana Bhaskarla, PhD – Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA. ### 2211806###Author###Postdoctoral Researcher###Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.###
Author: Chetana Bhaskarla, PhD – Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
### @@@ Ghanshyam Yadav, PhD – Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA. ### 2211807###Author###Postdoctoral Researcher###Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.###
Author: Ghanshyam Yadav, PhD – Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
### @@@ Sudeep Maurya, PhD – Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA. ### 2211808###Author###Postdoctoral Researcher###Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.###
Author: Sudeep Maurya, PhD – Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
### @@@ Chenna Galiveti, PhD – Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA. ### 2211809###Author###Postdoctoral Researcher###Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.###
Author: Chenna Galiveti, PhD – Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
### @@@ Joshua Tobin, BS – Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA. ### 2211810###Author###Laboratory Manager###Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.###
Author: Joshua Tobin, BS – Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
### @@@ Rachel Kann, BS – Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA. ### 2211811###Author###Medical Student###Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.###
Author: Rachel Kann, BS – Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
### @@@ Eishan Ashwat, BS – Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA. ### 2211812###Author###Medical Student###Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.###
Author: Eishan Ashwat, BS – Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
### @@@ Patrick Murphy, PhD – Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA. ### 2211813###Author###Research Assistant Professor###Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.###
Author: Patrick Murphy, PhD – Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
### @@@ Anish Chakka, PhD – Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA. ### 2211814###Author###Bioinformatics Analyst###Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA.###
Author: Anish Chakka, PhD – Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA.
### @@@ Vishal Soman, BS – Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA. ### 2211815###Author###Bioinformatics Analyst###Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA.###
Author: Vishal Soman, BS – Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA.
### @@@ Paul Cantalupo, PhD – Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA. ### 2211816###Author###Bioinformatics Analyst###Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA.###
Author: Paul Cantalupo, PhD – Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA.
### @@@ Xinming Zhuo, PhD – UPMC Genome Center, University of Pittsburgh, Pittsburgh, PA, USA. ### 2211817###Author###Bioinformatics Analyst###UPMC Genome Center, University of Pittsburgh, Pittsburgh, PA, USA.###
Author: Xinming Zhuo, PhD – UPMC Genome Center, University of Pittsburgh, Pittsburgh, PA, USA.
### @@@ Gopi Vyas, MS – UPMC Genome Center, University of Pittsburgh, Pittsburgh, PA, USA. ### 2211818###Author###Bioinformatics Analyst###UPMC Genome Center, University of Pittsburgh, Pittsburgh, PA, USA.###
Author: Gopi Vyas, MS – UPMC Genome Center, University of Pittsburgh, Pittsburgh, PA, USA.
### @@@ Dara Kozak, BS – UPMC Genome Center, University of Pittsburgh, Pittsburgh, PA, USA. ### 2211819###Author###Director of Laboratory Services###UPMC Genome Center, University of Pittsburgh, Pittsburgh, PA, USA.###
Author: Dara Kozak, BS – UPMC Genome Center, University of Pittsburgh, Pittsburgh, PA, USA.
### @@@ Lindsey Kelly, PhD – UPMC Genome Center, University of Pittsburgh, Pittsburgh, PA, USA. ### 2211820###Author###Laboratory Manager###UPMC Genome Center, University of Pittsburgh, Pittsburgh, PA, USA.###
Author: Lindsey Kelly, PhD – UPMC Genome Center, University of Pittsburgh, Pittsburgh, PA, USA.
### @@@ Ed Smith, MBA – UPMC Genome Center, University of Pittsburgh, Pittsburgh, PA, USA. ### 2211821###Author###Director of Clinical Genomics Services###UPMC Genome Center, University of Pittsburgh, Pittsburgh, PA, USA.###
Author: Ed Smith, MBA – UPMC Genome Center, University of Pittsburgh, Pittsburgh, PA, USA.
### @@@ Uma Chandran, PhD – Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA. ### 2211822###Author###Research Associate Professor###Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA.###
Author: Uma Chandran, PhD – Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA.
### @@@ Yen-Michael Hsu, MD, PhD – UPMC Immunologic Monitoring and Cellular Products Laboratory, University of Pittsburgh, Pittsburgh, PA, USA. ### 2211823###Author###Director###UPMC Immunologic Monitoring and Cellular Products Laboratory, University of Pittsburgh, Pittsburgh, PA, USA.###
Author: Yen-Michael Hsu, MD, PhD – UPMC Immunologic Monitoring and Cellular Products Laboratory, University of Pittsburgh, Pittsburgh, PA, USA.
### @@@ Udai Kammula, MD – Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA. ### 2211824###Author###Director###Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.###
Author: Udai Kammula, MD – Solid Tumor Cellular Immunotherapy Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
###
59: Surgical considerations for resecting the index lymph node after neo-adjuvant checkpoint inhibitors: lessons learned from the PRADO trial

Winan J. van Houdt, MD, PhD, MS – Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands ### 915789###Abstract Presenter###Surgical oncologist###Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands###
Abstract Presenter: Winan J. van Houdt, MD, PhD, MS – Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands
### @@@ Anke Kuijpers, MD, PhD – Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands ### 2212020###Author###Surgical Oncologist###Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands###
Author: Anke Kuijpers, MD, PhD – Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands
### @@@ Irene Reijers, MD – Netherlands Cancer Institute - Antoni van Leeuwenhoek ### 2212021###Author###PhD student###Netherlands Cancer Institute - Antoni van Leeuwenhoek###
Author: Irene Reijers, MD – Netherlands Cancer Institute - Antoni van Leeuwenhoek
### @@@ Dirk Grunhagen, MD PhD – Erasmus MC Rotterdam ### 2204704###Author###Surgical Oncologist###Erasmus MC Rotterdam###
Author: Dirk Grunhagen, MD PhD – Erasmus MC Rotterdam
### @@@ Yvonne Schrage, MD, PhD – Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands ### 2212022###Author###Surgical Oncologist###Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands###
Author: Yvonne Schrage, MD, PhD – Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands
### @@@ Michel W.J.M. Wouters, MD, PhD – Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands ### 2211943###Author###Surgical oncologist, professor Quality of Cancer Care###Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands###
Author: Michel W.J.M. Wouters, MD, PhD – Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands
### @@@ Charlotte Zuur, Professor – Netherlands Cancer Institute - Antoni van Leeuwenhoek ### 2212023###Author###Head and Neck surgeon###Netherlands Cancer Institute - Antoni van Leeuwenhoek###
Author: Charlotte Zuur, Professor – Netherlands Cancer Institute - Antoni van Leeuwenhoek
### @@@ Willem Klop, MD PhD – Netherlands Cancer Institute - Antoni van Leeuwenhoek ### 2212024###Author###Head and Neck surgeon###Netherlands Cancer Institute - Antoni van Leeuwenhoek###
Author: Willem Klop, MD PhD – Netherlands Cancer Institute - Antoni van Leeuwenhoek
### @@@ Jos van der Hage, Professor – Leiden University Medical Center ### 2212025###Author###Surgical Oncologist###Leiden University Medical Center###
Author: Jos van der Hage, Professor – Leiden University Medical Center
### @@@ Arjen J. Witkamp, MD PhD – UMC Utrecht ### 969533###Author###Surgical Oncologist###UMC Utrecht###
Author: Arjen J. Witkamp, MD PhD – UMC Utrecht
### @@@ Bart van der Wiel, MD PhD – Netherlands Cancer Institute - Antoni van Leeuwenhoek ### 2212026###Author###Pathologist###Netherlands Cancer Institute - Antoni van Leeuwenhoek###
Author: Bart van der Wiel, MD PhD – Netherlands Cancer Institute - Antoni van Leeuwenhoek
### @@@ Robyn Saw, MBBS, FRACS, MS – Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia ### 1850619###Author###Surgeon###Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia###
Author: Robyn Saw, MBBS, FRACS, MS – Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia
### @@@ Thomas Pennington, MBBS, FRACS – Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia ### 2211922###Author###Surgeon###Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia###
Author: Thomas Pennington, MBBS, FRACS – Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia
### @@@ Kerwin Shannon, MBBS, FRACS – Melanoma Institute Australia ### 1850617###Author###Head and Neck surgeon###Melanoma Institute Australia###
Author: Kerwin Shannon, MBBS, FRACS – Melanoma Institute Australia
### @@@ Andrew Spillane, MBBS, MD, FRACS – Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia ### 1850618###Author###Surgeon###Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia###
Author: Andrew Spillane, MBBS, MD, FRACS – Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia
### @@@ Richard Scolyer, BMedSci MBBS MD FRCPA FRCPath(UK) FAHMS – Melanoma Institute Australia ### 1849947###Author###Medical Director###Melanoma Institute Australia###
Author: Richard Scolyer, BMedSci MBBS MD FRCPA FRCPath(UK) FAHMS – Melanoma Institute Australia
### @@@ Georgina V. Long, MBBS PhD – Melanoma Institute Australia ### 1851981###Author###Medical Oncologist###Melanoma Institute Australia###
Author: Georgina V. Long, MBBS PhD – Melanoma Institute Australia
### @@@ Christian Blank, MD PhD – Netherlands Cancer Institute - Antoni van Leeuwenhoek ### 2212027###Author###Medical Oncologist###Netherlands Cancer Institute - Antoni van Leeuwenhoek###
Author: Christian Blank, MD PhD – Netherlands Cancer Institute - Antoni van Leeuwenhoek
### @@@ Alexander C.J van Akkooi, MD, PhD (he/him/his) – Melanoma Institute Australia / University of Sydney, Faculty of Medicine and Health / Royal Prince Alfred Hospital, Department of Melanoma and Surgical Oncology ### 1850616###Author###Surgical Oncologist###Melanoma Institute Australia / University of Sydney, Faculty of Medicine and Health / Royal Prince Alfred Hospital, Department of Melanoma and Surgical Oncology###
Author: Alexander C.J van Akkooi, MD, PhD (he/him/his) – Melanoma Institute Australia / University of Sydney, Faculty of Medicine and Health / Royal Prince Alfred Hospital, Department of Melanoma and Surgical Oncology
### he/him/his
6: Impact of clipped node as a sentinel lymph node on axillary staging following neoadjuvant chemotherapy in clinically node-positive breast cancer

Alexandra Moore, MD – MD Anderson Cancer Center ### 2212153###Abstract Presenter###Fellow Physician###MD Anderson Cancer Center###
Abstract Presenter: Alexandra Moore, MD – MD Anderson Cancer Center
### @@@ Alexandra Moore, MD – MD Anderson Cancer Center ### 2212153###Submitter###Fellow Physician###MD Anderson Cancer Center###
Submitter: Alexandra Moore, MD – MD Anderson Cancer Center
### @@@ Alexandra Moore, MD – MD Anderson Cancer Center ### 2212153###Author###Fellow Physician###MD Anderson Cancer Center###
Author: Alexandra Moore, MD – MD Anderson Cancer Center
### @@@ Abigail S. Caudle, MD, MS, FACS – MD Anderson Cancer Center ### 944409###Author###Associate Professor, Department of Breast Surgical Oncology###MD Anderson Cancer Center###
Author: Abigail S. Caudle, MD, MS, FACS – MD Anderson Cancer Center
### @@@ Susie X. Sun, MD – Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA ### 1850566###Author###Assistant Professor###Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA###
Author: Susie X. Sun, MD – Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
### @@@ Henry M. Kuerer, MD, PhD – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA ### 937372###Author###Professor###Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA###
Author: Henry M. Kuerer, MD, PhD – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA
### @@@ Kelly K. Hunt, MD (she/her/hers) – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA ### 937327###Author###Professor & Chair###Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA###
Author: Kelly K. Hunt, MD (she/her/hers) – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA
### she/her/hers @@@ Savitri Krishnamurthy, MD – MD Anderson Cancer Center ### 944410###Author###Professor, Department of Pathology, Division of Pathology and Laboratory Medicine###MD Anderson Cancer Center###
Author: Savitri Krishnamurthy, MD – MD Anderson Cancer Center
### @@@ Wei Yang, MBBS, FRCR – MD Anderson Cancer Center ### 1850448###Author###Professor and Chair, Department of Diagnostic Radiology###MD Anderson Cancer Center###
Author: Wei Yang, MBBS, FRCR – MD Anderson Cancer Center
### @@@ Benjamin D. Smith, MD – Department of Breast Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA ### 944428###Author###Professor###Department of Breast Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA###
Author: Benjamin D. Smith, MD – Department of Breast Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA
### @@@ Vicente Valero, MD, FACP – MD Anderson Cancer Center ### 1850449###Author###Professor and Deputy Chairman, Department of Breast Medical Oncology###MD Anderson Cancer Center###
Author: Vicente Valero, MD, FACP – MD Anderson Cancer Center
### @@@ Mediget Teshome, MD (she/her/hers) – UCLA ### 894417###Author###Associate Professor###UCLA###
Author: Mediget Teshome, MD (she/her/hers) – UCLA
### she/her/hers
60: Management and outcomes of patients with recurrence of cutaneous melanoma during or after completion of adjuvant immunotherapy: a multicenter study

Sophia McKinley, MD EdM (she/her/hers) – Massachusetts General Hospital ### 2211914###Abstract Presenter###Surgical Oncologist###Massachusetts General Hospital###
Abstract Presenter: Sophia McKinley, MD EdM (she/her/hers) – Massachusetts General Hospital
### she/her/hers @@@ Sophia McKinley, MD EdM (she/her/hers) – Massachusetts General Hospital ### 2211914###Submitter###Surgical Oncologist###Massachusetts General Hospital###
Submitter: Sophia McKinley, MD EdM (she/her/hers) – Massachusetts General Hospital
### she/her/hers @@@ Sophia McKinley, MD EdM (she/her/hers) – Massachusetts General Hospital ### 2211914###Author###Surgical Oncologist###Massachusetts General Hospital###
Author: Sophia McKinley, MD EdM (she/her/hers) – Massachusetts General Hospital
### she/her/hers @@@ Hannah L. Kalvin, MSPH – Memorial Sloan Kettering Cancer Center ### 1849730###Author###Biostatistician###Memorial Sloan Kettering Cancer Center###
Author: Hannah L. Kalvin, MSPH – Memorial Sloan Kettering Cancer Center
### @@@ Mackenzie L. Shindorf, MD – University of Louisville ### 1852024###Author###Fellow###University of Louisville###
Author: Mackenzie L. Shindorf, MD – University of Louisville
### @@@ Kristen E. Rhodin, MD, MHS – Duke University Medical Center ### 1530206###Author###General Surgery Resident###Duke University Medical Center###
Author: Kristen E. Rhodin, MD, MHS – Duke University Medical Center
### @@@ Murtuza Saifuddin, MD – Sunnybrook Health Sciences Centre ### 2211915###Author###Research fellow###Sunnybrook Health Sciences Centre###
Author: Murtuza Saifuddin, MD – Sunnybrook Health Sciences Centre
### @@@ Christine Tran, BA – UVA ### 2211916###Author###Research fellow###UVA###
Author: Christine Tran, BA – UVA
### @@@ Gabrielle Schwartzman, MD – UVA ### 2211917###Author###Research fellow###UVA###
Author: Gabrielle Schwartzman, MD – UVA
### @@@ Cimarron E. Sharon, MD – University of Pennsylvania ### 1534911###Author###Resident###University of Pennsylvania###
Author: Cimarron E. Sharon, MD – University of Pennsylvania
### @@@ Aleigha Lawless, BA – Massachusetts General Hospital ### 2211918###Author###Clinical Research Manager###Massachusetts General Hospital###
Author: Aleigha Lawless, BA – Massachusetts General Hospital
### @@@ Giorgos Karakousis, MD – Hospital of the University of Pennsylvania ### 915770###Author###Professor of Surgery###Hospital of the University of Pennsylvania###
Author: Giorgos Karakousis, MD – Hospital of the University of Pennsylvania
### @@@ Elizabeth Gaughan, MD – UVA ### 2212037###Author###Medical oncologist###UVA###
Author: Elizabeth Gaughan, MD – UVA
### @@@ Craig Slingluff, MD – UVA ### 2211920###Author###Surgical oncologist###UVA###
Author: Craig Slingluff, MD – UVA
### @@@ Frances C. Wright, MD MEd – Sunnybrook Health Sciences Centre ### 1851738###Author###Surgical oncologist, Professor###Sunnybrook Health Sciences Centre###
Author: Frances C. Wright, MD MEd – Sunnybrook Health Sciences Centre
### @@@ Genevieve M. Boland, MD, PhD – Massachusetts General Hospital ### 937423###Author###Section Head, Melanoma/Sarcoma Surgery###Massachusetts General Hospital###
Author: Genevieve M. Boland, MD, PhD – Massachusetts General Hospital
### @@@ Katherine Panageas, DrPH – MSKCC ### 2211921###Author###Statistician###MSKCC###
Author: Katherine Panageas, DrPH – MSKCC
### @@@ Georgia M. Beasley, MD MHS (she/her/hers) – Duke University Medical Center ### 938016###Author###Associate Professor of Surgery with tenure###Duke University Medical Center###
Author: Georgia M. Beasley, MD MHS (she/her/hers) – Duke University Medical Center
### she/her/hers @@@ Michael E. Egger, MD, MPH – University of Louisville ### 969528###Author###Surgical oncologist###University of Louisville###
Author: Michael E. Egger, MD, MPH – University of Louisville
### @@@ Edmund Bartlett, MD – MSKCC ### 944412###Author###Surgical oncologist###MSKCC###
Author: Edmund Bartlett, MD – MSKCC
###
61: Surgical considerations for tumor-infiltrating lymphocyte (TIL) therapy in melanoma: results from a randomized phase 3 trial.

Liselotte Tas, MD (she/her/hers) – Netherlands Cancer Institute, Division of Molecular Oncology and Immunology, Amsterdam, The Netherlands ### 2211886### Author###MD, PhD student###Netherlands Cancer Institute, Division of Molecular Oncology and Immunology, Amsterdam, The Netherlands###
Author: Liselotte Tas, MD (she/her/hers) – Netherlands Cancer Institute, Division of Molecular Oncology and Immunology, Amsterdam, The Netherlands
### she/her/hers @@@ Liselotte Tas, MD (she/her/hers) – Netherlands Cancer Institute, Division of Molecular Oncology and Immunology, Amsterdam, The Netherlands ### 2211886###Submitter###MD, PhD student###Netherlands Cancer Institute, Division of Molecular Oncology and Immunology, Amsterdam, The Netherlands###
Submitter: Liselotte Tas, MD (she/her/hers) – Netherlands Cancer Institute, Division of Molecular Oncology and Immunology, Amsterdam, The Netherlands
### she/her/hers @@@ Marie B. Weitemeyer, MD – Department of Plastic Surgery, Copenhagen University Hospital – Herlev and Gentofte, Herlev, Denmark ### 2212069###Author###MD, PhD student###Department of Plastic Surgery, Copenhagen University Hospital – Herlev and Gentofte, Herlev, Denmark###
Author: Marie B. Weitemeyer, MD – Department of Plastic Surgery, Copenhagen University Hospital – Herlev and Gentofte, Herlev, Denmark
### @@@ Maartje W. Rohaan, MD – Netherlands Cancer Institute, Division of Molecular Oncology and Immunology, Amsterdam, The Netherlands ### 2211888###Author###MD, PhD student###Netherlands Cancer Institute, Division of Molecular Oncology and Immunology, Amsterdam, The Netherlands###
Author: Maartje W. Rohaan, MD – Netherlands Cancer Institute, Division of Molecular Oncology and Immunology, Amsterdam, The Netherlands
### @@@ Troels H. Borch, MD, PhD – National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital – Herlev and Gentofte,Herlev, Denmark ### 2212070###Author###MD###National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital – Herlev and Gentofte,Herlev, Denmark###
Author: Troels H. Borch, MD, PhD – National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital – Herlev and Gentofte,Herlev, Denmark
### @@@ Alexander C.J van Akkooi, MD, PhD (he/him/his) – Melanoma Institute Australia / University of Sydney, Faculty of Medicine and Health / Royal Prince Alfred Hospital, Department of Melanoma and Surgical Oncology ### 1850616###Author###Surgical Oncologist###Melanoma Institute Australia / University of Sydney, Faculty of Medicine and Health / Royal Prince Alfred Hospital, Department of Melanoma and Surgical Oncology###
Author: Alexander C.J van Akkooi, MD, PhD (he/him/his) – Melanoma Institute Australia / University of Sydney, Faculty of Medicine and Health / Royal Prince Alfred Hospital, Department of Melanoma and Surgical Oncology
### he/him/his @@@ Michel W.J.M. Wouters, MD, PhD – Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands ### 2211943###Author###Surgical oncologist, professor Quality of Cancer Care###Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands###
Author: Michel W.J.M. Wouters, MD, PhD – Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands
### @@@ Koen J. Hartemink, MD, PhD – Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands ### 2212071###Author###Surgical oncologist###Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands###
Author: Koen J. Hartemink, MD, PhD – Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands
### @@@ Yvonne Schrage, MD, PhD – Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands ### 2212022###Author###Surgical Oncologist###Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands###
Author: Yvonne Schrage, MD, PhD – Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands
### @@@ Anke Kuijpers, MD, PhD – Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands ### 2212020###Author###Surgical Oncologist###Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands###
Author: Anke Kuijpers, MD, PhD – Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands
### @@@ Maaike Van Zon, BSc – Netherlands Cancer Institute, Biotherapeutics Unit, Amsterdam, The Netherlands ### 2212075###Author###Technician###Netherlands Cancer Institute, Biotherapeutics Unit, Amsterdam, The Netherlands###
Author: Maaike Van Zon, BSc – Netherlands Cancer Institute, Biotherapeutics Unit, Amsterdam, The Netherlands
### @@@ Inge jedema, PhD – Division of Molecular Oncology and Immunology, Netherlands Cancer Institute ### 2212076###Author###Head translational cellular therapy###Division of Molecular Oncology and Immunology, Netherlands Cancer Institute###
Author: Inge jedema, PhD – Division of Molecular Oncology and Immunology, Netherlands Cancer Institute
### @@@ Cynthia Nijenhuis, PhD – Netherlands Cancer Institute, Biotherapeutics Unit, Amsterdam, The Netherlands ### 2212077###Author###Head Biotherapeutics Unit###Netherlands Cancer Institute, Biotherapeutics Unit, Amsterdam, The Netherlands###
Author: Cynthia Nijenhuis, PhD – Netherlands Cancer Institute, Biotherapeutics Unit, Amsterdam, The Netherlands
### @@@ Bastiaan Nuijen, PhD – Netherlands Cancer Institute, Division of Pharmacy and Pharmacology, Amsterdam, The Netherlands ### 2212078###Author###Founder BTU and head of production###Netherlands Cancer Institute, Division of Pharmacy and Pharmacology, Amsterdam, The Netherlands###
Author: Bastiaan Nuijen, PhD – Netherlands Cancer Institute, Division of Pharmacy and Pharmacology, Amsterdam, The Netherlands
### @@@ Sebastian Klobuch, MD – Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, The Netherlands ### 2212079###Author###Medical oncologist###Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, The Netherlands###
Author: Sebastian Klobuch, MD – Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, The Netherlands
### @@@ Ferry Lalezari, MD – Netherlands Cancer Institute, Division of Radiology, Amsterdam, The Netherlands ### 2212080###Author###Radiologist###Netherlands Cancer Institute, Division of Radiology, Amsterdam, The Netherlands###
Author: Ferry Lalezari, MD – Netherlands Cancer Institute, Division of Radiology, Amsterdam, The Netherlands
### @@@ Marco Donia, MD, PhD – National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital – Herlev and Gentofte, Herlev, Denmark ### 2212081###Author###Clinician-scientist, oncologist###National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital – Herlev and Gentofte, Herlev, Denmark###
Author: Marco Donia, MD, PhD – National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital – Herlev and Gentofte, Herlev, Denmark
### @@@ Inge Marie Svane, MD, PhD – National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital – Herlev and Gentofte, Herlev, Denmark ### 2212082###Author###Professor in Clinical cancer immune therapy and director of the translational research centre###National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital – Herlev and Gentofte, Herlev, Denmark###
Author: Inge Marie Svane, MD, PhD – National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital – Herlev and Gentofte, Herlev, Denmark
### @@@ John B.A.G. Haanen, MD, PhD – Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, The Netherlands ### 2212083###Author###Professor of clinical oncology and director of center for cellular therapy, medical oncologist###Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, The Netherlands###
Author: John B.A.G. Haanen, MD, PhD – Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, The Netherlands
### @@@ Lisbet R. Holmich, MD, DMSc – Department of Plastic Surgery, Copenhagen University Hospital – Herlev and Gentofte, Herlev, Denmark ### 1850625###Author###Clinical professor###Department of Plastic Surgery, Copenhagen University Hospital – Herlev and Gentofte, Herlev, Denmark###
Author: Lisbet R. Holmich, MD, DMSc – Department of Plastic Surgery, Copenhagen University Hospital – Herlev and Gentofte, Herlev, Denmark
### @@@ Winan J. van Houdt, MD, PhD, MS – Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands ### 915789###Author###Surgical oncologist###Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands###
Author: Winan J. van Houdt, MD, PhD, MS – Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands
### @@@ Winan J. van Houdt, MD, PhD, MS – Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands ### 915789###Abstract Presenter###Surgical oncologist###Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands###
Abstract Presenter: Winan J. van Houdt, MD, PhD, MS – Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands
###
62: Prospective validation of the integrated 31-gene expression profile test for cutaneous melanoma to select patients who may consider foregoing sentinel lymph node biopsy

J. Michael Guenther, MD – St Elizabeth Physicians ### 937391###Abstract Presenter###Physician###St Elizabeth Physicians###
Abstract Presenter: J. Michael Guenther, MD – St Elizabeth Physicians
### @@@ Andrew Ward, PhD – Division of Surgical Oncology, University of Tennessee Medical Center ### 1851354###Author###Nurse Practictioner###Division of Surgical Oncology, University of Tennessee Medical Center###
Author: Andrew Ward, PhD – Division of Surgical Oncology, University of Tennessee Medical Center
### @@@ Brian Martin, PhD – Castle Biosciences, Inc. ### 2211942###Author###Senior Scientist II###Castle Biosciences, Inc.###
Author: Brian Martin, PhD – Castle Biosciences, Inc.
### @@@ Rohit Sharma, MD, FACS – Marshfield Medical Center ### 1859923###Author###Surgical Oncologist###Marshfield Medical Center###
Author: Rohit Sharma, MD, FACS – Marshfield Medical Center
### @@@ Maki Yamamoto, MD – School of Medicine, University of California-Irvine ### 1852327###Author###Physician###School of Medicine, University of California-Irvine###
Author: Maki Yamamoto, MD – School of Medicine, University of California-Irvine
###
63: An Externally Validated Online Tool To Calculate Personalized Probabilities Of Recurrence-Free And Overall-Survival In Stage II Melanoma Patients.

Alexander H R Varey, MBChB MRCS(Eng) FRACS FRCS(Plast) PhD (he/him/his) – Melanoma Institute Australia, University of Sydney, Westmead Hospital ### 1849887###Abstract Presenter###A/Prof###Melanoma Institute Australia, University of Sydney, Westmead Hospital###
Abstract Presenter: Alexander H R Varey, MBChB MRCS(Eng) FRACS FRCS(Plast) PhD (he/him/his) – Melanoma Institute Australia, University of Sydney, Westmead Hospital
### he/him/his @@@ Alexander H R Varey, MBChB MRCS(Eng) FRACS FRCS(Plast) PhD (he/him/his) – Melanoma Institute Australia, University of Sydney, Westmead Hospital ### 1849887###Submitter###A/Prof###Melanoma Institute Australia, University of Sydney, Westmead Hospital###
Submitter: Alexander H R Varey, MBChB MRCS(Eng) FRACS FRCS(Plast) PhD (he/him/his) – Melanoma Institute Australia, University of Sydney, Westmead Hospital
### he/him/his @@@ Alexander H R Varey, MBChB MRCS(Eng) FRACS FRCS(Plast) PhD (he/him/his) – Melanoma Institute Australia, University of Sydney, Westmead Hospital ### 1849887###Author###A/Prof###Melanoma Institute Australia, University of Sydney, Westmead Hospital###
Author: Alexander H R Varey, MBChB MRCS(Eng) FRACS FRCS(Plast) PhD (he/him/his) – Melanoma Institute Australia, University of Sydney, Westmead Hospital
### he/him/his @@@ Isabel Li, n/a – University of Sydney ### 2212166###Author###Biostatistician###University of Sydney###
Author: Isabel Li, n/a – University of Sydney
### @@@ Mary-Ann El Sharouni, MD PhD – University of Utrecht ### 2212167###Author###Dermatologist###University of Utrecht###
Author: Mary-Ann El Sharouni, MD PhD – University of Utrecht
### @@@ Julie Simon, MD – MD Anderson Cancer Center ### 2212168###Author###Oncologist###MD Anderson Cancer Center###
Author: Julie Simon, MD – MD Anderson Cancer Center
### @@@ Aikaterini Dedeilia, MD (she/her/hers) – Massachusetts General Hospital ### 1850164###Author###Postdoctoral Research Fellow###Massachusetts General Hospital###
Author: Aikaterini Dedeilia, MD (she/her/hers) – Massachusetts General Hospital
### she/her/hers @@@ Robyn Saw, MBBS, FRACS, MS – Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia ### 1850619###Author###Surgeon###Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia###
Author: Robyn Saw, MBBS, FRACS, MS – Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia
### @@@ Andrew Spillane, MBBS, MD, FRACS – Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia ### 1850618###Author###Surgeon###Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia###
Author: Andrew Spillane, MBBS, MD, FRACS – Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia
### @@@ Kerwin Shannon, MBBS, FRACS – Melanoma Institute Australia ### 1850617###Author###Head and Neck surgeon###Melanoma Institute Australia###
Author: Kerwin Shannon, MBBS, FRACS – Melanoma Institute Australia
### @@@ Jonathan R. Stretch, DPhil FRACS – Melanoma Institute Australia ### 1850620###Author###Plastic Surgeon###Melanoma Institute Australia###
Author: Jonathan R. Stretch, DPhil FRACS – Melanoma Institute Australia
### @@@ Ryan J. Sullivan, MD – Massachusetts General Hospital ### 2212182###Author###Oncologist###Massachusetts General Hospital###
Author: Ryan J. Sullivan, MD – Massachusetts General Hospital
### @@@ Genevieve M. Boland, MD, PhD – Massachusetts General Hospital ### 937423###Author###Section Head, Melanoma/Sarcoma Surgery###Massachusetts General Hospital###
Author: Genevieve M. Boland, MD, PhD – Massachusetts General Hospital
### @@@ Jeffrey E. Gershenwald, MD (he/him/his) – Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center ### 944429###Author###Professor###Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center###
Author: Jeffrey E. Gershenwald, MD (he/him/his) – Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center
### he/him/his @@@ Paul van Diest, MD – University of Utrecht ### 2212186###Author###Dermatologist###University of Utrecht###
Author: Paul van Diest, MD – University of Utrecht
### @@@ Richard Scolyer, BMedSci MBBS MD FRCPA FRCPath(UK) FAHMS – Melanoma Institute Australia ### 1849947###Author###Medical Director###Melanoma Institute Australia###
Author: Richard Scolyer, BMedSci MBBS MD FRCPA FRCPath(UK) FAHMS – Melanoma Institute Australia
### @@@ Georgina V. Long, MBBS PhD – Melanoma Institute Australia ### 1851981###Author###Medical Oncologist###Melanoma Institute Australia###
Author: Georgina V. Long, MBBS PhD – Melanoma Institute Australia
### @@@ John Thompson, MBBS, MD, DSc, FRACS, FACS (Hon), FAHMS – Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia ### 944391###Author###Surgeon###Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia###
Author: John Thompson, MBBS, MD, DSc, FRACS, FACS (Hon), FAHMS – Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia
### @@@ Serigne N. Lo, PhD – Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia ### 1849888###Author###Biostatistician###Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia###
Author: Serigne N. Lo, PhD – Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia
###
64: Hepatic and Overall Progression-Free Survival after Percutaneous Hepatic Perfusion as First-Line or Second-Line Therapy for Metastatic Uveal Melanoma

Helana Ghali, BS – University of South Florida Morsani College of Medicine, University of South Florida, Tampa, FL ### 2204604###Abstract Presenter###Medical Student###University of South Florida Morsani College of Medicine, University of South Florida, Tampa, FL###
Abstract Presenter: Helana Ghali, BS – University of South Florida Morsani College of Medicine, University of South Florida, Tampa, FL
### @@@ Helana Ghali, BS – University of South Florida Morsani College of Medicine, University of South Florida, Tampa, FL ### 2204604###Submitter###Medical Student###University of South Florida Morsani College of Medicine, University of South Florida, Tampa, FL###
Submitter: Helana Ghali, BS – University of South Florida Morsani College of Medicine, University of South Florida, Tampa, FL
### @@@ Helana Ghali, BS – University of South Florida Morsani College of Medicine, University of South Florida, Tampa, FL ### 2204604###Author###Medical Student###University of South Florida Morsani College of Medicine, University of South Florida, Tampa, FL###
Author: Helana Ghali, BS – University of South Florida Morsani College of Medicine, University of South Florida, Tampa, FL
### @@@ Michelle M. Dugan, MD – Cutaneous Oncology Department, Moffitt Cancer Center, Tampa, FL ### 2204602###Author###Research Fellow###Cutaneous Oncology Department, Moffitt Cancer Center, Tampa, FL###
Author: Michelle M. Dugan, MD – Cutaneous Oncology Department, Moffitt Cancer Center, Tampa, FL
### @@@ Shaliz Aflatooni, BS (she/her/hers) – University of South Florida Morsani College of Medicine, University of South Florida, Tampa, FL ### 2204601###Author###Medical Student###University of South Florida Morsani College of Medicine, University of South Florida, Tampa, FL###
Author: Shaliz Aflatooni, BS (she/her/hers) – University of South Florida Morsani College of Medicine, University of South Florida, Tampa, FL
### she/her/hers @@@ Aleena Boby, B.A. (she/her/hers) – University of South Florida Morsani College of Medicine, University of South Florida, Tampa, FL ### 2204603###Author###Medical Student###University of South Florida Morsani College of Medicine, University of South Florida, Tampa, FL###
Author: Aleena Boby, B.A. (she/her/hers) – University of South Florida Morsani College of Medicine, University of South Florida, Tampa, FL
### she/her/hers @@@ Danielle K. DePalo, MD (she/her/hers) – Department of General Surgery, University of Massachusetts Chan Medical School, Boston, MA ### 1530301###Author###Resident###Department of General Surgery, University of Massachusetts Chan Medical School, Boston, MA###
Author: Danielle K. DePalo, MD (she/her/hers) – Department of General Surgery, University of Massachusetts Chan Medical School, Boston, MA
### she/her/hers @@@ Jose Laborde, PhD – Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa FL ### 2211837###Author###Senior Biostatistician###Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa FL###
Author: Jose Laborde, PhD – Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa FL
### @@@ Jonathan S. Zager, MD – H. Lee Moffitt Cancer Center and Research Institute ### 917915###Author###Cutaneous Surgeon###H. Lee Moffitt Cancer Center and Research Institute###
Author: Jonathan S. Zager, MD – H. Lee Moffitt Cancer Center and Research Institute
###
65: Toward the Development of Functional Biomarker Assays: Analysis of Neoadjuvant Intralesional Oncolytic Virus Response in High-Risk Stage II Melanoma

Amanda R. Kirane, MD, PhD (she/her/hers) – Stanford University ### 1534976###Abstract Presenter###Assistant Professor###Stanford University###
Abstract Presenter: Amanda R. Kirane, MD, PhD (she/her/hers) – Stanford University
### she/her/hers @@@ David Lee, B.A. (he/him/his) – Loma Linda University School of Medicine ### 2212239###Submitter###Medical Student###Loma Linda University School of Medicine###
Submitter: David Lee, B.A. (he/him/his) – Loma Linda University School of Medicine
### he/him/his @@@ M. Usman Ahmad, MD (he/him/his) – Stanford University ### 1852459###Author###Research Fellow###Stanford University###
Author: M. Usman Ahmad, MD (he/him/his) – Stanford University
### he/him/his @@@ Saurabh Sharma, Ph.D. – Stanford University ### 2212241###Author###Postdoctoral Scholar###Stanford University###
Author: Saurabh Sharma, Ph.D. – Stanford University
### @@@ Mamatha Serasanambati, Ph.D. – Stanford University ### 2212242###Author###Senior Scientist###Stanford University###
Author: Mamatha Serasanambati, Ph.D. – Stanford University
### @@@ Michael C. Lowe, MD, MA – Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University ### 1169992###Author###Associate Professor of Surgery, Disease Team Lead and Co-Chair Melanoma Working Group###Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University###
Author: Michael C. Lowe, MD, MA – Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University
### @@@ Christopher Applebee, Ph.D. – University of Bath ### 2212245###Author###Postdoctoral Scholar###University of Bath###
Author: Christopher Applebee, Ph.D. – University of Bath
### @@@ Elena Safrygina, Ph.D. – University of Bath ### 2212246###Author###Postdoctoral Scholar###University of Bath###
Author: Elena Safrygina, Ph.D. – University of Bath
### @@@ Susan Swetter, M.D. – Stanford University ### 2212247###Author###Professor###Stanford University###
Author: Susan Swetter, M.D. – Stanford University
### @@@ Sunil Reddy, M.D. – Stanford University ### 2212248###Author###Associate Professor###Stanford University###
Author: Sunil Reddy, M.D. – Stanford University
### @@@ Alison Warner, M.D., Ph.D. – Stanford University ### 2212249###Author###Assistant Professor###Stanford University###
Author: Alison Warner, M.D., Ph.D. – Stanford University
### @@@ Pauline Funchain, M.D. – Stanford University ### 2212250###Author###Associate Professor###Stanford University###
Author: Pauline Funchain, M.D. – Stanford University
### @@@ Jennifer Wang, M.D. – Stanford University ### 2212251###Author###Assistant Professor###Stanford University###
Author: Jennifer Wang, M.D. – Stanford University
### @@@ Ronald Levy, M.D. – Stanford University ### 2212252###Author###Professor###Stanford University###
Author: Ronald Levy, M.D. – Stanford University
### @@@ Banafshe Larijani, n/a – University of Bath ### 2212253###Author###Professor###University of Bath###
Author: Banafshe Larijani, n/a – University of Bath
### @@@ Emanual Maverakis, M.D. – UC Davis ### 2212244###Author###Professor###UC Davis###
Author: Emanual Maverakis, M.D. – UC Davis
###
66: Improved Survival with Sentinel Node Biopsy - An Emulated Randomized Controlled Trial

Alexander H R Varey, MBChB MRCS(Eng) FRACS FRCS(Plast) PhD (he/him/his) – Melanoma Institute Australia, University of Sydney, Westmead Hospital ### 1849887###Abstract Presenter###A/Prof###Melanoma Institute Australia, University of Sydney, Westmead Hospital###
Abstract Presenter: Alexander H R Varey, MBChB MRCS(Eng) FRACS FRCS(Plast) PhD (he/him/his) – Melanoma Institute Australia, University of Sydney, Westmead Hospital
### he/him/his @@@ Alexander H R Varey, MBChB MRCS(Eng) FRACS FRCS(Plast) PhD (he/him/his) – Melanoma Institute Australia, University of Sydney, Westmead Hospital ### 1849887###Submitter###A/Prof###Melanoma Institute Australia, University of Sydney, Westmead Hospital###
Submitter: Alexander H R Varey, MBChB MRCS(Eng) FRACS FRCS(Plast) PhD (he/him/his) – Melanoma Institute Australia, University of Sydney, Westmead Hospital
### he/him/his @@@ Alexander H R Varey, MBChB MRCS(Eng) FRACS FRCS(Plast) PhD (he/him/his) – Melanoma Institute Australia, University of Sydney, Westmead Hospital ### 1849887###Author###A/Prof###Melanoma Institute Australia, University of Sydney, Westmead Hospital###
Author: Alexander H R Varey, MBChB MRCS(Eng) FRACS FRCS(Plast) PhD (he/him/his) – Melanoma Institute Australia, University of Sydney, Westmead Hospital
### he/him/his @@@ Raphael P. Feser, n/a – Melanoma Institute Australia ### 2212072###Author###Biostatistician###Melanoma Institute Australia###
Author: Raphael P. Feser, n/a – Melanoma Institute Australia
### @@@ Nurudeen A. Adegoke, n/a – Melanoma Institute Australia ### 2212073###Author###Biostatistician###Melanoma Institute Australia###
Author: Nurudeen A. Adegoke, n/a – Melanoma Institute Australia
### @@@ Richard Scolyer, BMedSci MBBS MD FRCPA FRCPath(UK) FAHMS – Melanoma Institute Australia ### 1849947###Author###Medical Director###Melanoma Institute Australia###
Author: Richard Scolyer, BMedSci MBBS MD FRCPA FRCPath(UK) FAHMS – Melanoma Institute Australia
### @@@ John Thompson, MBBS, MD, DSc, FRACS, FACS (Hon), FAHMS – Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia ### 944391###Author###Surgeon###Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia###
Author: John Thompson, MBBS, MD, DSc, FRACS, FACS (Hon), FAHMS – Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia
### @@@ Serigne N. Lo, PhD – Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia ### 1849888###Author###Biostatistician###Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia###
Author: Serigne N. Lo, PhD – Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia
###
67: The Role of Neoadjuvant Immunotherapy in the Management of Merkel Cell Carcinoma with Clinically Detected Regional Lymph Node Metastasis

Jenny H. Chang, MD (she/her/hers) – Cleveland Clinic ### 1852191###Abstract Presenter###Resident###Cleveland Clinic###
Abstract Presenter: Jenny H. Chang, MD (she/her/hers) – Cleveland Clinic
### she/her/hers @@@ Jenny H. Chang, MD (she/her/hers) – Cleveland Clinic ### 1852191###Submitter###Resident###Cleveland Clinic###
Submitter: Jenny H. Chang, MD (she/her/hers) – Cleveland Clinic
### she/her/hers @@@ Jenny H. Chang, MD (she/her/hers) – Cleveland Clinic ### 1852191###Author###Resident###Cleveland Clinic###
Author: Jenny H. Chang, MD (she/her/hers) – Cleveland Clinic
### she/her/hers @@@ Daphne Remulla, MD – Cleveland Clinic ### 2212018###Author###Resident###Cleveland Clinic###
Author: Daphne Remulla, MD – Cleveland Clinic
### @@@ Chase J. Wehrle, MD – Cleveland Clinic ### 1852188###Author###Resident###Cleveland Clinic###
Author: Chase J. Wehrle, MD – Cleveland Clinic
### @@@ Kimberly P. Woo, MD – Cleveland Clinic ### 1852194###Author###Resident###Cleveland Clinic###
Author: Kimberly P. Woo, MD – Cleveland Clinic
### @@@ Daniel Joyce, MBBCh – Cleveland Clinic ### 1852197###Author###Surgeon###Cleveland Clinic###
Author: Daniel Joyce, MBBCh – Cleveland Clinic
### @@@ Samer A. naffouje, MD – Cleveland Clinic Foundation ### 1184638###Author###Assistant Professor of Surgery###Cleveland Clinic Foundation###
Author: Samer A. naffouje, MD – Cleveland Clinic Foundation
###
68: Reliability of Recurrence-free Survival as an Efficacy Endpoint for Trials of Resected Colorectal Cancer Peritoneal Metastasis: Results from the PSOLARIS study group

Muhammad Talha Waheed, MD – Division of Surgical Oncology, City of Hope National Medical Center, Duarte, CA ### 1851651###Abstract Presenter###Research Fellow###Division of Surgical Oncology, City of Hope National Medical Center, Duarte, CA###
Abstract Presenter: Muhammad Talha Waheed, MD – Division of Surgical Oncology, City of Hope National Medical Center, Duarte, CA
### @@@ Muhammad Talha Waheed, MD – Division of Surgical Oncology, City of Hope National Medical Center, Duarte, CA ### 1851651###Submitter###Research Fellow###Division of Surgical Oncology, City of Hope National Medical Center, Duarte, CA###
Submitter: Muhammad Talha Waheed, MD – Division of Surgical Oncology, City of Hope National Medical Center, Duarte, CA
### @@@ Muhammad Talha Waheed, MD – Division of Surgical Oncology, City of Hope National Medical Center, Duarte, CA ### 1851651###Author###Research Fellow###Division of Surgical Oncology, City of Hope National Medical Center, Duarte, CA###
Author: Muhammad Talha Waheed, MD – Division of Surgical Oncology, City of Hope National Medical Center, Duarte, CA
### @@@ Vahan Kepenekian, MD – Department of Digestive Surgery, CHU Lyon Sud, Pierre-Benite, France ### 1859937###Author###Surgical Oncologist###Department of Digestive Surgery, CHU Lyon Sud, Pierre-Benite, France###
Author: Vahan Kepenekian, MD – Department of Digestive Surgery, CHU Lyon Sud, Pierre-Benite, France
### @@@ Isabelle Sourrouille, MD – Department of Surgical Oncology, Institut Gustav Roussy, Paris, France ### 2212170###Author###Surgical Oncologist###Department of Surgical Oncology, Institut Gustav Roussy, Paris, France###
Author: Isabelle Sourrouille, MD – Department of Surgical Oncology, Institut Gustav Roussy, Paris, France
### @@@ Frédéric Dumont, MD, PhD – Department of Surgical Oncology, Institut du Cancer Ouest, Nantes, France ### 2212171###Author###Surgical Oncologist###Department of Surgical Oncology, Institut du Cancer Ouest, Nantes, France###
Author: Frédéric Dumont, MD, PhD – Department of Surgical Oncology, Institut du Cancer Ouest, Nantes, France
### @@@ Marc Pocard, MD, PhD – Department of Digestive Surgery, CHU Pitié Salpêtriere, Paris, France ### 2212172###Author###Professor###Department of Digestive Surgery, CHU Pitié Salpêtriere, Paris, France###
Author: Marc Pocard, MD, PhD – Department of Digestive Surgery, CHU Pitié Salpêtriere, Paris, France
### @@@ Anai Kothari, MD, MS – Medical College of Wisconsin ### 1528202###Author###Assistant Professor###Medical College of Wisconsin###
Author: Anai Kothari, MD, MS – Medical College of Wisconsin
### @@@ Charles A. Staley, MD – Division of Surgical Oncology, Emory University, Atlanta, GA, United States ### 915797###Author###Professor###Division of Surgical Oncology, Emory University, Atlanta, GA, United States###
Author: Charles A. Staley, MD – Division of Surgical Oncology, Emory University, Atlanta, GA, United States
### @@@ Clarisse Eveno, MD, PhD – Department of Digestive Surgery, CHU Claude Huriez, Lille, France ### 2212173###Author###Professor###Department of Digestive Surgery, CHU Claude Huriez, Lille, France###
Author: Clarisse Eveno, MD, PhD – Department of Digestive Surgery, CHU Claude Huriez, Lille, France
### @@@ Sameer H. Patel, MD, FSSO (he/him/his) – Division of Surgical Oncology, University of Cincinnati, Cincinnati, OH, United States ### 1529257###Author###Associate Professor###Division of Surgical Oncology, University of Cincinnati, Cincinnati, OH, United States###
Author: Sameer H. Patel, MD, FSSO (he/him/his) – Division of Surgical Oncology, University of Cincinnati, Cincinnati, OH, United States
### he/him/his @@@ Jordan M. Cloyd, MD – Division of Surgical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, United States ### 915758###Author###Surgical Oncologist###Division of Surgical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, United States###
Author: Jordan M. Cloyd, MD – Division of Surgical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, United States
### @@@ Laura A. Lambert, MD – Division of Surgical Oncology, University of Utah, Salt Lake City, UT, United States ### 915773###Author###Professor###Division of Surgical Oncology, University of Utah, Salt Lake City, UT, United States###
Author: Laura A. Lambert, MD – Division of Surgical Oncology, University of Utah, Salt Lake City, UT, United States
### @@@ Martin Hübner, MD – Department of Digestive Surgery, CHUV, Lausanne, Switzerland ### 2212174###Author###Professor###Department of Digestive Surgery, CHUV, Lausanne, Switzerland###
Author: Martin Hübner, MD – Department of Digestive Surgery, CHUV, Lausanne, Switzerland
### @@@ Fabian M. Johnston, MD, MHS – Division of Gastrointestinal Surgical Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States ### 917904###Author###Associate Professor of Surgery###Division of Gastrointestinal Surgical Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States###
Author: Fabian M. Johnston, MD, MHS – Division of Gastrointestinal Surgical Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States
### @@@ Patrick R. Varley, MD, MS – Division of Surgical Oncology, School of Medicine and Public Health, University of Wisconsin–Madison, Madison, WI, USA ### 1850728###Author###Assistant Professor###Division of Surgical Oncology, School of Medicine and Public Health, University of Wisconsin–Madison, Madison, WI, USA###
Author: Patrick R. Varley, MD, MS – Division of Surgical Oncology, School of Medicine and Public Health, University of Wisconsin–Madison, Madison, WI, USA
### @@@ Keith F. Fournier, MD – Division of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, United States ### 1851095###Author###Associate Professor###Division of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, United States###
Author: Keith F. Fournier, MD – Division of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, United States
### @@@ Sean Dineen, MD – Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States ### 1214708###Author###Assistant Professor###Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States###
Author: Sean Dineen, MD – Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States
### @@@ Travis E. Grotz, MD – Mayo Clinic, Rochester, MN, United States ### 1214721###Author###Associate Professor###Mayo Clinic, Rochester, MN, United States###
Author: Travis E. Grotz, MD – Mayo Clinic, Rochester, MN, United States
### @@@ Lana Bijelic, MD – Department of Surgical Oncology, CHU Moises Broggi, Barcelona, Spain ### 2212047###Author###Chief Peritoneal Surface Malignancies Unit###Department of Surgical Oncology, CHU Moises Broggi, Barcelona, Spain###
Author: Lana Bijelic, MD – Department of Surgical Oncology, CHU Moises Broggi, Barcelona, Spain
### @@@ Olivia Sgarbura, MD, PhD – Department of Surgical Oncology, Institut du Cancer Montpellier, Montpellier, France ### 1213134###Author###Surgical Oncologist###Department of Surgical Oncology, Institut du Cancer Montpellier, Montpellier, France###
Author: Olivia Sgarbura, MD, PhD – Department of Surgical Oncology, Institut du Cancer Montpellier, Montpellier, France
### @@@ Mustafa Raoof, MD, MS – Division of Surgical Oncology, City of Hope National Medical Center, Duarte, CA ### 915788###Author###Assistant Professor###Division of Surgical Oncology, City of Hope National Medical Center, Duarte, CA###
Author: Mustafa Raoof, MD, MS – Division of Surgical Oncology, City of Hope National Medical Center, Duarte, CA
###
69: Detection and Concordance of Actionable Mutations in Solid Tumor and Circulating DNA Samples in Appendiceal Cancer

Sefali Patel, DO – Allegheny Health Network ### 2211897###Abstract Presenter###Research Fellow###Allegheny Health Network###
Abstract Presenter: Sefali Patel, DO – Allegheny Health Network
### @@@ Sefali Patel, DO – Allegheny Health Network ### 2211897###Submitter###Research Fellow###Allegheny Health Network###
Submitter: Sefali Patel, DO – Allegheny Health Network
### @@@ Sefali Patel, DO – Allegheny Health Network ### 2211897###Author###Research Fellow###Allegheny Health Network###
Author: Sefali Patel, DO – Allegheny Health Network
### @@@ Rose Blodgett, n/a – Allegheny Health Network ### 2204791###Author###Research Associate###Allegheny Health Network###
Author: Rose Blodgett, n/a – Allegheny Health Network
### @@@ Ashten Omstead, n/a – Allegheny Health Network ### 2204658###Author###Manager Medical Technology & Research###Allegheny Health Network###
Author: Ashten Omstead, n/a – Allegheny Health Network
### @@@ patricia Petrosko, n/a – Allegheny Health Network ### 2212157###Author###Molecular Biologist###Allegheny Health Network###
Author: patricia Petrosko, n/a – Allegheny Health Network
### @@@ Hyun Park, n/a – Allegheny Singer Research Institute ### 2204794###Author###Research Associate Senior###Allegheny Singer Research Institute###
Author: Hyun Park, n/a – Allegheny Singer Research Institute
### @@@ louis Gil, n/a – Allegheny Health Network ### 2212159###Author###Genomics Bioinformatics Analyst###Allegheny Health Network###
Author: louis Gil, n/a – Allegheny Health Network
### @@@ phillip Gallo, n/a – Allegheny Health Network ### 2212161###Author###Scientist###Allegheny Health Network###
Author: phillip Gallo, n/a – Allegheny Health Network
### @@@ Casey J. Allen, n/a – AHN ### 2204798###Author###Physician###AHN###
Author: Casey J. Allen, n/a – AHN
### @@@ Ali Zaidi, n/a – Allegheny Health Network ### 2204659###Author###Medical Director Research###Allegheny Health Network###
Author: Ali Zaidi, n/a – Allegheny Health Network
### @@@ David L. Bartlett, MD – AHN ### 917897###Author###Faculty###AHN###
Author: David L. Bartlett, MD – AHN
### @@@ william Laframboise, n/a – Allegheny Health Network ### 2212160###Author###Chief Genomics Technology Officer###Allegheny Health Network###
Author: william Laframboise, n/a – Allegheny Health Network
### @@@ Patrick L. Wagner – Allegheny Health Network Cancer Institute ### 1849809###Author###Director, Complex General Surgical Oncology###Allegheny Health Network Cancer Institute###
Author: Patrick L. Wagner – Allegheny Health Network Cancer Institute
###
7: Routine Use of Cavity Shave Margins with Breast Conserving Surgery Lowers Re-Excision Rates in a High Volume, Large Group Practice

Jeffery Chakedis, MD, FACS – The Permanente Medical Group ### 1502321###Abstract Presenter###Surgical Oncologist###The Permanente Medical Group###
Abstract Presenter: Jeffery Chakedis, MD, FACS – The Permanente Medical Group
### @@@ Jeffery Chakedis, MD, FACS – The Permanente Medical Group ### 1502321###Submitter###Surgical Oncologist###The Permanente Medical Group###
Submitter: Jeffery Chakedis, MD, FACS – The Permanente Medical Group
### @@@ Jeffery Chakedis, MD, FACS – The Permanente Medical Group ### 1502321###Author###Surgical Oncologist###The Permanente Medical Group###
Author: Jeffery Chakedis, MD, FACS – The Permanente Medical Group
### @@@ Annie Tang, MD – University of California San Francisco ### 2212048###Author###Breast Surgical Oncology Fellow###University of California San Francisco###
Author: Annie Tang, MD – University of California San Francisco
### @@@ Gillian Kuehner, MD – The Permanente Medical Group ### 2212049###Author###General Surgeon###The Permanente Medical Group###
Author: Gillian Kuehner, MD – The Permanente Medical Group
### @@@ Alison Savitz, MD – The Permanente Medical Group ### 2212050###Author###General Surgeon###The Permanente Medical Group###
Author: Alison Savitz, MD – The Permanente Medical Group
### @@@ Maris Jones, MD – The Permanente Medical Group ### 2212051###Author###Surgical Oncologist###The Permanente Medical Group###
Author: Maris Jones, MD – The Permanente Medical Group
### @@@ Lakhbir Sandhu, MD – The Permanente Medical Group ### 2212052###Author###Surgical Oncologist###The Permanente Medical Group###
Author: Lakhbir Sandhu, MD – The Permanente Medical Group
### @@@ Mindy Young-Reeves, MD – The Permanente Medical Group ### 2212053###Author###General Surgeon###The Permanente Medical Group###
Author: Mindy Young-Reeves, MD – The Permanente Medical Group
### @@@ Maihgan Kavanagh, MD – The Permanente Medical Group ### 2212054###Author###Surgical Oncologist###The Permanente Medical Group###
Author: Maihgan Kavanagh, MD – The Permanente Medical Group
### @@@ Sharon Chang, MD – The Permanente Medical Group ### 2212055###Author###Surgical Oncologist###The Permanente Medical Group###
Author: Sharon Chang, MD – The Permanente Medical Group
###
70: Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, Is it Appropriate?

Chris W. Mangieri, MD – Eisenhower Army Medical Center, Wake Forest University School of Medicine ### 2212232###Abstract Presenter###Chief of Surgical Oncology EAMC###Eisenhower Army Medical Center, Wake Forest University School of Medicine###
Abstract Presenter: Chris W. Mangieri, MD – Eisenhower Army Medical Center, Wake Forest University School of Medicine
### @@@ Chris W. Mangieri, MD – Eisenhower Army Medical Center, Wake Forest University School of Medicine ### 2212232###Submitter###Chief of Surgical Oncology EAMC###Eisenhower Army Medical Center, Wake Forest University School of Medicine###
Submitter: Chris W. Mangieri, MD – Eisenhower Army Medical Center, Wake Forest University School of Medicine
### @@@ Konstantinos I. Votanopoulos, MD, PhD, FACS – Wake Forest Baptist Medical Center ### 922517###Author###Professor Surgical Oncology###Wake Forest Baptist Medical Center###
Author: Konstantinos I. Votanopoulos, MD, PhD, FACS – Wake Forest Baptist Medical Center
### @@@ Perry Shen, MD – Wake Forest Baptist Medical Center ### 1850480###Author###Professor Surgical Oncology###Wake Forest Baptist Medical Center###
Author: Perry Shen, MD – Wake Forest Baptist Medical Center
### @@@ Edward A. Levine, MD – Wake Forest Baptist Medical Center ### 943361###Author###Chair Surgical Oncology###Wake Forest Baptist Medical Center###
Author: Edward A. Levine, MD – Wake Forest Baptist Medical Center
###
71: Phase I Trial of Intraperitoneal Paclitaxel in Patients with Gastric Adenocarcinoma and Peritoneal Carcinomatosis or Positive Peritoneal Cytology

Brian Badgwell, MD, MS – MD Anderson Cancer Center ### 915754###Abstract Presenter###Professor of Surgery###MD Anderson Cancer Center###
Abstract Presenter: Brian Badgwell, MD, MS – MD Anderson Cancer Center
### @@@ Brian Badgwell, MD, MS – MD Anderson Cancer Center ### 915754###Submitter###Professor of Surgery###MD Anderson Cancer Center###
Submitter: Brian Badgwell, MD, MS – MD Anderson Cancer Center
### @@@ Brian Badgwell, MD, MS – MD Anderson Cancer Center ### 915754###Author###Professor of Surgery###MD Anderson Cancer Center###
Author: Brian Badgwell, MD, MS – MD Anderson Cancer Center
### @@@ Mariela Blum, MD – MD Anderson Cancer Center ### 2211834###Author###Associate Professor###MD Anderson Cancer Center###
Author: Mariela Blum, MD – MD Anderson Cancer Center
### @@@ Naruhiko Ikoma, MD, MS – The University of Texas MD Anderson Cancer Center ### 944396###Author###Assistant Professor of Surgical Oncology###The University of Texas MD Anderson Cancer Center###
Author: Naruhiko Ikoma, MD, MS – The University of Texas MD Anderson Cancer Center
### @@@ Jeannelyn Estrella, MD – MD Anderson Cancer Center ### 1850633###Author###Professor###MD Anderson Cancer Center###
Author: Jeannelyn Estrella, MD – MD Anderson Cancer Center
### @@@ Jenny Li, MD – MD Anderson Cancer Center ### 2211835###Author###Assistant Professor###MD Anderson Cancer Center###
Author: Jenny Li, MD – MD Anderson Cancer Center
### @@@ Jitesh Kawedia, Pharm D – MD Anderson Cancer Center ### 2211848###Author###Clinical Pharmacy Specialist###MD Anderson Cancer Center###
Author: Jitesh Kawedia, Pharm D – MD Anderson Cancer Center
### @@@ Paul F. Mansfield, MD – MD Anderson Cancer Center ### 1850483###Author###Professor###MD Anderson Cancer Center###
Author: Paul F. Mansfield, MD – MD Anderson Cancer Center
### @@@ Jaffer Ajani, MD – MD Anderson Cancer Center ### 2211838###Author###Professor###MD Anderson Cancer Center###
Author: Jaffer Ajani, MD – MD Anderson Cancer Center
###
72: Predicting Severe Postoperative Complications After CRS-HIPEC: An Externally Validated Machine Learning Tool

Amir Ashraf Ganjouei, MD, MPH (he/him/his) – University of California San Francisco ### 1859985###Abstract Presenter###Research Fellow###University of California San Francisco###
Abstract Presenter: Amir Ashraf Ganjouei, MD, MPH (he/him/his) – University of California San Francisco
### he/him/his @@@ Amir Ashraf Ganjouei, MD, MPH (he/him/his) – University of California San Francisco ### 1859985###Submitter###Research Fellow###University of California San Francisco###
Submitter: Amir Ashraf Ganjouei, MD, MPH (he/him/his) – University of California San Francisco
### he/him/his @@@ Amir Ashraf Ganjouei, MD, MPH (he/him/his) – University of California San Francisco ### 1859985###Author###Research Fellow###University of California San Francisco###
Author: Amir Ashraf Ganjouei, MD, MPH (he/him/his) – University of California San Francisco
### he/him/his @@@ Jane Wang, MD (she/her/hers) – Department of Surgery, University of California San Francisco ### 1860031###Author###Resident###Department of Surgery, University of California San Francisco###
Author: Jane Wang, MD (she/her/hers) – Department of Surgery, University of California San Francisco
### she/her/hers @@@ Christopher Yi, BS – University of California, Berkeley ### 2212060###Author###Student###University of California, Berkeley###
Author: Christopher Yi, BS – University of California, Berkeley
### @@@ Fernanda Romero-Hernandez, MD – University of California, San Francisco ### 1860030###Author###Resident###University of California, San Francisco###
Author: Fernanda Romero-Hernandez, MD – University of California, San Francisco
### @@@ Adnan Alseidi, MD, EdM – University of California, San Francisco ### 2212061###Author###Professor###University of California, San Francisco###
Author: Adnan Alseidi, MD, EdM – University of California, San Francisco
### @@@ Daniel E. Abbott, MD, FACS – Surgical Director of UW Health Liver and Pancreas Center ### 937363###Author###University of Wisconsin Carbone Cancer Center###Surgical Director of UW Health Liver and Pancreas Center###
Author: Daniel E. Abbott, MD, FACS – Surgical Director of UW Health Liver and Pancreas Center
### @@@ Syed Nabeel Zafar, MD, MPH – University of Wisconsin School of Medical and Public Health ### 1850590###Author###Surgical Oncologist###University of Wisconsin School of Medical and Public Health###
Author: Syed Nabeel Zafar, MD, MPH – University of Wisconsin School of Medical and Public Health
### @@@ Patrick Schwartz, MD, PhD – University of Wisconsin School of Medical and Public Health ### 2212188###Author###Resident###University of Wisconsin School of Medical and Public Health###
Author: Patrick Schwartz, MD, PhD – University of Wisconsin School of Medical and Public Health
### @@@ Keith F. Fournier, MD – Division of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, United States ### 1851095###Author###Associate Professor###Division of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, United States###
Author: Keith F. Fournier, MD – Division of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, United States
### @@@ Charles A. Staley, MD – Division of Surgical Oncology, Emory University, Atlanta, GA, United States ### 915797###Author###Professor###Division of Surgical Oncology, Emory University, Atlanta, GA, United States###
Author: Charles A. Staley, MD – Division of Surgical Oncology, Emory University, Atlanta, GA, United States
### @@@ Sean Dineen, MD – Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States ### 1214708###Author###Assistant Professor###Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States###
Author: Sean Dineen, MD – Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States
### @@@ Mustafa Raoof, MD, MS – Division of Surgical Oncology, City of Hope National Medical Center, Duarte, CA ### 915788###Author###Assistant Professor###Division of Surgical Oncology, City of Hope National Medical Center, Duarte, CA###
Author: Mustafa Raoof, MD, MS – Division of Surgical Oncology, City of Hope National Medical Center, Duarte, CA
### @@@ David L. Bartlett, MD – AHN ### 917897###Author###Faculty###AHN###
Author: David L. Bartlett, MD – AHN
### @@@ Mohamed A. Adam, MD – University of California, San Francisco ### 1849933###Author###Assistant Professor###University of California, San Francisco###
Author: Mohamed A. Adam, MD – University of California, San Francisco
### @@@ Jordan M. Cloyd, MD – Division of Surgical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, United States ### 915758###Author###Surgical Oncologist###Division of Surgical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, United States###
Author: Jordan M. Cloyd, MD – Division of Surgical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, United States
### @@@ Haroon A. Choudry, MD – UPMC ### 915757###Author###Faculty###UPMC###
Author: Haroon A. Choudry, MD – UPMC
###
73: Human tumor vessel heterogeneity in ovarian cancer and its association with response to neoadjuvant chemotherapy

Emmanuel M. Gabriel, MD, PhD – Mayo Clinic Florida ### 918102###Abstract Presenter###Assistant Professor###Mayo Clinic Florida###
Abstract Presenter: Emmanuel M. Gabriel, MD, PhD – Mayo Clinic Florida
### @@@ Emmanuel M. Gabriel, MD, PhD – Mayo Clinic Florida ### 918102###Submitter###Assistant Professor###Mayo Clinic Florida###
Submitter: Emmanuel M. Gabriel, MD, PhD – Mayo Clinic Florida
### @@@ Emmanuel M. Gabriel, MD, PhD – Mayo Clinic Florida ### 918102###Author###Assistant Professor###Mayo Clinic Florida###
Author: Emmanuel M. Gabriel, MD, PhD – Mayo Clinic Florida
### @@@ Kristopher Attwood, PhD – Roswell Park Comprehensive Cancer Center ### 1850496###Author###Biostatistician###Roswell Park Comprehensive Cancer Center###
Author: Kristopher Attwood, PhD – Roswell Park Comprehensive Cancer Center
### @@@ Anthony George, MS – Roswell Park Comprehensive Cancer Center ### 2211776###Author###Biostatistician###Roswell Park Comprehensive Cancer Center###
Author: Anthony George, MS – Roswell Park Comprehensive Cancer Center
### @@@ Sanjay P. Bagaria, MD – Mayo Clinic Florida ### 970194###Author###Professor###Mayo Clinic Florida###
Author: Sanjay P. Bagaria, MD – Mayo Clinic Florida
### @@@ Keith Knutson, PhD – Mayo Clinic Florida ### 1851298###Author###Professor###Mayo Clinic Florida###
Author: Keith Knutson, PhD – Mayo Clinic Florida
### @@@ Joseph Skitzki, MD – Mayo Clinic Florida ### 2211777###Author###Professor###Mayo Clinic Florida###
Author: Joseph Skitzki, MD – Mayo Clinic Florida
### @@@ Matthew Robertson, MD – Mayo Clinic Florida ### 2211778###Author###Professor###Mayo Clinic Florida###
Author: Matthew Robertson, MD – Mayo Clinic Florida
### @@@ Tri Dinh, MD – Mayo Clinic Florida ### 2211779###Author###Professor###Mayo Clinic Florida###
Author: Tri Dinh, MD – Mayo Clinic Florida
###
74: In Vivo Analysis of Protein Level Effects of Hyperthermic Intraperitoneal Chemotherapy

Amber Leila Sarvestani, MD – NCI ### 1534946###Abstract Presenter###Surgical Oncology Research Fellow###NCI###
Abstract Presenter: Amber Leila Sarvestani, MD – NCI
### @@@ Amber Leila Sarvestani, MD – NCI ### 1534946###Submitter###Surgical Oncology Research Fellow###NCI###
Submitter: Amber Leila Sarvestani, MD – NCI
### @@@ Ashley Rainey, BS – National Cancer Institute ### 2212210###Author###Postbaccalaureate###National Cancer Institute###
Author: Ashley Rainey, BS – National Cancer Institute
### @@@ Shruthi R. Perati, MD – National Cancer Institute ### 2212211###Author###Surgical Oncology Research Fellow###National Cancer Institute###
Author: Shruthi R. Perati, MD – National Cancer Institute
### @@@ Shelby V. Johnson, MPH, n/a – NCI ### 2212212###Author###Medical Student###NCI###
Author: Shelby V. Johnson, MPH, n/a – NCI
### @@@ Ronald Holewinski, PhD – Fredrick National Labratory for Cancer Research ### 2212213###Author###Scientist II###Fredrick National Labratory for Cancer Research###
Author: Ronald Holewinski, PhD – Fredrick National Labratory for Cancer Research
### @@@ Thorkell Andresson, PhD – Fredrick National Labratory for Cancer Research ### 2212214###Author###Scientist, Team Lead###Fredrick National Labratory for Cancer Research###
Author: Thorkell Andresson, PhD – Fredrick National Labratory for Cancer Research
### @@@ Jonathan M. Hernandez, MD – Surgical Oncology Program, National Cancer Institute ### 972423###Author###Investigator###Surgical Oncology Program, National Cancer Institute###
Author: Jonathan M. Hernandez, MD – Surgical Oncology Program, National Cancer Institute
### @@@ Andrew M. Blakely, MD – National Cancer Institute ### 1849920###Author###Principal Investigator###National Cancer Institute###
Author: Andrew M. Blakely, MD – National Cancer Institute
### @@@ Stephanie N. Gregory, MD (she/her/hers) – Rutgers Robert Wood Johnson ### 1852496###Author###General Surgery Resident###Rutgers Robert Wood Johnson###
Author: Stephanie N. Gregory, MD (she/her/hers) – Rutgers Robert Wood Johnson
### she/her/hers
75: Peritoneal Lavage Exosomes Differential Gene Expression is Associated with Response to Intraperitoneal Chemotherapy in Patients with Gastric Carcinomatosis - Results from a Phase II Clinical Trial (STOPGAP)

Maheswari Senthil, MD (she/her/hers) – University of California, Irvine ### 915794###Abstract Presenter###Chief of Surgical Oncology###University of California, Irvine###
Abstract Presenter: Maheswari Senthil, MD (she/her/hers) – University of California, Irvine
### she/her/hers @@@ Maheswari Senthil, MD (she/her/hers) – University of California, Irvine ### 915794###Submitter###Chief of Surgical Oncology###University of California, Irvine###
Submitter: Maheswari Senthil, MD (she/her/hers) – University of California, Irvine
### she/her/hers @@@ Maheswari Senthil, MD (she/her/hers) – University of California, Irvine ### 915794###Author###Chief of Surgical Oncology###University of California, Irvine###
Author: Maheswari Senthil, MD (she/her/hers) – University of California, Irvine
### she/her/hers @@@ Vinodh Radhakrishnan, PhD – University of California Irvine ### 2212009###Author###Project Scientist###University of California Irvine###
Author: Vinodh Radhakrishnan, PhD – University of California Irvine
### @@@ Fatemeh Tajik, MD – University of California Irvine ### 2212010###Author###Research Associate###University of California Irvine###
Author: Fatemeh Tajik, MD – University of California Irvine
### @@@ Shaina Sedighim, MD – University of California, Irvine, Department of Surgery ### 2211839###Author###Resident Physician###University of California, Irvine, Department of Surgery###
Author: Shaina Sedighim, MD – University of California, Irvine, Department of Surgery
### @@@ Amy Y. Li, MD – University of California, Irvine, Department of Surgery ### 2211840###Author###Fellow Physician###University of California, Irvine, Department of Surgery###
Author: Amy Y. Li, MD – University of California, Irvine, Department of Surgery
### @@@ Oliver Eng, MD (he/him/his) – University of California, Irvine ### 1849737###Author###Associate Professor of Surgery###University of California, Irvine###
Author: Oliver Eng, MD (he/him/his) – University of California, Irvine
### he/him/his @@@ Shishir K. Maithel, MD, FACS – Winship Cancer Institute of Emory University ### 917909###Author###Professor, Department of Surgery###Winship Cancer Institute of Emory University###
Author: Shishir K. Maithel, MD, FACS – Winship Cancer Institute of Emory University
### @@@ Nataliya V. Uboha, MD, PhD – University of Wisconsin ### 2212011###Author###Associate Professor###University of Wisconsin###
Author: Nataliya V. Uboha, MD, PhD – University of Wisconsin
### @@@ Farshid Dayyani, MD, PhD – University of California Irvine ### 1850098###Author###Professor of Medicine###University of California Irvine###
Author: Farshid Dayyani, MD, PhD – University of California Irvine
###
76: Improved Survival with Immunotherapy for Microsatellite Unstable Colorectal Cancer with Peritoneal Metastases

Rhami Khorfan, MD MS – Loma Linda University ### 1852161###Abstract Presenter###CGSO Fellow###Loma Linda University###
Abstract Presenter: Rhami Khorfan, MD MS – Loma Linda University
### @@@ Rhami Khorfan, MD MS – Loma Linda University ### 1852161###Submitter###CGSO Fellow###Loma Linda University###
Submitter: Rhami Khorfan, MD MS – Loma Linda University
### @@@ Rhami Khorfan, MD MS – Loma Linda University ### 1852161###Author###CGSO Fellow###Loma Linda University###
Author: Rhami Khorfan, MD MS – Loma Linda University
### @@@ Shaina Sedighim, MD – University of California, Irvine, Department of Surgery ### 2211839###Author###Resident Physician###University of California, Irvine, Department of Surgery###
Author: Shaina Sedighim, MD – University of California, Irvine, Department of Surgery
### @@@ David Caba-Molina, MD MS MPH – Loma Linda University ### 1852163###Author###Assistant Professor###Loma Linda University###
Author: David Caba-Molina, MD MS MPH – Loma Linda University
### @@@ Thuy Tran, MD – University of California, Irvine ### 1849929###Author###Assistant Professor###University of California, Irvine###
Author: Thuy Tran, MD – University of California, Irvine
### @@@ Maheswari Senthil, MD (she/her/hers) – University of California, Irvine ### 915794###Author###Chief of Surgical Oncology###University of California, Irvine###
Author: Maheswari Senthil, MD (she/her/hers) – University of California, Irvine
### she/her/hers @@@ Michael P. O’Leary, MD (he/him/his) – Loma Linda University, Department of Surgery ### 1811049###Author###Attending Surgeon###Loma Linda University, Department of Surgery###
Author: Michael P. O’Leary, MD (he/him/his) – Loma Linda University, Department of Surgery
### he/him/his @@@ Oliver Eng, MD (he/him/his) – University of California, Irvine ### 1849737###Author###Associate Professor of Surgery###University of California, Irvine###
Author: Oliver Eng, MD (he/him/his) – University of California, Irvine
### he/him/his
77: Evolution of the Volume Outcome Association in Complex Cancer Surgery- Should Volume Thresholds be Reconsidered?

Akash Kartik, MBBS – Mayo Clinic Arizona ### 1534982### Author###Surgical Resident###Mayo Clinic Arizona###
Author: Akash Kartik, MBBS – Mayo Clinic Arizona
### @@@ Akash Kartik, MBBS – Mayo Clinic Arizona ### 1534982###Author###Surgical Resident###Mayo Clinic Arizona###
Author: Akash Kartik, MBBS – Mayo Clinic Arizona
### @@@ Zhi Ven Fong, MD MPH DrPH – Mayo Clinic Arizona ### 2211985###Author###Assistant Professor of Surgery###Mayo Clinic Arizona###
Author: Zhi Ven Fong, MD MPH DrPH – Mayo Clinic Arizona
### @@@ Chee-Chee Stucky, MD – Mayo Clinic Arizona ### 2119273###Author###Associate Professor of Surgery###Mayo Clinic Arizona###
Author: Chee-Chee Stucky, MD – Mayo Clinic Arizona
### @@@ Patricia A. Cronin, MD – Department of Surgical Oncology and Endocrine Surgery, Mayo Clinic Arizona ### 969535###Author###Assistant Professor of Surgery###Department of Surgical Oncology and Endocrine Surgery, Mayo Clinic Arizona###
Author: Patricia A. Cronin, MD – Department of Surgical Oncology and Endocrine Surgery, Mayo Clinic Arizona
### @@@ David Etzioni, MD, MS – Mayo Clinic Arizona ### 2212028###Author###Professor of Surgery###Mayo Clinic Arizona###
Author: David Etzioni, MD, MS – Mayo Clinic Arizona
### @@@ Yu-Hui Chang, MPH, PhD – Mayo Clinic Arizona ### 2212029###Author###Assistant Professor of Surgery###Mayo Clinic Arizona###
Author: Yu-Hui Chang, MPH, PhD – Mayo Clinic Arizona
### @@@ Richard Bold, MD – Mayo Clinic Arizona ### 2212209###Author###Professor of Surgery###Mayo Clinic Arizona###
Author: Richard Bold, MD – Mayo Clinic Arizona
### @@@ Nabil Wasif, MD, MPH – Mayo Clinic in Arizona ### 937476###Submitter###Professor of Surgery###Mayo Clinic in Arizona###
Submitter: Nabil Wasif, MD, MPH – Mayo Clinic in Arizona
### @@@ Nabil Wasif, MD, MPH – Mayo Clinic in Arizona ### 937476###Abstract Presenter###Professor of Surgery###Mayo Clinic in Arizona###
Abstract Presenter: Nabil Wasif, MD, MPH – Mayo Clinic in Arizona
###
78: Health Outcomes among Patients with New Persistent Opioid Use Following Gastrointestinal Cancer Surgery

Mujtaba Khalil, MD (he/him/his) – Department of Surgery, The Ohio State University Wexner Medical Center ### 2204722###Abstract Presenter###Research Fellow###Department of Surgery, The Ohio State University Wexner Medical Center###
Abstract Presenter: Mujtaba Khalil, MD (he/him/his) – Department of Surgery, The Ohio State University Wexner Medical Center
### he/him/his @@@ Mujtaba Khalil, MD (he/him/his) – Department of Surgery, The Ohio State University Wexner Medical Center ### 2204722###Author###Research Fellow###Department of Surgery, The Ohio State University Wexner Medical Center###
Author: Mujtaba Khalil, MD (he/him/his) – Department of Surgery, The Ohio State University Wexner Medical Center
### he/him/his @@@ Selamawit Woldesenbet, PhD – Department of Surgery, The Ohio State University Wexner Medical Center ### 1850858###Author###Statistician###Department of Surgery, The Ohio State University Wexner Medical Center###
Author: Selamawit Woldesenbet, PhD – Department of Surgery, The Ohio State University Wexner Medical Center
### @@@ Muhammad Musaab Munir, MBBS (he/him/his) – Department of Surgery, The Ohio State University Wexner Medical Center ### 1850857###Author###Research Fellow###Department of Surgery, The Ohio State University Wexner Medical Center###
Author: Muhammad Musaab Munir, MBBS (he/him/his) – Department of Surgery, The Ohio State University Wexner Medical Center
### he/him/his @@@ Muhammad Muntazir Mehdi Khan, MBBS – Department of Surgery, The Ohio State University Wexner Medical Center ### 2204732###Author###Research Fellow###Department of Surgery, The Ohio State University Wexner Medical Center###
Author: Muhammad Muntazir Mehdi Khan, MBBS – Department of Surgery, The Ohio State University Wexner Medical Center
### @@@ Erryk S. Katayama, BA – The Ohio State University College of Medicine ### 2212030###Author###Medical Student###The Ohio State University College of Medicine###
Author: Erryk S. Katayama, BA – The Ohio State University College of Medicine
### @@@ Zayed Rashid, MD (he/him/his) – The Ohio State University Wexner Medical Center ### 2204749###Author###Research fellow###The Ohio State University Wexner Medical Center###
Author: Zayed Rashid, MD (he/him/his) – The Ohio State University Wexner Medical Center
### he/him/his @@@ Mary E. Dillhoff, MD – The Ohio State University Wexner Medical Center ### 937478###Author###Surgical Oncologist###The Ohio State University Wexner Medical Center###
Author: Mary E. Dillhoff, MD – The Ohio State University Wexner Medical Center
### @@@ Aslam Ejaz, MD – The Ohio State University Wexner Medical Center ### 1502392###Author###Surgical Oncologist###The Ohio State University Wexner Medical Center###
Author: Aslam Ejaz, MD – The Ohio State University Wexner Medical Center
### @@@ Jordan M. Cloyd, MD – Division of Surgical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, United States ### 915758###Author###Surgical Oncologist###Division of Surgical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, United States###
Author: Jordan M. Cloyd, MD – Division of Surgical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, United States
### @@@ Timothy M. Pawlik, MD, PhD, MPH, MTS, MBA, FACS, FRACS (Hon.), FRCSEd (Hon.) – The Ohio State University Wexner Medical Center ### 937481###Submitter###Surgical Oncologist###The Ohio State University Wexner Medical Center###
Submitter: Timothy M. Pawlik, MD, PhD, MPH, MTS, MBA, FACS, FRACS (Hon.), FRCSEd (Hon.) – The Ohio State University Wexner Medical Center
### @@@ Timothy M. Pawlik, MD, PhD, MPH, MTS, MBA, FACS, FRACS (Hon.), FRCSEd (Hon.) – The Ohio State University Wexner Medical Center ### 937481###Author###Surgical Oncologist###The Ohio State University Wexner Medical Center###
Author: Timothy M. Pawlik, MD, PhD, MPH, MTS, MBA, FACS, FRACS (Hon.), FRCSEd (Hon.) – The Ohio State University Wexner Medical Center
###
79: Enhancing the National Cancer Database Content and Usability Using Contemporary Statistical Methods

Christina M. Stuart, MD (she/her/hers) – University of Colorado, Department of Surgery ### 1849778###Abstract Presenter###Resident Physician###University of Colorado, Department of Surgery###
Abstract Presenter: Christina M. Stuart, MD (she/her/hers) – University of Colorado, Department of Surgery
### she/her/hers @@@ Christina M. Stuart, MD (she/her/hers) – University of Colorado, Department of Surgery ### 1849778###Submitter###Resident Physician###University of Colorado, Department of Surgery###
Submitter: Christina M. Stuart, MD (she/her/hers) – University of Colorado, Department of Surgery
### she/her/hers @@@ Christina M. Stuart, MD (she/her/hers) – University of Colorado, Department of Surgery ### 1849778###Author###Resident Physician###University of Colorado, Department of Surgery###
Author: Christina M. Stuart, MD (she/her/hers) – University of Colorado, Department of Surgery
### she/her/hers @@@ Yizhou Fei, MS – University of Colorado, Anschutz Medical Campus ### 2212129###Author###Analyst###University of Colorado, Anschutz Medical Campus###
Author: Yizhou Fei, MS – University of Colorado, Anschutz Medical Campus
### @@@ Richard D. Schulick, MD, MBA – University of Colorado, Department of Surgery ### 1849721###Author###Chair of Surgery and Cancer Center Director###University of Colorado, Department of Surgery###
Author: Richard D. Schulick, MD, MBA – University of Colorado, Department of Surgery
### @@@ Kathryn L. Colborn, PhD – University of Colorado School of Medicine, Adult & Child Center for Outcomes Research & Delivery Science ### 1849718###Author###Associate Professor###University of Colorado School of Medicine, Adult & Child Center for Outcomes Research & Delivery Science###
Author: Kathryn L. Colborn, PhD – University of Colorado School of Medicine, Adult & Child Center for Outcomes Research & Delivery Science
### @@@ Robert A. Meguid, MD, MPH – University of Colorado, Department of Surgery ### 1849789###Author###Professor of Surgery###University of Colorado, Department of Surgery###
Author: Robert A. Meguid, MD, MPH – University of Colorado, Department of Surgery
###
8: A high pre-existing TCR repertoire diversity may predict response to preoperative radiotherapy and pembrolizumab in early-stage breast cancer – NCT04454528 preliminary results

Fengjuan Zhang, PhD – University of Pennsylvania ### 2211987###Author###Postdoctoral fellow###University of Pennsylvania###
Author: Fengjuan Zhang, PhD – University of Pennsylvania
### @@@ Joseph Fraietta, PhD – Universiy of Pennsylvania ### 2211912###Author###Assistant Professor###Universiy of Pennsylvania###
Author: Joseph Fraietta, PhD – Universiy of Pennsylvania
### @@@ Amy Clark, MD – University of Pennsylvania ### 2211988###Author###Assistant Professor###University of Pennsylvania###
Author: Amy Clark, MD – University of Pennsylvania
### @@@ Neil taunk, MD – University of Pennsylvania ### 2211989###Author###Assistant Professor###University of Pennsylvania###
Author: Neil taunk, MD – University of Pennsylvania
### @@@ Nucleus H Xu, PhD – University of Pennsylvania ### 2211911###Author###Research Assistant Professor###University of Pennsylvania###
Author: Nucleus H Xu, PhD – University of Pennsylvania
### @@@ Anupma Nayak, MD – University of Pennsylvania ### 1851561###Author###Associate Professor###University of Pennsylvania###
Author: Anupma Nayak, MD – University of Pennsylvania
### @@@ Zahra Ahmad, BS – University of Pennsylvania ### 2211910###Author###Research Fellow###University of Pennsylvania###
Author: Zahra Ahmad, BS – University of Pennsylvania
### @@@ Diego Gonzalves, BA – University of Pennsylvania ### 1851263###Author###Research Fellow###University of Pennsylvania###
Author: Diego Gonzalves, BA – University of Pennsylvania
### @@@ Alexander C Huang, MD – University of Pennsylvania ### 2211990###Author###Assistant Professor###University of Pennsylvania###
Author: Alexander C Huang, MD – University of Pennsylvania
### @@@ Andy Minn, MD PhD – University of Pennsylvania ### 2211991###Author###Professor###University of Pennsylvania###
Author: Andy Minn, MD PhD – University of Pennsylvania
### @@@ Julia Tchou, MD PhD – University of Pennsylvania ### 1530212###Abstract Presenter###Professor of Clinical Surgery###University of Pennsylvania###
Abstract Presenter: Julia Tchou, MD PhD – University of Pennsylvania
### @@@ Julia Tchou, MD PhD – University of Pennsylvania ### 1530212###Submitter###Professor of Clinical Surgery###University of Pennsylvania###
Submitter: Julia Tchou, MD PhD – University of Pennsylvania
###
80: Thromboembolic Events After Major Hepatectomy: Emphasizing Patient Selection for Prophylaxis

Salvador Rodriguez Franco, MD (he/him/his) – University of Colorado Anschutz Medical Campus ### 1849717###Abstract Presenter###Senior Research Associate###University of Colorado Anschutz Medical Campus###
Abstract Presenter: Salvador Rodriguez Franco, MD (he/him/his) – University of Colorado Anschutz Medical Campus
### he/him/his @@@ Salvador Rodriguez Franco, MD (he/him/his) – University of Colorado Anschutz Medical Campus ### 1849717###Submitter###Senior Research Associate###University of Colorado Anschutz Medical Campus###
Submitter: Salvador Rodriguez Franco, MD (he/him/his) – University of Colorado Anschutz Medical Campus
### he/him/his @@@ Salvador Rodriguez Franco, MD (he/him/his) – University of Colorado Anschutz Medical Campus ### 1849717###Author###Senior Research Associate###University of Colorado Anschutz Medical Campus###
Author: Salvador Rodriguez Franco, MD (he/him/his) – University of Colorado Anschutz Medical Campus
### he/him/his @@@ Sumaya Abdul Ghaffar, MD – University of Colorado ### 2211794###Author###Research Fellow###University of Colorado###
Author: Sumaya Abdul Ghaffar, MD – University of Colorado
### @@@ Mona Hamermesh, PA – University of Colorado Anschutz Medical Campus ### 1852538###Author###Senior Instructor###University of Colorado Anschutz Medical Campus###
Author: Mona Hamermesh, PA – University of Colorado Anschutz Medical Campus
### @@@ Reed Weiss, RN, NP – University of Colorado Anschutz Medical Campus ### 1852540###Author###Senior Instructor###University of Colorado Anschutz Medical Campus###
Author: Reed Weiss, RN, NP – University of Colorado Anschutz Medical Campus
### @@@ Kyle Bata, MS – University of Colorado Anschutz Medical Campus ### 2212231###Author###QI & data analyst###University of Colorado Anschutz Medical Campus###
Author: Kyle Bata, MS – University of Colorado Anschutz Medical Campus
### @@@ Nalu Navarro Alvarez, MD – Univeristy of Colorado Anschutz Medical Campus ### 2212230###Author###Assistant professor###Univeristy of Colorado Anschutz Medical Campus###
Author: Nalu Navarro Alvarez, MD – Univeristy of Colorado Anschutz Medical Campus
### @@@ Marco Del Chiaro, MD, PhD – University of Colorado Anschutz Medical Campus ### 1849720###Author###Division Chief Surgical Oncology###University of Colorado Anschutz Medical Campus###
Author: Marco Del Chiaro, MD, PhD – University of Colorado Anschutz Medical Campus
### @@@ Richard D. Schulick, MD, MBA – University of Colorado, Department of Surgery ### 1849721###Author###Chair of Surgery and Cancer Center Director###University of Colorado, Department of Surgery###
Author: Richard D. Schulick, MD, MBA – University of Colorado, Department of Surgery
### @@@ Ana Gleisner, MD, PhD – University of Colorado ### 1502393###Author###Associate Professor###University of Colorado###
Author: Ana Gleisner, MD, PhD – University of Colorado
###
81: Practice Patterns of Surgical Oncology Fellowship Graduates

Aaron T. Scott, MD – City of Hope Medical Center ### 1849954###Abstract Presenter###Fellow###City of Hope Medical Center###
Abstract Presenter: Aaron T. Scott, MD – City of Hope Medical Center
### @@@ Aaron T. Scott, MD – City of Hope Medical Center ### 1849954###Submitter###Fellow###City of Hope Medical Center###
Submitter: Aaron T. Scott, MD – City of Hope Medical Center
### @@@ Aaron T. Scott, MD – City of Hope Medical Center ### 1849954###Author###Fellow###City of Hope Medical Center###
Author: Aaron T. Scott, MD – City of Hope Medical Center
### @@@ Andrew H. Nguyen, MD – City of Hope Medical Center ### 970174###Author###Assistant Clinical Professor of Surgery###City of Hope Medical Center###
Author: Andrew H. Nguyen, MD – City of Hope Medical Center
### @@@ Christina Perez, n/a – City of Hope Medical Center ### 2212191###Author###Training Program Administrator###City of Hope Medical Center###
Author: Christina Perez, n/a – City of Hope Medical Center
### @@@ Laleh Melstrom, MD – Division of Surgical Oncology, Department of Surgery, City of Hope National Medical Center, Duarte, CA ### 969536###Author###Associate Professor###Division of Surgical Oncology, Department of Surgery, City of Hope National Medical Center, Duarte, CA###
Author: Laleh Melstrom, MD – Division of Surgical Oncology, Department of Surgery, City of Hope National Medical Center, Duarte, CA
### @@@ Lily L. Lai, MD – Department of Surgical Oncology, City of Hope National Medical Center, Duarte, CA ### 937487###Author###Associate Professor###Department of Surgical Oncology, City of Hope National Medical Center, Duarte, CA###
Author: Lily L. Lai, MD – Department of Surgical Oncology, City of Hope National Medical Center, Duarte, CA
###
82: Neoadjuvant Radiation Therapy (RT) for Primary Retroperitoneal Well-Differentiated Liposarcoma (RP WDLPS): A Transatlantic Australasian Retroperitoneal Working Group (TARPSWG) Study

Mark Fairweather, MD – Brigham and Women's Hospital/Harvard Medical School ### 1851860###Abstract Presenter###Surgical Oncologist###Brigham and Women's Hospital/Harvard Medical School###
Abstract Presenter: Mark Fairweather, MD – Brigham and Women's Hospital/Harvard Medical School
### @@@ Mark Fairweather, MD – Brigham and Women's Hospital/Harvard Medical School ### 1851860###Submitter###Surgical Oncologist###Brigham and Women's Hospital/Harvard Medical School###
Submitter: Mark Fairweather, MD – Brigham and Women's Hospital/Harvard Medical School
### @@@ Megan L. Sulciner, MD – Brigham and Women's Hospital ### 1851854###Author###Resident###Brigham and Women's Hospital###
Author: Megan L. Sulciner, MD – Brigham and Women's Hospital
### @@@ Joshua S. Jolissaint, MD, MSc – Memorial Sloan Kettering Cancer Center ### 2212031###Author###Complex General Surgical Oncology Fellow###Memorial Sloan Kettering Cancer Center###
Author: Joshua S. Jolissaint, MD, MSc – Memorial Sloan Kettering Cancer Center
### @@@ Marco Fiore, MD, FACS, FEBSh – Sarcoma Service, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ### 969941###Author###Surgical Oncologist###Sarcoma Service, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy###
Author: Marco Fiore, MD, FACS, FEBSh – Sarcoma Service, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### @@@ Dorian Yarih Garcia Ortega, MD, MSc – Skin and Soft Tumors Department, National Cancer Institute (Mexico) ### 970202###Author###Surgical Oncologist###Skin and Soft Tumors Department, National Cancer Institute (Mexico)###
Author: Dorian Yarih Garcia Ortega, MD, MSc – Skin and Soft Tumors Department, National Cancer Institute (Mexico)
### @@@ Carol Swallow, MD, PhD (she/her/hers) – Department of Surgical Oncology, Mount Sinai Hospital and Princess Margaret Cancer Centre ### 2105690###Author###Surgical Oncologist###Department of Surgical Oncology, Mount Sinai Hospital and Princess Margaret Cancer Centre###
Author: Carol Swallow, MD, PhD (she/her/hers) – Department of Surgical Oncology, Mount Sinai Hospital and Princess Margaret Cancer Centre
### she/her/hers @@@ Samuel Ford, MD, PhD – Department of Surgery, University Hospitals Birmingham ### 1849925###Author###Surgical Oncologist###Department of Surgery, University Hospitals Birmingham###
Author: Samuel Ford, MD, PhD – Department of Surgery, University Hospitals Birmingham
### @@@ Shintaro Iwata, MD – Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Japan ### 1850790###Author###Surgical Oncologist###Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Japan###
Author: Shintaro Iwata, MD – Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Japan
### @@@ Eran Nizri, n/a – Tel-Aviv Sourasky Medical Center ### 969944###Author###Chairman, Department of Surgery B###Tel-Aviv Sourasky Medical Center###
Author: Eran Nizri, n/a – Tel-Aviv Sourasky Medical Center
### @@@ Vittorio Quagliuolo, MD – Department of Surgery, Istituto Clinico Humanitas ### 2212032###Author###Surgical Oncologist###Department of Surgery, Istituto Clinico Humanitas###
Author: Vittorio Quagliuolo, MD – Department of Surgery, Istituto Clinico Humanitas
### @@@ Dagmar A. Adamkova, MD, PhD – Department of Cancer Comprehensive Care, Masaryk Memorial Cancer Institute ### 1850784###Author###Attending physician###Department of Cancer Comprehensive Care, Masaryk Memorial Cancer Institute###
Author: Dagmar A. Adamkova, MD, PhD – Department of Cancer Comprehensive Care, Masaryk Memorial Cancer Institute
### @@@ Carolyn Nessim, MD, MSc, FRCSC, FACS (she/her/hers) – The Ottawa Hospital, University of Ottawa, Ottawa Hospital Research Institute ### 1795369###Author###Surgical Oncologist, Associate Professor, Clinician Investigator, CGSO Program Director###The Ottawa Hospital, University of Ottawa, Ottawa Hospital Research Institute###
Author: Carolyn Nessim, MD, MSc, FRCSC, FACS (she/her/hers) – The Ottawa Hospital, University of Ottawa, Ottawa Hospital Research Institute
### she/her/hers @@@ Piotr Rutkowski, MD, PhD – Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology ### 2212033###Author###Surgical Oncologist###Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology###
Author: Piotr Rutkowski, MD, PhD – Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology
### @@@ Kenneth Cardona, MD – Winship Cancer Institute, Emory University ### 2119256###Author###Patricia R. Reynolds Professor of Sarcoma Lead, Winship Sarcoma Disease Team Chair, NCI ECOG-ACRIN Sarcoma Working Group###Winship Cancer Institute, Emory University###
Author: Kenneth Cardona, MD – Winship Cancer Institute, Emory University
### @@@ Edward Kim, MD – Department of Radiation Oncology, University of Washington ### 2212034###Author###Radiation Oncologist###Department of Radiation Oncology, University of Washington###
Author: Edward Kim, MD – Department of Radiation Oncology, University of Washington
### @@@ Andrea S. Porpiglia, MD, Mac – Department of Surgical Oncology, Fox Chase Cancer Center ### 1850581###Author###Surgical Oncologist###Department of Surgical Oncology, Fox Chase Cancer Center###
Author: Andrea S. Porpiglia, MD, Mac – Department of Surgical Oncology, Fox Chase Cancer Center
### @@@ Fabian M. Johnston, MD, MHS – Division of Gastrointestinal Surgical Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States ### 917904###Author###Associate Professor of Surgery###Division of Gastrointestinal Surgical Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States###
Author: Fabian M. Johnston, MD, MHS – Division of Gastrointestinal Surgical Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States
### @@@ Elizabeth Baldini, MD, MPH – Department of Radiation Oncology, Brigham and Women’s Hospital ### 2212035###Author###Radiation Oncologist###Department of Radiation Oncology, Brigham and Women’s Hospital###
Author: Elizabeth Baldini, MD, MPH – Department of Radiation Oncology, Brigham and Women’s Hospital
### @@@ Alessandro Gronchi, MD, FSSO – Sarcoma Service, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ### 953892###Author###Chief of Surgical Department###Sarcoma Service, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy###
Author: Alessandro Gronchi, MD, FSSO – Sarcoma Service, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### @@@ Chandrajit P. Raut, MD, MSc (he/him/his) – Brigham and Women's Hospital ### 1213135###Author###Chief, Division of Surgical Oncology###Brigham and Women's Hospital###
Author: Chandrajit P. Raut, MD, MSc (he/him/his) – Brigham and Women's Hospital
### he/him/his
83: Neoadjuvant Radiotherapy in Retroperitoneal Sarcoma (RPS): Data Dissemination and Practice Patterns Post STRASS

Alexandra Allard-Coutu, BSc, MDCM, MScClin, FRCSC (she/her/hers) – University of Ottawa ### 1852544###Abstract Presenter###Breast Oncologist, Complex Surgical Oncology Fellow###University of Ottawa###
Abstract Presenter: Alexandra Allard-Coutu, BSc, MDCM, MScClin, FRCSC (she/her/hers) – University of Ottawa
### she/her/hers @@@ Alexandra Allard-Coutu, BSc, MDCM, MScClin, FRCSC (she/her/hers) – University of Ottawa ### 1852544###Submitter###Breast Oncologist, Complex Surgical Oncology Fellow###University of Ottawa###
Submitter: Alexandra Allard-Coutu, BSc, MDCM, MScClin, FRCSC (she/her/hers) – University of Ottawa
### she/her/hers @@@ Alexandra Allard-Coutu, BSc, MDCM, MScClin, FRCSC (she/her/hers) – University of Ottawa ### 1852544###Author###Breast Oncologist, Complex Surgical Oncology Fellow###University of Ottawa###
Author: Alexandra Allard-Coutu, BSc, MDCM, MScClin, FRCSC (she/her/hers) – University of Ottawa
### she/her/hers @@@ Victoria Dobson, MSc Clin – University of Ottawa ### 2212179###Author###Research Coordinator###University of Ottawa###
Author: Victoria Dobson, MSc Clin – University of Ottawa
### @@@ Christina L. Roland, MD MS – The University of Texas MD Anderson Cancer Center ### 894415###Author###Associate Professor of Surgical Oncology###The University of Texas MD Anderson Cancer Center###
Author: Christina L. Roland, MD MS – The University of Texas MD Anderson Cancer Center
### @@@ Ashka Shah, BSc – Department of Surgery, The Ottawa Hospital and Research Institute, University of Ottawa, Ottawa, ON K1H 8L6, Canada ### 2212178###Author###Student###Department of Surgery, The Ottawa Hospital and Research Institute, University of Ottawa, Ottawa, ON K1H 8L6, Canada###
Author: Ashka Shah, BSc – Department of Surgery, The Ottawa Hospital and Research Institute, University of Ottawa, Ottawa, ON K1H 8L6, Canada
### @@@ Sinziana Dumitra, MD, FRSCS – Department of Surgical Oncology, McGill University Health Centre, Montreal, QC H4A 3J1, Canada ### 2212176###Author###Faculty###Department of Surgical Oncology, McGill University Health Centre, Montreal, QC H4A 3J1, Canada###
Author: Sinziana Dumitra, MD, FRSCS – Department of Surgical Oncology, McGill University Health Centre, Montreal, QC H4A 3J1, Canada
### @@@ Carolyn Freeman, MD FRCPC – Department of Radiation Oncology, McGill University Health Centre, Montreal, QC H4A 3J1, Canada ### 2212175###Author###Faculty###Department of Radiation Oncology, McGill University Health Centre, Montreal, QC H4A 3J1, Canada###
Author: Carolyn Freeman, MD FRCPC – Department of Radiation Oncology, McGill University Health Centre, Montreal, QC H4A 3J1, Canada
### @@@ Dario Callegaro, MD (he/him/his) – Sarcoma service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ### 1849989###Author###Surgical oncologist###Sarcoma service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy###
Author: Dario Callegaro, MD (he/him/his) – Sarcoma service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### he/him/his @@@ Sarah Corn, MD, FRCSC – Department of Surgical Oncology, McGill University Health Centre, Montreal, QC H4A 3J1, Canada ### 2212177###Author###Faculty###Department of Surgical Oncology, McGill University Health Centre, Montreal, QC H4A 3J1, Canada###
Author: Sarah Corn, MD, FRCSC – Department of Surgical Oncology, McGill University Health Centre, Montreal, QC H4A 3J1, Canada
### @@@ Chandrajit P. Raut, MD, MSc (he/him/his) – Brigham and Women's Hospital ### 1213135###Author###Chief, Division of Surgical Oncology###Brigham and Women's Hospital###
Author: Chandrajit P. Raut, MD, MSc (he/him/his) – Brigham and Women's Hospital
### he/him/his @@@ Alessandro Gronchi, MD, FSSO – Sarcoma Service, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ### 953892###Author###Chief of Surgical Department###Sarcoma Service, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy###
Author: Alessandro Gronchi, MD, FSSO – Sarcoma Service, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### @@@ Carolyn Nessim, MD, MSc, FRCSC, FACS (she/her/hers) – The Ottawa Hospital, University of Ottawa, Ottawa Hospital Research Institute ### 1795369###Author###Surgical Oncologist, Associate Professor, Clinician Investigator, CGSO Program Director###The Ottawa Hospital, University of Ottawa, Ottawa Hospital Research Institute###
Author: Carolyn Nessim, MD, MSc, FRCSC, FACS (she/her/hers) – The Ottawa Hospital, University of Ottawa, Ottawa Hospital Research Institute
### she/her/hers
84: Single cell pharmacogenomic pipeline identifies novel opportunities in uterine leiomyosarcoma

Sara K. Daniel, MD (she/her/hers) – Stanford University ### 1850532###Abstract Presenter###Fellow###Stanford University###
Abstract Presenter: Sara K. Daniel, MD (she/her/hers) – Stanford University
### she/her/hers @@@ Sara K. Daniel, MD (she/her/hers) – Stanford University ### 1850532###Submitter###Fellow###Stanford University###
Submitter: Sara K. Daniel, MD (she/her/hers) – Stanford University
### she/her/hers @@@ Sara K. Daniel, MD (she/her/hers) – Stanford University ### 1850532###Author###Fellow###Stanford University###
Author: Sara K. Daniel, MD (she/her/hers) – Stanford University
### she/her/hers @@@ Deshka Foster, MD, PhD – Stanford University ### 1850681###Author###Fellow###Stanford University###
Author: Deshka Foster, MD, PhD – Stanford University
### @@@ Fatemah Nosrati, BS – Stanford University ### 1850745###Author###Research Assistant###Stanford University###
Author: Fatemah Nosrati, BS – Stanford University
### @@@ Maria Korah, MD – Stanford University ### 2211878###Author###Resident###Stanford University###
Author: Maria Korah, MD – Stanford University
### @@@ Mahsa Fallah, PhD – Stanford University ### 2211879###Author###Post-doctoral Fellow###Stanford University###
Author: Mahsa Fallah, PhD – Stanford University
### @@@ Beatrice J. Sun, MD (she/her/hers) – Stanford University School of Medicine ### 1850374###Author###Resident###Stanford University School of Medicine###
Author: Beatrice J. Sun, MD (she/her/hers) – Stanford University School of Medicine
### she/her/hers @@@ Tyler Loftus, MD – University of Florida ### 2211880###Author###Assitant Professor###University of Florida###
Author: Tyler Loftus, MD – University of Florida
### @@@ Die Hu, PhD – University of Florida ### 2211887###Author###Statistician###University of Florida###
Author: Die Hu, PhD – University of Florida
### @@@ Monica Dua, MD – Stanford University ### 1851541###Author###Clinical Associate Professor###Stanford University###
Author: Monica Dua, MD – Stanford University
### @@@ Brendan C. Visser, MD – Stanford University ### 894421###Author###Professor###Stanford University###
Author: Brendan C. Visser, MD – Stanford University
### @@@ George Poultsides, MD (he/him/his) – Stanford University ### 1214754###Author###Attending Surgeon###Stanford University###
Author: George Poultsides, MD (he/him/his) – Stanford University
### he/him/his @@@ Amanda R. Kirane, MD, PhD (she/her/hers) – Stanford University ### 1534976###Author###Assistant Professor###Stanford University###
Author: Amanda R. Kirane, MD, PhD (she/her/hers) – Stanford University
### she/her/hers @@@ Michael Longaker, MD – Stanford University ### 1850684###Author###Professor###Stanford University###
Author: Michael Longaker, MD – Stanford University
### @@@ Kristen Ganjoo, MD – Stanford University ### 2211881###Author###Professor###Stanford University###
Author: Kristen Ganjoo, MD – Stanford University
### @@@ Byrne Lee, MD (he/him/his) – Stanford University School of Medicine ### 1214742###Author###Clinical Professor###Stanford University School of Medicine###
Author: Byrne Lee, MD (he/him/his) – Stanford University School of Medicine
### he/him/his @@@ Daniel Delitto, MD, PhD – Stanford University ### 1850682###Author###Assistant Professor###Stanford University###
Author: Daniel Delitto, MD, PhD – Stanford University
###
85: Initial Multivisceral Resection for Retroperitoneal Liposarcoma Does Not Predict Improved Outcomes After Recurrence

Beatrice J. Sun, MD (she/her/hers) – Stanford University School of Medicine ### 1850374###Abstract Presenter###Resident###Stanford University School of Medicine###
Abstract Presenter: Beatrice J. Sun, MD (she/her/hers) – Stanford University School of Medicine
### she/her/hers @@@ Beatrice J. Sun, MD (she/her/hers) – Stanford University School of Medicine ### 1850374###Submitter###Resident###Stanford University School of Medicine###
Submitter: Beatrice J. Sun, MD (she/her/hers) – Stanford University School of Medicine
### she/her/hers @@@ Beatrice J. Sun, MD (she/her/hers) – Stanford University School of Medicine ### 1850374###Author###Resident###Stanford University School of Medicine###
Author: Beatrice J. Sun, MD (she/her/hers) – Stanford University School of Medicine
### she/her/hers @@@ Tiffany M. Yue, BS – Stanford University School of Medicine ### 1851072###Author###Medical Student###Stanford University School of Medicine###
Author: Tiffany M. Yue, BS – Stanford University School of Medicine
### @@@ Chloe K. Nobuhara, MD – Stanford University School of Medicine ### 2212066###Author###Resident###Stanford University School of Medicine###
Author: Chloe K. Nobuhara, MD – Stanford University School of Medicine
### @@@ Samuel Castro, Jr., BS – Stanford University School of Medicine ### 2212067###Author###Medical Student###Stanford University School of Medicine###
Author: Samuel Castro, Jr., BS – Stanford University School of Medicine
### @@@ James P. Agolia, MD – Stanford University School of Medicine ### 2212068###Author###Resident###Stanford University School of Medicine###
Author: James P. Agolia, MD – Stanford University School of Medicine
### @@@ Byrne Lee, MD (he/him/his) – Stanford University School of Medicine ### 1214742###Author###Clinical Professor###Stanford University School of Medicine###
Author: Byrne Lee, MD (he/him/his) – Stanford University School of Medicine
### he/him/his
86: Targeting Small Non-coding RNAs to Treat Dedifferentiated Liposarcoma

Elizaveta K. Titerina, MD – Department of Surgery, Division of Surgical Oncology, The James Comprehensive Cancer Center, The Ohio State University ### 2212117###Abstract Presenter###Post Doctoral Scholar###Department of Surgery, Division of Surgical Oncology, The James Comprehensive Cancer Center, The Ohio State University###
Abstract Presenter: Elizaveta K. Titerina, MD – Department of Surgery, Division of Surgical Oncology, The James Comprehensive Cancer Center, The Ohio State University
### @@@ Elizaveta K. Titerina, MD – Department of Surgery, Division of Surgical Oncology, The James Comprehensive Cancer Center, The Ohio State University ### 2212117###Submitter###Post Doctoral Scholar###Department of Surgery, Division of Surgical Oncology, The James Comprehensive Cancer Center, The Ohio State University###
Submitter: Elizaveta K. Titerina, MD – Department of Surgery, Division of Surgical Oncology, The James Comprehensive Cancer Center, The Ohio State University
### @@@ Elizaveta K. Titerina, MD – Department of Surgery, Division of Surgical Oncology, The James Comprehensive Cancer Center, The Ohio State University ### 2212117###Author###Post Doctoral Scholar###Department of Surgery, Division of Surgical Oncology, The James Comprehensive Cancer Center, The Ohio State University###
Author: Elizaveta K. Titerina, MD – Department of Surgery, Division of Surgical Oncology, The James Comprehensive Cancer Center, The Ohio State University
### @@@ Marina Goryunova, MD – Department of Surgery, Division of Surgical Oncology, The James Comprehensive Cancer Center, The Ohio State University ### 1849998###Author###Post Doctoral Scholar###Department of Surgery, Division of Surgical Oncology, The James Comprehensive Cancer Center, The Ohio State University###
Author: Marina Goryunova, MD – Department of Surgery, Division of Surgical Oncology, The James Comprehensive Cancer Center, The Ohio State University
### @@@ Nipin Sp, PhD – Department of Surgery, Division of Surgical Oncology, The James Comprehensive Cancer Center, The Ohio State University ### 1850004###Author###Post Doctoral Scholar###Department of Surgery, Division of Surgical Oncology, The James Comprehensive Cancer Center, The Ohio State University###
Author: Nipin Sp, PhD – Department of Surgery, Division of Surgical Oncology, The James Comprehensive Cancer Center, The Ohio State University
### @@@ Carson Karakis, n/a – Department of Surgery, Division of Surgical Oncology, The James Comprehensive Cancer Center, The Ohio State University ### 2212118###Author###Student Assistant###Department of Surgery, Division of Surgical Oncology, The James Comprehensive Cancer Center, The Ohio State University###
Author: Carson Karakis, n/a – Department of Surgery, Division of Surgical Oncology, The James Comprehensive Cancer Center, The Ohio State University
### @@@ Patricia Sarchet, PhD – Department of Surgery, Division of Surgical Oncology, The James Comprehensive Cancer Center, The Ohio State University ### 2212119###Author###Researcher###Department of Surgery, Division of Surgical Oncology, The James Comprehensive Cancer Center, The Ohio State University###
Author: Patricia Sarchet, PhD – Department of Surgery, Division of Surgical Oncology, The James Comprehensive Cancer Center, The Ohio State University
### @@@ Raphael E. Pollock, MD, PhD – Department of Surgery, Division of Surgical Oncology, The James Comprehensive Cancer Center, The Ohio State University ### 1849832###Author###Professor###Department of Surgery, Division of Surgical Oncology, The James Comprehensive Cancer Center, The Ohio State University###
Author: Raphael E. Pollock, MD, PhD – Department of Surgery, Division of Surgical Oncology, The James Comprehensive Cancer Center, The Ohio State University
### @@@ Carlo M. Croce, MD – Department of Cancer Biology and Genetics, The James Comprehensive Cancer Center, The Ohio State University ### 2212120###Author###Professor###Department of Cancer Biology and Genetics, The James Comprehensive Cancer Center, The Ohio State University###
Author: Carlo M. Croce, MD – Department of Cancer Biology and Genetics, The James Comprehensive Cancer Center, The Ohio State University
### @@@ Alessandro La Ferlita, PhD – Department of Cancer Biology and Genetics, The James Comprehensive Cancer Center, The Ohio State University ### 1850003###Author###Post Doctoral Scholar###Department of Cancer Biology and Genetics, The James Comprehensive Cancer Center, The Ohio State University###
Author: Alessandro La Ferlita, PhD – Department of Cancer Biology and Genetics, The James Comprehensive Cancer Center, The Ohio State University
### @@@ Joal D. Beane, MD – The Ohio State University ### 1461519###Author###Assistant Professor of Surgery###The Ohio State University###
Author: Joal D. Beane, MD – The Ohio State University
###
87: Differences in Gene Expression and Potential Therapeutic Targets in Recurrent Liposarcoma

Jessie M. Dalman, BA (she/her/hers) – University of Michigan Medical School ### 1852497###Abstract Presenter###Medical Student###University of Michigan Medical School###
Abstract Presenter: Jessie M. Dalman, BA (she/her/hers) – University of Michigan Medical School
### she/her/hers @@@ Jessie M. Dalman, BA (she/her/hers) – University of Michigan Medical School ### 1852497###Author###Medical Student###University of Michigan Medical School###
Author: Jessie M. Dalman, BA (she/her/hers) – University of Michigan Medical School
### she/her/hers @@@ Ahmed El-hossiny, BPharm, MS – Bioinformatics, University of Michigan ### 1850834###Author###PhD Student###Bioinformatics, University of Michigan###
Author: Ahmed El-hossiny, BPharm, MS – Bioinformatics, University of Michigan
### @@@ Amanda Shafer, BS – Department of Surgery, University of Michigan ### 2212267###Author###Research Specialist###Department of Surgery, University of Michigan###
Author: Amanda Shafer, BS – Department of Surgery, University of Michigan
### @@@ Scott C. Bresler, MD, PhD (he/him/his) – Department of Surgery, Rogel Cancer Center, University of Michigan ### 1852498###Author###Assistant Professor of Dermatology and Pathology###Department of Surgery, Rogel Cancer Center, University of Michigan###
Author: Scott C. Bresler, MD, PhD (he/him/his) – Department of Surgery, Rogel Cancer Center, University of Michigan
### he/him/his @@@ Jodi Wilkowski, BS – Department of Surgery, University of Michigan ### 2212269###Author###Research Specialist###Department of Surgery, University of Michigan###
Author: Jodi Wilkowski, BS – Department of Surgery, University of Michigan
### @@@ Arvind Rao, PhD – Dept of Computational Medicine and Bioinformatics, University of Michigan ### 2212272###Author###Associate Professor###Dept of Computational Medicine and Bioinformatics, University of Michigan###
Author: Arvind Rao, PhD – Dept of Computational Medicine and Bioinformatics, University of Michigan
### @@@ Christina V. Angeles, MD (she/her/hers) – Department of Surgery, Rogel Cancer Center, University of Michigan ### 937458###Author###Surgical Oncologist###Department of Surgery, Rogel Cancer Center, University of Michigan###
Author: Christina V. Angeles, MD (she/her/hers) – Department of Surgery, Rogel Cancer Center, University of Michigan
### she/her/hers
88: Spatially resolved transcriptomic analysis of hereditary diffuse gastric cancer reveals a unique phenotype of early-stage signet ring cell cancers

Amber F. Gallanis, MD – National Cancer Institute ### 2211882###Abstract Presenter###Surgical Oncology Research Fellow###National Cancer Institute###
Abstract Presenter: Amber F. Gallanis, MD – National Cancer Institute
### @@@ Amber F. Gallanis, MD – National Cancer Institute ### 2211882###Submitter###Surgical Oncology Research Fellow###National Cancer Institute###
Submitter: Amber F. Gallanis, MD – National Cancer Institute
### @@@ Amber F. Gallanis, MD – National Cancer Institute ### 2211882###Author###Surgical Oncology Research Fellow###National Cancer Institute###
Author: Amber F. Gallanis, MD – National Cancer Institute
### @@@ Lauren A. Gamble, MD – National Cancer Institute ### 2212005###Author###Surgical Oncology Research Fellow###National Cancer Institute###
Author: Lauren A. Gamble, MD – National Cancer Institute
### @@@ Sarah Samaranayake, MS – National Cancer Institute ### 2212006###Author###Post-baccalaureate researcher###National Cancer Institute###
Author: Sarah Samaranayake, MS – National Cancer Institute
### @@@ Cassidy R. Bowden, n/a – National Cancer Institute ### 2211883###Author###Post-baccalaureate researcher###National Cancer Institute###
Author: Cassidy R. Bowden, n/a – National Cancer Institute
### @@@ Cihan Oguz, PhD – Integrated Data Sciences Section, National Institute of Allergy and Infectious Diseases ### 2212007###Author###Bioinformatics Scientist###Integrated Data Sciences Section, National Institute of Allergy and Infectious Diseases###
Author: Cihan Oguz, PhD – Integrated Data Sciences Section, National Institute of Allergy and Infectious Diseases
### @@@ Justin Lack, PhD – Integrated Data Sciences Section, National Institute of Allergy and Infectious Diseases ### 2212008###Author###Bioinformatics Scientist###Integrated Data Sciences Section, National Institute of Allergy and Infectious Diseases###
Author: Justin Lack, PhD – Integrated Data Sciences Section, National Institute of Allergy and Infectious Diseases
### @@@ Theo Heller, MD – National Institute of Diabetes and Digestive and Kidney Diseases ### 2211884###Author###Professor###National Institute of Diabetes and Digestive and Kidney Diseases###
Author: Theo Heller, MD – National Institute of Diabetes and Digestive and Kidney Diseases
### @@@ Andrew M. Blakely, MD – National Cancer Institute ### 1849920###Author###Principal Investigator###National Cancer Institute###
Author: Andrew M. Blakely, MD – National Cancer Institute
### @@@ Jonathan M. Hernandez, MD – Surgical Oncology Program, National Cancer Institute ### 972423###Author###Investigator###Surgical Oncology Program, National Cancer Institute###
Author: Jonathan M. Hernandez, MD – Surgical Oncology Program, National Cancer Institute
### @@@ Jeremy L. Davis, MD, FACS (he/him/his) – National Cancer Institute ### 969549###Author###Principal Investigator###National Cancer Institute###
Author: Jeremy L. Davis, MD, FACS (he/him/his) – National Cancer Institute
### he/him/his
89: Survival Outcomes in Patients with Resectable Gastric Cancer Treated with Total Neoadjuvant Therapy

Yun Song, MD (she/her/hers) – The University of Texas MD Anderson Cancer Center ### 2211909###Abstract Presenter###Complex General Surgical Oncology Fellow###The University of Texas MD Anderson Cancer Center###
Abstract Presenter: Yun Song, MD (she/her/hers) – The University of Texas MD Anderson Cancer Center
### she/her/hers @@@ Yun Song, MD (she/her/hers) – The University of Texas MD Anderson Cancer Center ### 2211909###Submitter###Complex General Surgical Oncology Fellow###The University of Texas MD Anderson Cancer Center###
Submitter: Yun Song, MD (she/her/hers) – The University of Texas MD Anderson Cancer Center
### she/her/hers @@@ Yun Song, MD (she/her/hers) – The University of Texas MD Anderson Cancer Center ### 2211909###Author###Complex General Surgical Oncology Fellow###The University of Texas MD Anderson Cancer Center###
Author: Yun Song, MD (she/her/hers) – The University of Texas MD Anderson Cancer Center
### she/her/hers @@@ Yuki Hirata, MD, PhD – The University of Texas MD Anderson Cancer Center ### 1850893###Author###Postdoctoral Fellow###The University of Texas MD Anderson Cancer Center###
Author: Yuki Hirata, MD, PhD – The University of Texas MD Anderson Cancer Center
### @@@ Jaffer Ajani, MD – MD Anderson Cancer Center ### 2211838###Author###Professor###MD Anderson Cancer Center###
Author: Jaffer Ajani, MD – MD Anderson Cancer Center
### @@@ Mariela Blum, MD – MD Anderson Cancer Center ### 2211834###Author###Associate Professor###MD Anderson Cancer Center###
Author: Mariela Blum, MD – MD Anderson Cancer Center
### @@@ Jenny Li, MD – MD Anderson Cancer Center ### 2211835###Author###Assistant Professor###MD Anderson Cancer Center###
Author: Jenny Li, MD – MD Anderson Cancer Center
### @@@ Prajnan Das, MD – MD Anderson Cancer Center ### 2211833###Author###Chair Ad Interim###MD Anderson Cancer Center###
Author: Prajnan Das, MD – MD Anderson Cancer Center
### @@@ Bruce Minsky, MD – MD Anderson Cancer Center ### 2211836###Author###Professor###MD Anderson Cancer Center###
Author: Bruce Minsky, MD – MD Anderson Cancer Center
### @@@ Paul F. Mansfield, MD – MD Anderson Cancer Center ### 1850483###Author###Professor###MD Anderson Cancer Center###
Author: Paul F. Mansfield, MD – MD Anderson Cancer Center
### @@@ Naruhiko Ikoma, MD, MS – The University of Texas MD Anderson Cancer Center ### 944396###Author###Assistant Professor of Surgical Oncology###The University of Texas MD Anderson Cancer Center###
Author: Naruhiko Ikoma, MD, MS – The University of Texas MD Anderson Cancer Center
### @@@ Brian Badgwell, MD, MS – MD Anderson Cancer Center ### 915754###Author###Professor of Surgery###MD Anderson Cancer Center###
Author: Brian Badgwell, MD, MS – MD Anderson Cancer Center
###
9: The Impact of Presenting Stage on Overall Survival in Patients Treated with Neoadjuvant Chemotherapy in Triple Negative Breast Cancer

Jennifer F. Carroll, MD, FACS – Mayo Clinic ### 2211831###Abstract Presenter###Breast Surgical Oncology Fellow###Mayo Clinic###
Abstract Presenter: Jennifer F. Carroll, MD, FACS – Mayo Clinic
### @@@ Jennifer F. Carroll, MD, FACS – Mayo Clinic ### 2211831###Submitter###Breast Surgical Oncology Fellow###Mayo Clinic###
Submitter: Jennifer F. Carroll, MD, FACS – Mayo Clinic
### @@@ Tanya L. Hoskin, MS – Mayo Clinic ### 1849694###Author###Principal Biostatistician###Mayo Clinic###
Author: Tanya L. Hoskin, MS – Mayo Clinic
### @@@ Roberto A. Leon Ferre, MD – Mayo Clinic ### 2211832###Author###Consultant, Medical Oncology###Mayo Clinic###
Author: Roberto A. Leon Ferre, MD – Mayo Clinic
### @@@ Judy C. Boughey, MD (she/her/hers) – Mayo Clinic ### 937371###Author###Chair, Division of Breast and Melanoma Surgical Oncology###Mayo Clinic###
Author: Judy C. Boughey, MD (she/her/hers) – Mayo Clinic
### she/her/hers
90: Pathological complete response to FLOT chemotherapy with or without durvalumab in resectable gastric and gastroesophageal junction cancer: subgroup analysis by region from the phase 3, randomized, double-blind MATTERHORN study

Daniela Molena, MD (she/her/hers) – Division of Thoracic Surgery, Memorial Sloan Kettering Cancer Center ### 2212105###Abstract Presenter###Director of Esophageal Surgery###Division of Thoracic Surgery, Memorial Sloan Kettering Cancer Center###
Abstract Presenter: Daniela Molena, MD (she/her/hers) – Division of Thoracic Surgery, Memorial Sloan Kettering Cancer Center
### she/her/hers @@@ Yelena Y. Janjigian, MD – Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center ### 1849792###Author###Chief###Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center###
Author: Yelena Y. Janjigian, MD – Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center
### @@@ Salah-Eddin Al-Batran, MD – Institute of Clinical Cancer Research, Krankenhaus Nordwest, University Cancer Center ### 2212095###Author###Medical Director###Institute of Clinical Cancer Research, Krankenhaus Nordwest, University Cancer Center###
Author: Salah-Eddin Al-Batran, MD – Institute of Clinical Cancer Research, Krankenhaus Nordwest, University Cancer Center
### @@@ Zev A. Wainberg, MD – Department of Gastrointestinal Medical Oncology, David Geffen School of Medicine at UCLA ### 2212097###Author###Professor of Medicine###Department of Gastrointestinal Medical Oncology, David Geffen School of Medicine at UCLA###
Author: Zev A. Wainberg, MD – Department of Gastrointestinal Medical Oncology, David Geffen School of Medicine at UCLA
### @@@ Eric Van Cutsem, MD, PhD – Department of Gastroenterology/Digestive Oncology, University Hospitals Leuven and KU Leuven ### 2212104###Author###Head of Digestive Oncology###Department of Gastroenterology/Digestive Oncology, University Hospitals Leuven and KU Leuven###
Author: Eric Van Cutsem, MD, PhD – Department of Gastroenterology/Digestive Oncology, University Hospitals Leuven and KU Leuven
### @@@ Daniela Molena, MD (she/her/hers) – Division of Thoracic Surgery, Memorial Sloan Kettering Cancer Center ### 2212105###Author###Director of Esophageal Surgery###Division of Thoracic Surgery, Memorial Sloan Kettering Cancer Center###
Author: Daniela Molena, MD (she/her/hers) – Division of Thoracic Surgery, Memorial Sloan Kettering Cancer Center
### she/her/hers @@@ Kei Muro, MD, PhD – Department of Clinical Oncology, Aichi Cancer Center Hospital ### 2212106###Author###Chief and Director###Department of Clinical Oncology, Aichi Cancer Center Hospital###
Author: Kei Muro, MD, PhD – Department of Clinical Oncology, Aichi Cancer Center Hospital
### @@@ Woo Jin Hyung, MD, PhD – Department of Surgery, Yonsei University College of Medicine, ### 2212107###Author###Director###Department of Surgery, Yonsei University College of Medicine,###
Author: Woo Jin Hyung, MD, PhD – Department of Surgery, Yonsei University College of Medicine,
### @@@ Lucjan Wyrwicz, MD, PhD – Department of Oncology and Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology ### 2212110###Author###Head of Department###Department of Oncology and Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology###
Author: Lucjan Wyrwicz, MD, PhD – Department of Oncology and Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology
### @@@ Do-Youn Oh, MD, PhD – Division of Medical Oncology, Department of Internal Medicine, Seoul National University Hospital; Cancer Research Institute, Seoul National University College of Medicine ### 2212111###Author###Professor###Division of Medical Oncology, Department of Internal Medicine, Seoul National University Hospital; Cancer Research Institute, Seoul National University College of Medicine###
Author: Do-Youn Oh, MD, PhD – Division of Medical Oncology, Department of Internal Medicine, Seoul National University Hospital; Cancer Research Institute, Seoul National University College of Medicine
### @@@ Takeshi Omori, MD, PhD – Department of Gastroenterological Surgery, Osaka International Cancer Institute ### 2212112###Author###Director###Department of Gastroenterological Surgery, Osaka International Cancer Institute###
Author: Takeshi Omori, MD, PhD – Department of Gastroenterological Surgery, Osaka International Cancer Institute
### @@@ Markus Moehler, MD, PhD – Research Center for Immunotherapy (FZI), Johannes Gutenberg-University Clinic ### 2212113###Author###Head of the Gastroenterological and Oncology Outpatient Clinic###Research Center for Immunotherapy (FZI), Johannes Gutenberg-University Clinic###
Author: Markus Moehler, MD, PhD – Research Center for Immunotherapy (FZI), Johannes Gutenberg-University Clinic
### @@@ Marcelo Garrido, MD – SAGA Clinical Trial Centre and Universidad Mayor ### 2212114###Author###Medical Director###SAGA Clinical Trial Centre and Universidad Mayor###
Author: Marcelo Garrido, MD – SAGA Clinical Trial Centre and Universidad Mayor
### @@@ Sulene CS Oliveira, MD – Clinical Oncology, The Clinical Research Center, Northern Riograndense League Against Cancer ### 2212115###Author###Residency Coordinator###Clinical Oncology, The Clinical Research Center, Northern Riograndense League Against Cancer###
Author: Sulene CS Oliveira, MD – Clinical Oncology, The Clinical Research Center, Northern Riograndense League Against Cancer
### @@@ Moishe Liberman, MD, PhD – Division of Thoracic Surgery, Department of Surgery, Centre Hospitalier de l'Université de Montréal, Centre de Recherche du CHUM ### 2212116###Author###Associate Professor###Division of Thoracic Surgery, Department of Surgery, Centre Hospitalier de l'Université de Montréal, Centre de Recherche du CHUM###
Author: Moishe Liberman, MD, PhD – Division of Thoracic Surgery, Department of Surgery, Centre Hospitalier de l'Université de Montréal, Centre de Recherche du CHUM
### @@@ Victor C. Oliden, MD – National Institute of Neoplastic Diseases (INEN) and Detecta Clínica ### 2212121###Author###Director General###National Institute of Neoplastic Diseases (INEN) and Detecta Clínica###
Author: Victor C. Oliden, MD – National Institute of Neoplastic Diseases (INEN) and Detecta Clínica
### @@@ Mehmet Bilici, MD – Department of Medical Oncology, Atatürk University Faculty of Medicine ### 2212124###Author###Professor###Department of Medical Oncology, Atatürk University Faculty of Medicine###
Author: Mehmet Bilici, MD – Department of Medical Oncology, Atatürk University Faculty of Medicine
### @@@ John Kurland, MD – AstraZeneca ### 2212125###Author###VP, Global Product Leader###AstraZeneca###
Author: John Kurland, MD – AstraZeneca
### @@@ Ioannis Xynos, MD, PhD – AstraZeneca ### 2212126###Author###Global Clinical Head###AstraZeneca###
Author: Ioannis Xynos, MD, PhD – AstraZeneca
### @@@ Helen Mann, MSc – AstraZeneca ### 2212128###Author###Senior Director, Statistics###AstraZeneca###
Author: Helen Mann, MSc – AstraZeneca
### @@@ Josep Tabernero, MD, PhD – Medical Oncology Department, Vall d’Hebron Hospital Campus & Institute of Oncology (VHIO), IOB-Quiron, UVic-UCC ### 2211885###Author###Director###Medical Oncology Department, Vall d’Hebron Hospital Campus & Institute of Oncology (VHIO), IOB-Quiron, UVic-UCC###
Author: Josep Tabernero, MD, PhD – Medical Oncology Department, Vall d’Hebron Hospital Campus & Institute of Oncology (VHIO), IOB-Quiron, UVic-UCC
###
91: Intensifying Supportive Care is Associated with Improved Survival in Gastric Cancer Patients with Malignant Ascites

John D. Karalis, MD – University of Texas Southwestern Medical Center ### 1530295###Abstract Presenter###Resident###University of Texas Southwestern Medical Center###
Abstract Presenter: John D. Karalis, MD – University of Texas Southwestern Medical Center
### @@@ John D. Karalis, MD – University of Texas Southwestern Medical Center ### 1530295###Submitter###Resident###University of Texas Southwestern Medical Center###
Submitter: John D. Karalis, MD – University of Texas Southwestern Medical Center
### @@@ John D. Karalis, MD – University of Texas Southwestern Medical Center ### 1530295###Author###Resident###University of Texas Southwestern Medical Center###
Author: John D. Karalis, MD – University of Texas Southwestern Medical Center
### @@@ Michelle R. Ju, MD MPH – Duke University Hospital ### 2211829###Author###Fellow###Duke University Hospital###
Author: Michelle R. Ju, MD MPH – Duke University Hospital
### @@@ Rachel Feig, PA-C – University of Texas Southwestern Medical Center ### 2211830###Author###Physician Assistant###University of Texas Southwestern Medical Center###
Author: Rachel Feig, PA-C – University of Texas Southwestern Medical Center
### @@@ Raechelle Estrella, PA-C – University of Texas Southwestern Medical Center ### 1851363###Author###Physician Assistant###University of Texas Southwestern Medical Center###
Author: Raechelle Estrella, PA-C – University of Texas Southwestern Medical Center
### @@@ Morgan F. Pettigrew, MD – University of Texas Southwestern Medical Center ### 2204628###Author###Resident###University of Texas Southwestern Medical Center###
Author: Morgan F. Pettigrew, MD – University of Texas Southwestern Medical Center
### @@@ Rodrigo E. Alterio, MD – University of Texas Southwestern Medical Center ### 1850515###Author###Resident###University of Texas Southwestern Medical Center###
Author: Rodrigo E. Alterio, MD – University of Texas Southwestern Medical Center
### @@@ Andres A. Abreu, MD (he/him/his) – Department of Surgery, University of Texas Southwestern Medical Center ### 1850136###Author###Postsdoctoral Researcher###Department of Surgery, University of Texas Southwestern Medical Center###
Author: Andres A. Abreu, MD (he/him/his) – Department of Surgery, University of Texas Southwestern Medical Center
### he/him/his @@@ Emile Farah, MD – Department of Surgery, University of Texas Southwestern Medical Center ### 1850133###Author###Postdoctoral Researcher###Department of Surgery, University of Texas Southwestern Medical Center###
Author: Emile Farah, MD – Department of Surgery, University of Texas Southwestern Medical Center
### @@@ Tarek Sawas, MD – University of Texas Southwestern Medical Center ### 2211908###Author###Assistant Professor###University of Texas Southwestern Medical Center###
Author: Tarek Sawas, MD – University of Texas Southwestern Medical Center
### @@@ Nina Sanford, MD – University of Texas Southwestern Medical Center ### 1851366###Author###Assistant Professor###University of Texas Southwestern Medical Center###
Author: Nina Sanford, MD – University of Texas Southwestern Medical Center
### @@@ Aravind Sanjeevaiah, MD – University of Texas Southwestern Medical Center ### 1851365###Author###Associate Professor###University of Texas Southwestern Medical Center###
Author: Aravind Sanjeevaiah, MD – University of Texas Southwestern Medical Center
### @@@ Suntrea T.G. Hammer, MD – University of Texas Southwestern Medical Center ### 1850514###Author###Associate Professor###University of Texas Southwestern Medical Center###
Author: Suntrea T.G. Hammer, MD – University of Texas Southwestern Medical Center
### @@@ Matthew R. Porembka, MD (he/him/his) – University of Texas Southwestern Medical Center ### 969515###Author###Associate Professor###University of Texas Southwestern Medical Center###
Author: Matthew R. Porembka, MD (he/him/his) – University of Texas Southwestern Medical Center
### he/him/his @@@ Sam C. Wang, MD – University of Texas Southwestern Medical Center ### 969956###Author###Associate Professor###University of Texas Southwestern Medical Center###
Author: Sam C. Wang, MD – University of Texas Southwestern Medical Center
###
92: Phase I Trial of Short-Course Chemoradiotherapy followed by Chemotherapy as Total Neoadjuvant Therapy for Patients with Potentially Resectable Gastric Cancer

Brian Badgwell, MD, MS – MD Anderson Cancer Center ### 915754###Abstract Presenter###Professor of Surgery###MD Anderson Cancer Center###
Abstract Presenter: Brian Badgwell, MD, MS – MD Anderson Cancer Center
### @@@ Brian Badgwell, MD, MS – MD Anderson Cancer Center ### 915754###Submitter###Professor of Surgery###MD Anderson Cancer Center###
Submitter: Brian Badgwell, MD, MS – MD Anderson Cancer Center
### @@@ Brian Badgwell, MD, MS – MD Anderson Cancer Center ### 915754###Author###Professor of Surgery###MD Anderson Cancer Center###
Author: Brian Badgwell, MD, MS – MD Anderson Cancer Center
### @@@ Prajnan Das, MD – MD Anderson Cancer Center ### 2211833###Author###Chair Ad Interim###MD Anderson Cancer Center###
Author: Prajnan Das, MD – MD Anderson Cancer Center
### @@@ Naruhiko Ikoma, MD, MS – The University of Texas MD Anderson Cancer Center ### 944396###Author###Assistant Professor of Surgical Oncology###The University of Texas MD Anderson Cancer Center###
Author: Naruhiko Ikoma, MD, MS – The University of Texas MD Anderson Cancer Center
### @@@ Mariela Blum, MD – MD Anderson Cancer Center ### 2211834###Author###Associate Professor###MD Anderson Cancer Center###
Author: Mariela Blum, MD – MD Anderson Cancer Center
### @@@ Jenny Li, MD – MD Anderson Cancer Center ### 2211835###Author###Assistant Professor###MD Anderson Cancer Center###
Author: Jenny Li, MD – MD Anderson Cancer Center
### @@@ Jeannelyn Estrella, MD – MD Anderson Cancer Center ### 1850633###Author###Professor###MD Anderson Cancer Center###
Author: Jeannelyn Estrella, MD – MD Anderson Cancer Center
### @@@ Bruce Minsky, MD – MD Anderson Cancer Center ### 2211836###Author###Professor###MD Anderson Cancer Center###
Author: Bruce Minsky, MD – MD Anderson Cancer Center
### @@@ Paul F. Mansfield, MD – MD Anderson Cancer Center ### 1850483###Author###Professor###MD Anderson Cancer Center###
Author: Paul F. Mansfield, MD – MD Anderson Cancer Center
### @@@ Jaffer Ajani, MD – MD Anderson Cancer Center ### 2211838###Author###Professor###MD Anderson Cancer Center###
Author: Jaffer Ajani, MD – MD Anderson Cancer Center
###
93: Trans-oral Delivery of Oncolytic Vaccinia Virus expressing Membrane-Bound IL2 for Esophageal Cancer Treatment.

Sefali Patel, DO – Allegheny Health Network ### 2211897###Abstract Presenter###Research Fellow###Allegheny Health Network###
Abstract Presenter: Sefali Patel, DO – Allegheny Health Network
### @@@ Sefali Patel, DO – Allegheny Health Network ### 2211897###Submitter###Research Fellow###Allegheny Health Network###
Submitter: Sefali Patel, DO – Allegheny Health Network
### @@@ Sefali Patel, DO – Allegheny Health Network ### 2211897###Author###Research Fellow###Allegheny Health Network###
Author: Sefali Patel, DO – Allegheny Health Network
### @@@ Ashten Omstead, n/a – Allegheny Health Network ### 2204658###Author###Manager Medical Technology & Research###Allegheny Health Network###
Author: Ashten Omstead, n/a – Allegheny Health Network
### @@@ Zuqiang Liu, PhD – Allegheny Singer Research Institute ### 2211944###Author###Associate Professor###Allegheny Singer Research Institute###
Author: Zuqiang Liu, PhD – Allegheny Singer Research Institute
### @@@ David L. Bartlett, MD – AHN ### 917897###Author###Faculty###AHN###
Author: David L. Bartlett, MD – AHN
### @@@ Ali Zaidi, n/a – Allegheny Health Network ### 2204659###Author###Medical Director Research###Allegheny Health Network###
Author: Ali Zaidi, n/a – Allegheny Health Network
###
94: Pathologic Response to Neoadjuvant Immunotherapy in DNA Mismatch Repair Protein-Deficient Gastroesophageal Cancers

Adrienne B. Shannon, MD (she/her/hers) – H. Lee Moffitt Cancer Center and Research Institute ### 1184677###Abstract Presenter###Complex General Surgical Oncology Fellow###H. Lee Moffitt Cancer Center and Research Institute###
Abstract Presenter: Adrienne B. Shannon, MD (she/her/hers) – H. Lee Moffitt Cancer Center and Research Institute
### she/her/hers @@@ Adrienne B. Shannon, MD (she/her/hers) – H. Lee Moffitt Cancer Center and Research Institute ### 1184677###Submitter###Complex General Surgical Oncology Fellow###H. Lee Moffitt Cancer Center and Research Institute###
Submitter: Adrienne B. Shannon, MD (she/her/hers) – H. Lee Moffitt Cancer Center and Research Institute
### she/her/hers @@@ Adrienne B. Shannon, MD (she/her/hers) – H. Lee Moffitt Cancer Center and Research Institute ### 1184677###Author###Complex General Surgical Oncology Fellow###H. Lee Moffitt Cancer Center and Research Institute###
Author: Adrienne B. Shannon, MD (she/her/hers) – H. Lee Moffitt Cancer Center and Research Institute
### she/her/hers @@@ Rutika J. Mehta, MD, MPH – H. Lee Moffitt Cancer Center and Research Institute ### 1850851###Author###Medical Oncologist###H. Lee Moffitt Cancer Center and Research Institute###
Author: Rutika J. Mehta, MD, MPH – H. Lee Moffitt Cancer Center and Research Institute
### @@@ Shaffer R. Mok, MD – H. Lee Moffitt Cancer Center and Research Institute ### 2212004###Author###Advanced Endoluminal Gastroenterologist###H. Lee Moffitt Cancer Center and Research Institute###
Author: Shaffer R. Mok, MD – H. Lee Moffitt Cancer Center and Research Institute
### @@@ Gregory Y. Lauwers, MD – H. Lee Moffitt Cancer Center and Research Institute ### 1850900###Author###Pathologist###H. Lee Moffitt Cancer Center and Research Institute###
Author: Gregory Y. Lauwers, MD – H. Lee Moffitt Cancer Center and Research Institute
### @@@ Jobelle J. A. R. Baldonado, MD – H. Lee Moffitt Cancer Center and Research Institute ### 1850904###Author###Thoracic Surgeon###H. Lee Moffitt Cancer Center and Research Institute###
Author: Jobelle J. A. R. Baldonado, MD – H. Lee Moffitt Cancer Center and Research Institute
### @@@ Jacques P. Fontaine, MD – H. Lee Moffitt Cancer Center and Research Institute ### 1850905###Author###Thoracic Surgeon###H. Lee Moffitt Cancer Center and Research Institute###
Author: Jacques P. Fontaine, MD – H. Lee Moffitt Cancer Center and Research Institute
### @@@ Jose M. Pimiento, MD, FACS (he/him/his) – H. Lee Moffitt Cancer Center and Research Institute ### 969529###Author###Gastrointestinal Surgeon###H. Lee Moffitt Cancer Center and Research Institute###
Author: Jose M. Pimiento, MD, FACS (he/him/his) – H. Lee Moffitt Cancer Center and Research Institute
### he/him/his @@@ Andrew J. Sinnamon, MD – H. Lee Moffitt Cancer Center and Research Institute ### 1530310###Author###Gastrointestinal Surgeon###H. Lee Moffitt Cancer Center and Research Institute###
Author: Andrew J. Sinnamon, MD – H. Lee Moffitt Cancer Center and Research Institute
###
95: Efficacy of Ursodeoxycholic Acid for Bile Reflux After Distal Gastrectomy in Patients with Gastric Cancer: A Secondary Analysis of the PEGASUS-D Trial

Do Joong Park, MD, PhD, FACS – Seoul National University Hospital ### 969509###Abstract Presenter###Professor###Seoul National University Hospital###
Abstract Presenter: Do Joong Park, MD, PhD, FACS – Seoul National University Hospital
### @@@ Do Joong Park, MD, PhD, FACS – Seoul National University Hospital ### 969509###Submitter###Professor###Seoul National University Hospital###
Submitter: Do Joong Park, MD, PhD, FACS – Seoul National University Hospital
### @@@ Do Joong Park, MD, PhD, FACS – Seoul National University Hospital ### 969509###Author###Professor###Seoul National University Hospital###
Author: Do Joong Park, MD, PhD, FACS – Seoul National University Hospital
### @@@ Dong Kee Jang, MD, PhD – Dongguk University Ilsan Hospital ### 2211849###Author###Professor###Dongguk University Ilsan Hospital###
Author: Dong Kee Jang, MD, PhD – Dongguk University Ilsan Hospital
### @@@ Young Suk Park, MD – Seoul National University Bundang Hospital ### 2211850###Author###Professor###Seoul National University Bundang Hospital###
Author: Young Suk Park, MD – Seoul National University Bundang Hospital
### @@@ Moon-Won Yoo, MD, PhD – Asan Medical Center ### 2211865###Author###Professor###Asan Medical Center###
Author: Moon-Won Yoo, MD, PhD – Asan Medical Center
### @@@ Sun-Hwi Hwang, MD, PhD – Pusan National University Yangsan Hospital ### 2211851###Author###Professor###Pusan National University Yangsan Hospital###
Author: Sun-Hwi Hwang, MD, PhD – Pusan National University Yangsan Hospital
### @@@ Seong-Yeob Ryu, MD, PhD – Chosun University Hospital ### 2211852###Author###Professor###Chosun University Hospital###
Author: Seong-Yeob Ryu, MD, PhD – Chosun University Hospital
### @@@ Oh Kyoung Kwon, MD, PhD – Kyoungpook National University Chilgok Hospital ### 2211853###Author###Professor###Kyoungpook National University Chilgok Hospital###
Author: Oh Kyoung Kwon, MD, PhD – Kyoungpook National University Chilgok Hospital
### @@@ Hoon Hur, MD, PhD – Ajou University Hospital ### 2211854###Author###Professor###Ajou University Hospital###
Author: Hoon Hur, MD, PhD – Ajou University Hospital
### @@@ Hong Man Yoon, MD, PhD – National Cancer Center ### 2211855###Author###Doctor###National Cancer Center###
Author: Hong Man Yoon, MD, PhD – National Cancer Center
### @@@ Bang Wool Eom, MD, PhD – National Cancer Center ### 2211856###Author###Professor###National Cancer Center###
Author: Bang Wool Eom, MD, PhD – National Cancer Center
### @@@ Hye Seong Ahn, MD, PhD – Boramae Medical Center ### 2211857###Author###Professor###Boramae Medical Center###
Author: Hye Seong Ahn, MD, PhD – Boramae Medical Center
### @@@ Taeil Son, MD, PhD – Yonsei University Severance Hospital ### 2211858###Author###Professor###Yonsei University Severance Hospital###
Author: Taeil Son, MD, PhD – Yonsei University Severance Hospital
### @@@ Kyo Young Song, MD, PhD – Catholic University Seoul St. Mary’s Hospital ### 2211859###Author###Professor###Catholic University Seoul St. Mary’s Hospital###
Author: Kyo Young Song, MD, PhD – Catholic University Seoul St. Mary’s Hospital
### @@@ Han Hong Lee, MD, PhD – Catholic University Seoul St. Mary’s Hospital ### 2211860###Author###Professor###Catholic University Seoul St. Mary’s Hospital###
Author: Han Hong Lee, MD, PhD – Catholic University Seoul St. Mary’s Hospital
### @@@ Min-Gew Choi, MD, PhD – Samsung Medical Center ### 2211861###Author###Professor###Samsung Medical Center###
Author: Min-Gew Choi, MD, PhD – Samsung Medical Center
### @@@ Ji Yeong An, MD, PhD – Samsung Medical Center ### 2211862###Author###Professor###Samsung Medical Center###
Author: Ji Yeong An, MD, PhD – Samsung Medical Center
### @@@ Sang-Il Lee, MD, PhD – Chungnam National University Hospital ### 2211863###Author###Professor###Chungnam National University Hospital###
Author: Sang-Il Lee, MD, PhD – Chungnam National University Hospital
### @@@ Sang Hyub Lee, MD, PhD – Seoul National University Hospital ### 2211864###Author###Professor###Seoul National University Hospital###
Author: Sang Hyub Lee, MD, PhD – Seoul National University Hospital
###
96: Targeting Gastric Cancer Metastatic Lymph Nodes with a NIR-fluorescent anti-CEA Antibody Enables Their Identification for Resection in Orthotopic Mouse Models

Kristin Cox, MD (she/her/hers) – Department of Surgery, University of California San Diego, La Jolla, CA ### 1849738###Abstract Presenter###Resident Physician###Department of Surgery, University of California San Diego, La Jolla, CA###
Abstract Presenter: Kristin Cox, MD (she/her/hers) – Department of Surgery, University of California San Diego, La Jolla, CA
### she/her/hers @@@ Kristin Cox, MD (she/her/hers) – Department of Surgery, University of California San Diego, La Jolla, CA ### 1849738###Submitter###Resident Physician###Department of Surgery, University of California San Diego, La Jolla, CA###
Submitter: Kristin Cox, MD (she/her/hers) – Department of Surgery, University of California San Diego, La Jolla, CA
### she/her/hers @@@ Kristin Cox, MD (she/her/hers) – Department of Surgery, University of California San Diego, La Jolla, CA ### 1849738###Author###Resident Physician###Department of Surgery, University of California San Diego, La Jolla, CA###
Author: Kristin Cox, MD (she/her/hers) – Department of Surgery, University of California San Diego, La Jolla, CA
### she/her/hers @@@ Siamak Amirfakhri, PhD – VA San Diego Healthcare System, San Diego, CA ### 1849739###Author###Post-doctoral research scientist###VA San Diego Healthcare System, San Diego, CA###
Author: Siamak Amirfakhri, PhD – VA San Diego Healthcare System, San Diego, CA
### @@@ Thinzar M. Lwin, MD (she/her/hers) – Department of Surgical Oncology, City of Hope National Medical Center, Duarte, CA ### 1849921###Author###Assistant Professor###Department of Surgical Oncology, City of Hope National Medical Center, Duarte, CA###
Author: Thinzar M. Lwin, MD (she/her/hers) – Department of Surgical Oncology, City of Hope National Medical Center, Duarte, CA
### she/her/hers @@@ Pradipta Ghosh, MD – Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA ### 1849843###Author###Professor###Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA###
Author: Pradipta Ghosh, MD – Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA
### @@@ Marygorret Obonyo, PhD – Department of Medicine, University of California San Diego, La Jolla, CA ### 1849844###Author###Associate Professor###Department of Medicine, University of California San Diego, La Jolla, CA###
Author: Marygorret Obonyo, PhD – Department of Medicine, University of California San Diego, La Jolla, CA
### @@@ Robert Hoffman, PhD – AntiCancer Inc., San Diego CA ### 1849741###Author###Scientist###AntiCancer Inc., San Diego CA###
Author: Robert Hoffman, PhD – AntiCancer Inc., San Diego CA
### @@@ Paul Yazaki, PhD – Department of Immunology and Theranostics, Beckman Research Institute of the City of Hope, Duarte, CA ### 1849742###Author###Professor###Department of Immunology and Theranostics, Beckman Research Institute of the City of Hope, Duarte, CA###
Author: Paul Yazaki, PhD – Department of Immunology and Theranostics, Beckman Research Institute of the City of Hope, Duarte, CA
### @@@ Michael Bouvet, MD – Department of Surgery, University of California San Diego ### 1849743###Author###Professor###Department of Surgery, University of California San Diego###
Author: Michael Bouvet, MD – Department of Surgery, University of California San Diego
###
C
2024 Clinical Investigator and Young Investigator Awards
S
2021-2023 Clinical Investigator Award

Christina L. Roland, MD MS – The University of Texas MD Anderson Cancer Center ### 894415###Presenter###Associate Professor of Surgical Oncology###The University of Texas MD Anderson Cancer Center###
Presenter: Christina L. Roland, MD MS – The University of Texas MD Anderson Cancer Center
###
2022-2024 Clinical Investigator Award

Carlos Chan, MD, PhD – Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA USA ### 2213154###Presenter###Associate Professor###Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA USA###
Presenter: Carlos Chan, MD, PhD – Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA USA
###
2022 Young Investigator Award-ACPMP

Georgios Karagkounis, MD – Memorial Sloan Kettering Cancer Center ### 1850126###Presenter###Assistant Attending###Memorial Sloan Kettering Cancer Center###
Presenter: Georgios Karagkounis, MD – Memorial Sloan Kettering Cancer Center
###
2022 Young Investigator Award

Emily Z. Keung, MD (she/her/hers) – The University of Texas MD Anderson Cancer Center ### 969506###Presenter###Assistant Professor of Surgical Oncology###The University of Texas MD Anderson Cancer Center###
Presenter: Emily Z. Keung, MD (she/her/hers) – The University of Texas MD Anderson Cancer Center
### she/her/hers